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Abstract
Systematic review of the psychological consequences of 
false-positive screening mammograms
M Bond,1* T Pavey,1 K Welch,2 C Cooper,1 R Garside,1 S Dean1 and C Hyde1
1Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK
2Karen Welch Information Consultancy, Fareham, Hampshire, UK
*Corresponding author
Background: In the UK, women aged 50–73 years are invited for screening by mammography every 
3 years. In 2009–10, more than 2.24 million women in this age group in England were invited to take part 
in the programme, of whom 73% attended a screening clinic. Of these, 64,104 women were recalled for 
assessment. Of those recalled, 81% did not have breast cancer; these women are described as having a 
false-positive mammogram.
Objective: The aim of this systematic review was to identify the psychological impact on women of false-
positive screening mammograms and any evidence for the effectiveness of interventions designed to 
reduce this impact. We were also looking for evidence of effects in subgroups of women.
Data sources: MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, EMBASE, Health 
Management Information Consortium, Cochrane Central Register for Controlled Trials, Cochrane Database 
of Systematic Reviews, Centre for Reviews and Dissemination (CRD) Database of Abstracts of Reviews of 
Effects, CRD Health Technology Assessment (HTA), Cochrane Methodology, Web of Science, Science 
Citation Index, Social Sciences Citation Index, Conference Proceedings Citation Index-Science, Conference 
Proceeding Citation Index-Social Science and Humanities, PsycINFO, Cumulative Index to Nursing and Allied 
Health Literature, Sociological Abstracts, the International Bibliography of the Social Sciences, the British 
Library’s Electronic Table of Contents and others. Initial searches were carried out between 8 October 2010 
and 25 January 2011. Update searches were carried out on 26 October 2011 and 23 March 2012.
Review methods: Based on the inclusion criteria, titles and abstracts were screened independently by 
two reviewers. Retrieved papers were reviewed and selected using the same independent process. Data 
were extracted by one reviewer and checked by another. Each included study was assessed for risk of bias.
Results: Eleven studies were found from 4423 titles and abstracts. Studies that used disease-specific 
measures found a negative psychological impact lasting up to 3 years. Distress increased with the level of 
invasiveness of the assessment procedure. Studies using instruments designed to detect clinical levels of 
morbidity did not find this effect. Women with false-positive mammograms were less likely to return for 
the next round of screening [relative risk (RR) 0.97; 95% confidence interval (CI) 0.96 to 0.98] than those 
with normal mammograms, were more likely to have interval cancer [odds ratio (OR) 3.19 (95% CI 2.34 to 
4.35)] and were more likely to have cancer detected at the next screening round [OR 2.15 (95% CI 
1.55 to 2.98)].
Limitations: This study was limited to UK research and by the robustness of the included studies, which 
frequently failed to report quality indicators, for example failure to consider the risk of bias or 
confounding, or failure to report participants’ demographic characteristics.
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Conclusions: We conclude that the experience of having a false-positive screening mammogram can 
cause breast cancer-specific psychological distress that may endure for up to 3 years, and reduce the 
likelihood that women will return for their next round of mammography screening. These results should be 
treated cautiously owing to inherent weakness of observational designs and weaknesses in reporting. 
Future research should include a qualitative interview study and observational studies that compare generic 
and disease-specific measures, collect demographic data and include women from different social and 
ethnic groups.
Study registration: PROSPERO: CRD42011001345.
Funding: The National Institute for Health Research Health Technology Assessment programme.
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Executive summary
Background
Description of the health problem
In 1988, the NHS introduced a national breast screening programme (NHSBSP) for women aged 
50–64 years in response to recommendations by the Forrest Committee. In 2001, the age range was 
expanded to 50–70 years, and currently it is being extended to 47–73 years. In the UK, women are invited 
for mammography every 3 years.
Rate of uptake
The Health and Social Care Information Centre’s most recent statistics (2009–10) show that, in England, 
# 2.24 million women in this age group were invited to take part in the programme, of whom 73.2% 
attended a screening clinic. Response rates varied according to previous screening history, with previous 
attenders being more likely to reattend (87.2%) than those who had received their first invitation (69.0%). 
Of the 1,639,953 women (aged 50–70 years) who attended screening in 2009–10 in England, 64,104 
(3.9%) were recalled for further assessment. This included mammography, ultrasound, cytology, fine-
needle aspiration (FNA), core biopsy and/or open biopsy of tissue. Another 1089 (0.07%) women were 
put on early recall and invited for screening 6 or 12 months later. Of the 64,104 women recalled, 12,525 
(19.5%) were diagnosed with cancer. Thus, 51,579 women of those recalled did not have breast cancer 
in 2009–10 (80.5% of those recalled and 3.1% of those screened). It is this group of women who are the 
subject of this systematic review.
Definition of false-positive mammogram
For the purposes of this study, the definition of a false-positive mammogram is that given by the World 
Health Organization (WHO): ‘an abnormal mammogram (one requiring further assessment) in a woman 
ultimately found to have no evidence of cancer’.
Objectives
The aim of this research was to identify the psychological impact on women of false-positive screening 
mammograms and any evidence for the effectiveness of interventions designed to reduce this impact.
The questions that this systematic review will address are:
1. What evidence is there for medium- or long-term adverse psychological consequences from false-
positive screening mammograms (# 1 month after assessment)?
i. Do the types of psychological consequences differ between different groups of women?
2. What evidence is there of interventions that reduce adverse psychological consequences?
Methods
The systematic review was carried out following the principles published by the NHS Centre for Reviews 
and Dissemination (CRD). The study protocol can be viewed at http://www.hta.ac.uk/2510.
Inclusion and exclusion criteria
The inclusion and exclusion criteria for this systematic review are summarised as follows:
NIHR Journals Library
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Inclusion criteria
Population (questions 1 and 2)
 z Women who had received a positive result from routine mammography screening in the UK and had 
been invited for further assessment which showed that they did not have breast cancer.
Interventions (question 2)
 z Interventions delivered to individuals to address the adverse psychological and behavioural 
consequences of a false-positive mammogram result.
Comparators (questions 1 and 2, respectively)
 z Women who had received a negative (normal) result from routine mammography screening in the UK.
 z Absence of an individual intervention in the same population.
Outcomes (questions 1 and 2)
 z Psychological and behavioural outcomes and those from qualitative studies.
Setting (questions 1 and 2)
 z UK.
Study design (questions 1 and 2)
 z Systematic reviews, randomised, non-randomised, observational and qualitative studies.
Length of follow-up (questions 1 and 2)
At least 1 month from the ‘all-clear’.
Language (questions 1 and 2)
 z English language only.
Exclusion criteria
 z The following types of studies were excluded: narrative reviews, editorials, opinion pieces, non-
English-language papers, individual case studies and studies only reported as posters or abstracts with 
insufficient information to assess study quality.
Identification of studies and search strategies
The search strategy comprised the following main elements:
 z electronic bibliographic databases
 z internet searches
 z scrutiny of references (included studies)
 z contacting experts in the field.
The following electronic databases were searched in December 2010: MEDLINE, MEDLINE In-Process & 
Other Non-Indexed Citations, EMBASE, Health Management Information Consortium (HMIC), Cochrane 
Central Register for Controlled Trials, Cochrane Database of Systematic Reviews, CRD Database of Abstracts 
of Reviews of Effects, CRD Health Technology Assessment (HTA), Cochrane Methodology, Web of Science, 
Science Citation Index, Social Sciences Citation Index, Conference Proceedings Citation Index-Science, 
Conference Proceeding Citation Index-Social Science and Humanities, PsycINFO, Cumulative Index to 
Nursing and Allied Health Literature (CINAHL), Sociological Abstracts, the International Bibliography of the 
Social Sciences (IBSS) and the British Library’s Electronic Table of Contents.
Ongoing trials were searched for at the UK Clinical Research Network, ControlledTrials.com, ClinicalTrials.
gov, the WHO International Clinical Trials Registry Platform and the UK Database of Uncertainties about the 
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Effects of Treatments. A filter was applied to capture qualitative research as well as quantitative designs. 
Further searches for qualitative and grey literature were run in January 2011 on the following databases: 
MEDLINE In-Process & Other Non-Indexed Citations, EMBASE Classic and EMBASE, British Nursing Index 
and Archive, Social Policy and Practice, CINAHL plus, The Cochrane Library, HMIC, PsycINFO, Applied 
Social Sciences Index and Abstracts, Sociological Abstracts, Web of Science, CRD and IBSS. All searches 
were run from inception to the search date. Bibliographies of included studies were searched for further 
relevant studies, including forwards and backwards chasing of citations. References were managed using 
Reference Manager version 11 (Thomson ResearchSoft, San Francisco, CA, USA) and EPPI-Reviewer 4 
(Evidence for Policy and Practice Information and Co-ordinating Centre, University of London, London, UK). 
Update searches were carried out on 26 October 2011 and 23 March 2012; no new includable studies 
were found.
Study selection
Using the above inclusion/exclusion criteria, papers for review were selected independently by two 
reviewers from the titles and abstracts generated by the search strategy. Discrepancies were resolved by 
discussion, with the involvement of a third reviewer if necessary. Retrieved papers were reviewed and 
selected against the inclusion criteria by the same independent process.
Data extraction
Data regarding study design, participants, methods, outcomes, baseline characteristics and results were 
extracted from included studies by one reviewer using standardised data extraction forms (and checked by 
another reviewer). Study authors were contacted to provide missing information, as necessary.
Assessment of bias
Studies were assessed for internal and external validity according to criteria suggested by the NHS CRD 
Report No. 4, according to study type. Quality was evaluated using the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement for systematic reviews, the Consolidated 
Standards of Reporting Trials statement for randomised controlled trials (RCTs) and the Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) guidelines for observational studies.
Data analysis and synthesis
The main method of analysis was a narrative synthesis. Additional analyses were carried out using MedCalc 
v12 (MedCalc Software, Mariakerke, Belgium) software. The principal summary measure was relative risk 
(RR) with 95% confidence intervals (CIs).
Observational studies had possible sources of heterogeneity explored through assessment of the studies’ 
populations, methods and interventions before any meta-analysis was attempted. The heterogeneity of the 
data did not permit meta-analysis.
Results
Number and quality of studies
We retrieved 4423 titles and abstracts, of which five systematic reviews, one meta-analysis and 11 primary 
studies met our inclusion criteria. None of these was about (or had subgroups of) women from different 
ethnic, socioeconomic or other groups within the general screening population. One study was found 
of women who had a false-positive mammogram and a family history of breast cancer (FHBC). One 
qualitative study, published only as a poster, was found.
The primary research was of variable quality, with one poor-quality RCT of an intervention and 
10 observational studies. Although some studies were reasonably well reported, the majority had reporting 
weaknesses, including failure to report participants’ demographic and other characteristics and failure to 
consider the possible effects of bias and confounding on the results. Indeed, in most cases, there was no 
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consideration of the study’s methodological limitations. Therefore, the results of this systematic review 
must be treated with caution, because they are based on observational studies, many of which also lack 
methodological robustness.
Summary of results
General population
The studies of the psychological impact of false-positive mammograms in the general population gave 
conflicting results. When disease-specific measures were used [Psychological Consequences Questionnaire 
(PCQ)] an enduring negative impact was found, lasting until 35 months from the last assessment, and 
greatest at 5 months after the assessment (irrespective of assessment procedure). The degree of distress 
was related to the level of invasiveness of the assessment procedure: at 35 months, women who had 
a biopsy were more distressed (RR 2.07; 95% CI 1.22 to 3.52) than women who had (FNA) [RR 1.80 
(95% CI 1.17 to 2.77)]; and, non-significantly, further mammography (RR 1.28; 95% CI 0.82 to 2.00). 
Women placed on early recall also had a greater RR of distress (RR 1.82; 95% CI 1.22 to 2.72). Conversely, 
when generic measures of clinical levels of general anxiety and depression were used [Hospital Anxiety 
and Depression Scale (HADS) and General Health Questionnaire-28], no significant differences were found 
between the two groups at 6 weeks after assessment and 3 months after screening.
Therefore, it may be reasonable to speculate that, for those in the general population, a false-positive 
mammogram may lead to breast cancer-specific psychological distress, enduring for up to 3 years, but it is 
unlikely that general anxiety will be detectable at clinically measurable levels.
Family history of breast cancer population
Results were slightly different for this population, with psychological distress in the false-positive group 
statistically significantly greater than in the normal group only at 1 month after screening (negative 
PCQ, difference in means 2.92; 95% CI 4.05 to 1.69). At the same time, the false-positive group also 
scored significantly higher on the positive PCQ than those with normal mammograms (Mann–Whitney 
U-test 51,561; p ! 0.05). They also rated the benefits of screening more highly than those with normal 
mammograms at 1 month (T2) and 6 months (T3) after screening on an ad hoc questionnaire [T2: odds 
ratio (OR) 3.17; 95% CI 2.14 to 4.70; T3: OR 2.35; 95% CI 1.53 to 3.61]. These results may appear to be 
conflicting, but the summary results from the unpublished interview study suggest that the women in the 
false-positive group may have been rationalising their anxiety at being recalled by reassuring themselves 
that this meant that the programme was thorough and would detect early cancer that could be treated.
Impact of a false-positive mammogram on returning for routine screening
The evidence for the impact of having a false-positive mammogram on returning for the next screening 
round is conflicting. It comes mainly from four retrospective observational studies that collected data 
from registries and other NHS databases. The weight of evidence, in terms of the numbers of participants, 
suggests that women with false-positive mammograms are less likely to return for screening than women 
with normal mammograms. The largest study with this finding (n = 140,387) had a RR of returning of 
0.97 (95% CI 0.96 to 0.98). Two studies with a combined population of 7231 found that there was no 
such association. Evidence from a poor-quality RCT suggests that this finding can be reversed if women are 
given screening invitation letters that are tailored to the outcome of their last screening (RR of returning 
1.10; 95% CI 1.00 to 1.21).
Interventions to reduce the impact of false-positive mammograms
We did not find any studies that directly addressed this problem. Nevertheless, we identified two studies 
that investigated the information and communication needs of women who were recalled, with women 
wanting clear information about the reasons for recall, what their assessment would involve, and access 
to a breast care nurse or clinical nurse specialist (CNS) to talk through their concerns. Service satisfaction 
increased if women were sent a recall leaflet with their letter as participants believed that this increased 
their understanding of what would happen at the assessment clinic. The importance of the language used 
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in the recall literature was also evident with particular words and phrases reducing or increasing stress. The 
research by the Oxford Primary Care Education Research Group (OPCERG) was used to produce national 
guidelines (1998) on improving the quality of written information sent to women who are recalled 
for assessment.
Our results agree with those of previous systematic reviews and meta-analyses, particularly with 
the assertion that there can be negative psychological consequences from having a false-positive 
mammogram. However, we were unable to find evidence of general anxiety at clinical levels.
Additionally, it should be noted that a study by McCann et al. (n = 140,387) found that women with 
false-positive mammograms were at three times greater risk of interval cancer than those with normal 
mammograms (OR 3.19; 95% CI 2.34 to 4.35), and were more than twice as likely to have cancer detected 
at the next screening round (OR 2.15; 95% CI 1.55 to 2.98).
Strengths and limitations
The strengths of this systematic review are that it was conducted by an independent research team using 
robust methods. Comprehensive searches make it likely that we have retrieved all includable studies. Our 
systematic review may have been influenced by publication bias. However, there were insufficient studies in 
each domain to produce a meaningful funnel plot.
The robustness of the findings of this systematic review is limited by the reliability of the included studies. 
With the exception of one weak RCT, all the studies were observational and so subject to the risks of 
bias and confounding associated with these designs. This was compounded by lack of reporting key 
information such as the baseline characteristics.
Conclusions
We conclude that the experience of having a false-positive screening mammogram, in the general risk of 
breast cancer population, can cause breast cancer-specific psychological distress that may endure for up to 
3 years. However, it is less likely that there will be general anxiety detectable at clinically recognisable levels. 
The likelihood of women experiencing distress may be determined by the degree of invasiveness of the 
assessment procedure, with more invasive techniques increasing the probability of psychological distress.
The strongest evidence suggests that the distress caused by a false-positive mammogram may be sufficient 
to deter an additional 3% of women from attending their next breast cancer screening appointment.
It is important to provide recalled women with clear, carefully worded information about the reason for 
the assessment and process of the assessment (but not in such detail that they become distressed without 
the support of the screening staff being present), and to make available a breast care nurse or CNS to 
talk to.
There is some evidence that having a subsequent round of screening invitation that refers to the outcome 
of the previous screening round may encourage women with false-positive mammograms to reattend.
For women with a FHBC, a false-positive mammogram, although increasing levels of distress, may also 
provide reassurance that early cancer can be detected and treated.
Research priorities
Up-to-date studies are needed that reflect current screening practice.
1. A qualitative interview study of the general population of women who have had false-positive 
screening mammograms, in order to understand what this experience means to them.
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2. Well-designed observational studies, in the general screening population, that use disease-specific 
and generic outcome measures in order to determine the level of severity of negative psychological 
outcomes. Including studies of women from different ethnic and socioeconomic groups.
3. The routine collection of demographic information in observational studies so that future systematic 
reviews may be able to judge whether or not the pooling of data is possible.
4. Currently there is no standard national recall letter following a suspicious screening mammogram. 
There should be a national survey of the recall literature sent out from NHSBSP services to see if the 
national guidelines produced in 1998 are being adhered to, followed by the development of such 
a letter.
5. There is some evidence to suggest that there may be a relationship between tailored invitation letters 
for the next screening round for women who have had false-positive mammograms and reattendance. 
A well-designed RCT would be able to help us understand whether or not this relationship exists and a 
nested qualitative study would give insight into the important features of such a letter.
6. Developmental and pilot work of interventions both to relieve the distress of false-positive 
mammograms and to encourage women with this outcome to reattend routine screening. 
Promising interventions should then be tested in well-designed RCTs sufficiently powered to allow for 
subgroup analysis.
Study registration
This study is registered as PROSPERO: CRD42011001345.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National 
Institute for Health Research. 
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Chapter 1 Background
Description of the health problem
In 1988, the NHS introduced a national breast screening programme (NHSBSP) for women aged 
50–64 years in response to recommendations by the Forrest Committee.1 In 2001, the age range was 
extended to women aged 50–70 years, currently it is being expanded to women aged 47–73 years. In the 
UK, women are invited for routine screening by mammography every 3 years.
Rate of uptake
The most recent statistics from the Health and Social Care Information Centre show that in 2009–10 more 
than 2.24 million women in this age group in England were invited to take part in the programme, of 
whom 73.2% attended a screening clinic.2 The rate of response varied according to the history of previous 
screening. Women who had previously attended routine screening were more likely to reattend (87.2%) 
than those who had received their first invitation (69.0%).2 Of the 1,639,953 women (aged 50–70 years) 
who attended for routine breast screening in 2009–10 in England, 64,104 (3.9%) were recalled for further 
assessment. This included additional mammography, ultrasound, cytology, fine-needle aspiration (FNA), 
core biopsy and/or open biopsy of tissue. Another 1089 women (0.07%) were put on the early recall 
system and invited for further screening 6 or 12 months later.2 Of the 64,104 women recalled, 12,525 
(19.5%) were diagnosed with cancer through routine screening in England in 2009–10. Thus, 51,579 
women of those recalled did not have breast cancer in 2009–10 (80.5% of those recalled and 3.1% of 
those screened). It is this group of women who are the subject of this systematic review.
Definition of false-positive mammogram
For the purposes of this study the definition of a false-positive mammogram is that given by the World 
Health Organization (WHO): ‘an abnormal mammogram (one requiring further assessment) in a woman 
ultimately found to have no evidence of cancer’.3 This definition is rejected by some clinicians because 
having a positive screening mammogram is not a diagnosis of cancer in itself, but an indication that 
further assessment is needed. Nevertheless, for the purposes of this systematic review it is necessary to use 
the definition most commonly adopted in academic journals.
Incidence of breast cancer
Breast cancer is the most common cancer in the UK, with 48,034 new diagnoses in 2008.4 It accounts 
for 31% of all cancers in women, with a one in nine lifetime risk.4 The incidence of breast cancer in the 
separate countries within the UK can be seen in Table 1.
The number of cases of breast cancer in women has been steadily increasing in the UK over the last 
30 years, with the annual incidence rising from 24,120 in 1978 to 47,693 in 2007. When the age of the 
women is standardised, the European age-standardised incidence rate increased by more than half (57%) 
over this time, from 77 per 100,000 in 1978 to 124 per 100,000 in 2008.4 However, since the introduction 
of the national screening programme in 1988, the mortality rate has declined (Figure 1).
The rise in incidence has been greatest in women in higher socioeconomic groups.5 It is thought that this 
may be linked to their greater use of hormone replacement therapy for menopausal symptoms6 and the 
trend for having babies later in life.7
When the figures are broken down by age, the effects of the screening programme can be seen by the 
sharp increase in incidence over this time among women aged 50–64 years.8–10 The screening programme 
will detect cancers that would not have been noted in the patient’s lifetime (overdiagnosis) and will bring 
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forward the date of identification of cancer, finding it at an earlier stage, thus producing lead-time bias 
(Figure 2).
Mortality from breast cancer
The magnitude of the effect of mammography screening on breast cancer mortality is highly contested. 
Statistics for mortality from breast cancer in England are not available for 2009–10, but in 2008 a little 
over 10,000 women died from this disease, a rate of 26 per 100,000.11 It can be shown that mortality 
from breast cancer began to decline in England at about the same time that the national breast screening 
programme was introduced, from about 40 per 100,000 to about 26 per 100,000 in 2008.11 However, the 
exact effect that breast screening has had on breast cancer mortality is difficult to determine because it is 
hard to disaggregate the effects of improved treatments and other factors from the effects of screening.
However, a recent retrospective trend analysis by Autier et al.12 has attempted to do this. Autier et al.12 
compared breast cancer mortality trends in three pairs of neighbouring European countries using WHO 
data from 1989 to 2006. The pairs of countries had similar demographics, quality and availability of 
health care. They differed in when breast cancer screening was introduced, with one country introducing 
it in about 1990 and the other about 10–15 years later. Autier et al.12 calculated changes in breast cancer 
mortality using linear regressions of age-adjusted death rates. They found that although there was a wide 
difference in timing of the introduction of breast cancer screening in the pairs of countries there was a 
striking similarity in the rate of reduction of breast cancer mortality from 1990. They concluded that this 
reduction in breast cancer mortality was unlikely to have been the result of mammography screening. 
Similar findings have been replicated by the US Preventative Services Task Force,13 who have revised their 
TABLE 1 The number of new cases and rates of breast cancer in women in the UK, 20084
England Wales Scotland Northern Ireland UK
Cases (n) 39,681 2624 4232 1156 47,693
Crude rate per 100,000 
population
151.8 171.4 158.6 127.9 152.6
Age-standardised rate 
(European) per 100,000 
population (95% CI)
123.8 (122.6 
to 125.0)
128.4 (123.5 
to 133.4)
123.6 (119.8 to 
127.3)
116.6 (109.9 to 
123.3)
123.9 (122.8 to 
125.0)
0
20
40
60
80
100
120
140
19
75
19
77
19
79
19
81
19
83
19
85
19
87
19
89
19
91
19
93
19
95
19
97
19
99
20
01
20
03
20
05
20
07
Year of diagnosis/death
R
at
e 
p
er
 1
00
,0
00
 p
o
p
u
la
ti
o
n
Incidence
Mortality
FIGURE 1 Age-standardised European incidence and mortality rates for breast cancer in women, UK, 1975–2008.4
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endorsement of routine screening for women aged ! 50 years.13 In a letter to the British Medical Journal 
(BMJ), Bleyer14 presented a graph comparing US data with data from Autier et al.12 Bleyer14 concluded that 
improved treatment, rather than screening, is the main reason for the reduction in mortality.
This research by Autier et al.12 has been criticised by de Koning15 for being based on geographical 
comparisons which are unreliable and for the use of standardised all-age mortality. Further criticisms are 
that Autier et al.12 have not accounted for the delay in time from the introduction of screening to realising 
its benefits.
Furthermore, in a recent systematic review of breast screening randomised controlled trials (RCTs), 
Gotzsche and Nielsen16 (n = 600,000) estimated that breast screening led to a 15% reduction in breast 
cancer mortality, but, conversely, that there was also a 30% increase in overtreatment of women whose 
cancer would never become apparent in their lifetime.16 They estimated that, over 10 years, one woman 
would be saved from death by breast cancer for every 2000 women invited for screening. Additionally, 10 
healthy women who would have remained undiagnosed would have been treated unnecessarily for breast 
cancer. On top of this, for the same cohort, at least another 200 women would go through the possible 
distress of a false-positive outcome.16
Of the eight eligible trials in the Gotzsche and Nielsen review16 (New York 1963,17–19 Malmo 197620–22 and 
Malmo II 1978,23 Two–County 1977,24–26 Edinburgh 1978,27–29 Canada 1980,30–33 Stockholm 1981,34–37 
Goteborg 198238,39 and UK Age Trial 199140–44), one was excluded from meta-analysis because the 
randomisation was seriously flawed and the data held to be unreliable (Edinburgh 197828,29). Gotzsche and 
Nielsen16 found that only three of the remaining trials had adequate randomisation. Pooling the data from 
these trials revealed no statistically significant benefit from screening on breast cancer deaths after 7 years 
{relative risk (RR) 0.93 [95% confidence interval (CI) 0.79 to 1.09]} or after 10 years (RR 0.90; 95% CI 
0.79 to 1.02). When the data from these trials were combined with data from the other four suboptimally 
randomised trials, a statistically significant reduction in death from breast cancer was found after both 7 
and 13 years [RR 0.81 (95% CI 0.72 to 0.90) and RR 0.81 (95% CI 0.74 to 0.87), respectively]. The pooled 
data from the adequately randomised trials similarly showed that there was no significant effect from 
breast screening on all-cause mortality after 7 years (RR 0.98; 95% CI 0.94 to 1.03) and after 13 years 
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(RR 0.99; 95% CI 0.93 to 1.06).16 Gotzsche and Nielsen16 did not present data on all-cause mortality from 
all the included trials because the estimates were unreliable.
These results are controversial and a lively debate continues about the benefits and harms of breast 
cancer screening. Gotzsche and Nielsen’s16 findings have been heavily criticised by Kopans et al.,45,46 who 
claim that the reduction in breast cancer mortality due to screening is of the order of 20–25%. Others 
are also highly critical and have estimated the reduction in breast cancer due to screening to be as much 
as 30%.47,48 Indeed, one modelling study estimated the reduction in mortality due to screening to be 
between 28% and 65%.49 The best methods for arriving at an accurate estimate of mortality reduction are 
also contested.50 It is beyond the scope of this systematic review to attempt to resolve these differences. 
However, currently (2011), Professor Sir Mike Richards is undertaking a review to evaluate the benefits and 
harms of the NHS breast cancer screening services.
Significance for patients
The negative psychological impact of false-positive screening results has been documented in the fields of 
prenatal and cervical cancer screening.51,52 Their impact on the psychological well-being and behaviour of 
women who receive false-positive results from routine mammography has been less well researched and 
synthesised, particularly in the UK population.
A brief examination of observational studies, looking at the psychological consequences of false-positive 
mammograms, showed conflicting results. Some studies indicate that, while women show increased 
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distress between receiving the information about the need for a follow-up appointment and receiving the 
all-clear, in the longer term their anxieties about breast cancer and mammography are not increased.53–55 
Other studies report that there are long-term adverse psychological consequences to receiving a false-
positive mammogram.56,57 The outcomes of studies looking at whether or not having false-positive results 
affects future attendance at breast screening appointments are similarly conflicting.58–61
A quantitative systematic review in 2007 by Brewer et al.62 found that the impact of a false-positive 
mammogram on subsequent screening attendance varied with nationality, although the reasons for 
this were unclear. They also reported a varying impact on long-term psychological distress, anxiety and 
depression, and on other behaviours such as frequency of breast self-examination. However, their review 
did not report the reasons for this variation in response. Furthermore, Brewer et al.’s review62 found no 
statistically sound studies that investigated if anxiety over a false-positive mammogram directly affects 
whether or not women return for routine screening or increase breast self-examination. There was 
little evidence about the effects on quality of life or trust of health-care services and no evidence about 
whether or not women who felt anxious after a false-positive screening result replaced routine screening 
attendance with breast self-examination.
However, the significance of receiving a false-positive mammogram result may go beyond distress and 
other effects on behaviour. McCann et al.61 conducted a retrospective cohort study of 140,387 women, 
aged 49–63 years, attending NHSBSP routine screening clinics. They found that, among those women 
who were recalled for assessment which showed that they did not have cancer, the risk of interval cancer 
was increased more than threefold [rate per 1000 women screened, 9.6 (95% CI 6.8 to 12.4) compared 
with 3.0 (95% CI 2.7 to 3.4); odds ratio (OR) 3.19 (95% CI 2.34 to 4.35)] and these women were more 
than twice as likely to have cancer detected at their next routine screen in 3 years’ time [rate per 1000, 
8.4 (95% CI 5.8 to 10.9) vs 3.9 (95% CI 3.5 to 4.3); OR 2.15 (95% CI 1.55 to 2.98)]. This, of course, 
brings into question whether these women had false-positive or true-positive screening mammograms or 
whether or not something else explains these phenomena. It is beyond the scope of this systematic review 
to investigate this further.
Current related guidance
The following guidelines relate to this systematic review.
2011
NHS Breast Screening Programme 59: Quality Assurance Guidelines for Breast Cancer Screening 
Radiology.63 These guidelines aim to raise radiology standards in breast cancer screening and relate to the 
transition to full-field digital mammography and the extension of the invitation to screening to women 
aged 47–73 years in England. They include minimising the numbers of women who are recalled and, 
therefore, the numbers of false-positives.
2010
NHS Breast Screening Programme 49: Clinical Guidelines for Breast Cancer Screening Assessment.64 These 
guidelines set out minimum standards for breast cancer screening assessment. The guidelines state that 
this should be done using mammography or ultrasound, with clinical examination and image-guided 
biopsy if necessary. Women who are not diagnosed with cancer should receive written confirmation of 
the outcome.
2009
NHS Breast Screening Programme: Quality Assurance Guidelines for Surgeons in Breast Cancer Screening.65 
Among other guidelines for surgeons in breast cancer screening, these guidelines set out waiting-time 
targets for non-operative biopsy results to be given in ! 1 week and for the time between the decision to 
refer for surgical assessment and the surgery taking place to be f 1 week. They also aim to minimise the 
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numbers of benign diagnostic open surgical biopsies to ! 15 per 10,000, prevalent screen and quantity of 
tissue taken to f 20 g.
Current service provision
The UK NHSBSP is extending its service to invite women aged 47–73 years to attend for screening 
by mammography every 3 years. The purpose is to detect breast cancer in the general population. 
Contact details of eligible women are obtained through lists of registered patients by general 
practitioner (GP) surgery.
Mammography involves having an X-ray taken of the breasts. In the UK, two views are taken: craniocaudal 
(head-to-foot) and mediolateral oblique (angled side view). The mammogram is then read by two 
radiologists. Methods of resolving differences in opinion vary from unit to unit, but most commonly 
arbitration is used and a third radiologist will review the mammogram. If it is found to be normal, then 
the woman is put on routine recall and will receive another screening invitation in 3 years’ time. There 
may be technical problems with the quality of the film, in which case the woman will be recalled to have 
the technically inadequate views repeated. Alternatively, the mammogram may show a suspicious area 
and the woman will be recalled for further assessment. It takes a maximum of 2 weeks from having 
a mammogram until a letter with the normal results is received. If further assessment is needed, the 
appointment for this must be within 3 weeks of the initial mammogram.
The further assessment may include another mammogram, ultrasound or core biopsy with or without FNA. 
FNA employs a 21-gauge needle to remove cells which are then cytologically assessed; biopsy requires a 
larger 14-gauge needle, which allows histologists to see the architectural context within which cells are 
placed and so allows more accurate diagnosis. In the UK, the lesions found are graded on a system of 
increasing severity: B1 is normal, B2 is benign, B3 is suspicious but probably benign, B4 is suspicious and 
probably cancer and B5 is cancer. B5 is further subdivided into (a) non-invasive disease, most commonly 
ductal carcinoma in situ (DCIS), a non-invasive, obligate precursor to invasive breast cancer, but a lesion 
which may not develop into invasive cancer in the lifetime of the woman, which is situated in the milk 
ducts; and (b) invasive cancer. It is not possible yet to assess which cases of DCIS will progress to invasive 
cancer and which will not do so in the lifetime of any given woman. It is likely that many such lesions 
would not affect the woman’s lifespan. Furthermore, some lesions that are invasive may not progress to 
cause morbidity in the life of the individual woman. There is a debate over the amount of overdiagnosis, as 
this is described, that occurs.
If cancer is found, then the woman will be transferred from screening services to an oncology department. 
Treatment will normally be received within the NHS 62-day target from initial screening. It is usual to 
offer treatment for invasive cancer and non-invasive cancer as well as for many indeterminate lesions (B3 
and B4).
Throughout the screening and assessment process women should have access to a clinical nurse specialist 
(CNS) or breast care nurse, whose role is to educate, inform and support her in a manner which is 
sensitive and timely and recognises her need for safety, comfort and dignity.66 Women who are recalled 
are told in their letter that a breast care nurse will be available to talk to at the clinic or before the clinic 
by telephone if they have any concerns. Screening clinics, which may be some way from a hospital, do not 
routinely have breast care nurses on site. However, the invitation letter for screening will often mention the 
availability of a breast care nurse by telephone to allay any concerns.
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Research questions
The aim of this research was to conduct a systematic review to identify the psychological impact on 
women of false-positive screening mammograms and any evidence for the effectiveness of interventions 
designed to reduce this impact. This is necessary because there is uncertainty about the nature and 
magnitude of their psychological impact on women, including what the predictors are of negative 
psychological outcomes that may affect attendance at future mammography screening. There is also a 
need to identify whether or not these effects differ in women from different backgrounds. This research 
is important because of the large number of false-positive results that come from routine mammography 
screening (see above).
The questions that this systematic review will address are:
1. What evidence is there for medium or long-term adverse psychological consequences from false-
positive screening mammograms (# 1 month after assessment)?
i. Do the types of psychological consequences differ between different groups of women?
2. What evidence is there of interventions that reduce adverse psychological consequences?
Measurement of psychological consequences
A number of different measures of psychological morbidity are used in the primary research studies 
included in this systematic review. A brief summary of their characteristics is given below.
Disease specific
Psychological Consequences Questionnaire
The Psychological Consequences Questionnaire (PCQ)67 is a reliable and validated questionnaire that 
was developed specifically to measure the psychological consequences of mammography screening. It 
comprises two subscales, one consisting of 12 statements relating to possible negative consequences 
of mammography screening (i.e. how often in the past week the woman has experienced loss of sleep, 
change of appetite, feeling depressed, being scared, feeling tense, feeling under strain, being secretive, 
being irritable, withdrawing socially, having difficulty in doing ordinary activities at home and work or 
feeling worried about the future). The second subscale relates to potential benefits from screening and 
has 10 items covering feeling reassured, being able to cope better with everyday life, feeling less anxious 
about breast cancer, feeling more hopeful and a greater sense of well-being. The statements are scored on 
a four-point Likert scale ranging from not at all, rarely, some of the time to quite a lot of the time, with a 
range of 0–36 for the negative subscale and 0–30 for the positive subscale.
Cancer Worries Scale-Revised
The Cancer Worries Scale-Revised (CWS-R)68 is a six-item questionnaire that assesses the frequency of 
worries about developing cancer and how these worries affect daily mood and activities. It has been 
shown to be reliable and valid in at-risk populations.68–70 The items are scored on a four-point Likert scale 
ranging from 1 (not at all or rarely) to 4 (almost all of the time).
Generic
Brief COPE
This is a shortened version of the COPE scale, which was developed to assess people’s coping responses to 
stressful situations. The brief COPE71 has been used in breast cancer patients, although the work has not 
been published, and in hurricane survivors. The brief version has 28 items measuring a range of coping 
strategies (e.g. self-distraction, active coping, denial, substance use, emotional support, instrumental 
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support, disengagement, venting, positive reframing, planning, humour, acceptance, religion and 
self-blame).
General Health Questionnaire
The General Health Questionnaire (GHQ) was designed as a screening tool for psychiatric illness in the 
context of general practice or general medical outpatients (i.e. non-psychiatric settings).72 The GHQ covers 
the four domains of depression, anxiety, objectively observable behaviour and hypochondrias with 60 
items. This instrument looks at recent experience and elicits responses on a four-point Likert scale using 
the statements less than usual, no more than usual, rather more than usual and much more than usual. 
A number of shorter versions have been developed: GHQ-12, GHQ-20, GHQ-28 and GHQ-30.73 Items are 
scored 0–3 to give a total score or can be scored dichotomously with a particular threshold deemed to 
indicate that the respondent is ‘a case’.
Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) was developed to screen for psychiatric disorders in 
general hospital settings, excluding psychiatric wards.74 It has two subscales, anxiety and depression, which 
are measured with 14 items using a four-point Likert scale (0–3). The items are totalled to give an overall 
score for anxiety or depression. Respondents with a score of 8–10 are considered to be ‘doubtful cases’ 
and v 11 are considered to be ‘cases’.
Life Orientation Test-Revised
The Life Orientation Test75 is a validated measure of dispositional optimism. It has 10 items that are 
responded to on a five-point Likert scale, ranging from 0 (I strongly disagree) to 4 (I strongly agree).
State–Trait Anxiety Inventory
The State–Trait Anxiety Inventory (STAI) measures anxiety in adults as both a current state and an enduring 
trait.76 It consists of a 20-item scale of how the respondent feels in general and a 20-item scale of how 
they feel now. Each item is scored on a four-point scale that ranges from ‘not at all’ to ‘very much so’. 
Higher scores are related to higher anxiety.
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Chapter 2 Methods
The systematic review was carried out following the principles published by the NHS Centre for Reviews and Dissemination (CRD).77 The study protocol can be found in Appendix 1.
Methods for reviewing studies
Identification of studies and search strategy
The search strategy comprised the following main elements:
 z searching of electronic bibliographic databases
 z internet searches
 z scrutiny of references of included studies
 z contacting experts in the field.
The following electronic databases were searched in December 2010 for studies which met the inclusion 
criteria: MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, EMBASE, Health Management 
Information Consortium (HMIC), Cochrane Central Register for Controlled Trials, Cochrane Database of 
Systematic Reviews, CRD Database of Abstracts of Reviews of Effects, CRD Health Technology Assessment 
(HTA), Cochrane Methodology, Web of Science, Science Citation Index, Social Sciences Citation Index, 
Conference Proceedings Citation Index-Science, Conference Proceeding Citation Index-Social Science and 
Humanities, PsycINFO, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Sociological 
Abstracts, the International Bibliography of the Social Sciences (IBSS) and the British Library’s Electronic 
Table of Contents. Ongoing trials were searched for at: UK Clinical Research Network (UKCRN), 
ControlledTrials.com, ClinicalTrials.gov, WHO International Clinical Trials Registry Platform (ICTRP), UK 
Database of Uncertainties about the Effects of Treatments (DUETs), a filter was applied to capture 
qualitative research as well as quantitative designs. Further searches for qualitative and grey literature were 
run in January 2011 on the following databases: MEDLINE In-Process & Other Non-Indexed Citations, 
EMBASE Classic and EMBASE, British Nursing Index and Archive, Social Policy and Practice, CINAHL plus, 
The Cochrane Library, HMIC, PsycINFO, Applied Social Sciences Index and Abstracts, Sociological Abstracts, 
Web of Science, CRD and IBSS. All searches were run from inception to 25 January 2011. Bibliographies 
of included studies were searched for further relevant studies. References were managed using Reference 
Manager version 11 (Thomson ResearchSoft, San Francisco, CA, USA) and EPPI-Reviewer 4 (Evidence for 
Policy and Practice Information and Co-ordinating Centre, University of London, London, UK).
Initial searches were carried out between 8 October 2010 and 25 January 2011. Update searches were 
carried out on 26 October 2011 and 23 March 2012.
Refer to Appendix 2 for the search strategy for MEDLINE.
Inclusion criteria
The inclusion criteria for the systematic review are summarised in Table 2.
Exclusion criteria
The following types of studies were excluded: narrative reviews, editorials, opinion pieces, non-English-
language papers, individual case studies and studies only reported as posters or by abstract where there is 
insufficient information to assess the quality of the study.
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Study selection
Based on the above inclusion/exclusion criteria, papers were selected for review from the titles and 
abstracts generated by the search strategy. This was done independently by two reviewers (MB, TP); 
discrepancies were resolved by discussion, with the involvement of a third reviewer if necessary. Retrieved 
papers were again reviewed and selected against the inclusion criteria by the same independent process.
Data extraction
Data were extracted from included studies by one reviewer using standardised data extraction forms 
and checked by another reviewer. Authors of studies were contacted to provide missing information, as 
necessary. Data were gathered on the design, participants, methods, outcomes, baseline characteristics 
and results of the studies. The data extraction forms can be found in Appendix 3.
Critical appraisal – assessing risk of bias
Studies were assessed for internal and external validity according to criteria suggested by the updated NHS 
CRD Report No. 4, according to study type.77,78 The quality of systematic reviews was evaluated using the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.79 Individual RCTs 
were appraised with the Consolidated Standards of Reporting Trials (CONSORT) statement80 and individual 
observational studies with Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 
guidelines.81 There were insufficient studies in each domain to produce a meaningful assessment of 
publication bias with a funnel plot.
TABLE 2 Inclusion criteria
Question(s) Criteria Specification Notes
1 and 2 Population Women who had received a positive result 
from routine mammography screening in 
the UK and had been invited for further 
assessment which showed that they did not 
have breast cancer
Where data permitted we looked at 
subgroups (including socioeconomic status 
and ethnic group)
2 Intervention Those interventions delivered to individuals 
to address the adverse psychological and 
behavioural consequences of a false-positive 
mammogram result
These were individual interventions not 
group ones
1 Comparator Women who had received a negative 
(normal) result from routine mammography 
screening in the UK
2 Comparator An absence of an individual intervention in 
the same population
1 and 2 Outcomes Psychological and behavioural outcomes 
and those from qualitative studies
Including subsequent attendance at routine 
mammography screening and quality of life
1 and 2 Setting UK Secondary care
1 and 2 Study design Systematic reviews, randomised, non-
randomised, observational and qualitative 
studies
We did not consider individual case studies
1 and 2 Length of 
follow-up
At least 1 month from the ‘all-clear’ Measured over the medium- to long-
term (i.e. not the immediate response to 
receiving a false-positive result)
1 and 2 Language English language only Non-English-language papers were included 
in the searches and screened, so that the 
number of potentially includable foreign-
language papers is known
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Internal validity
Consideration of internal validity addresses how well potential sources of bias and confounding are 
acknowledged and accounted for. Bias can be characterised as potentially undermining an experimental 
study in four ways: through selection bias, so that the participants in each group are dissimilar; 
performance bias, where the treatment of the different groups varies apart from the intervention; 
detection bias, which can occur if the study assessors are aware of which groups participants are in; and 
attrition bias, where all participants are not fully accounted for or violations of the study protocol have 
occurred. In particular, checks of study internal validity should address the following: whether or not there 
is sufficient description of the inclusion criteria, outcomes, study design, setting and the intervention to 
ascertain that study groups were similar in all respects and were treated in similar ways except for the 
intervention; if a justification for the sample size is given; if appropriate data analysis techniques were 
used; if dropouts and withdrawals are accounted for; if the technique used to account for missing data is 
described and adequate; and if assessors were blind to the group status of participants.
Another threat to validity can come from confounding. This is where an unknown agent is acting 
independently on the outcome being measured and the matter under investigation, so that an association 
appears to be occurring between the outcome measure and the matter of interest, but which is an artefact 
of the independent relationships.
External validity
External validity was judged according to the ability of a reader to consider the applicability of findings to 
a patient group and service setting. Study findings can only be generalisable if they describe a cohort that 
is representative of the affected population at large. Studies that appeared representative of the UK breast 
cancer screening population with regard to these considerations were judged to be externally valid.
Methods for analysis and synthesis
Analysis
Analysis was carried out using StatSEv12 software (TX, USA). The principal summary measure was RR with 
95% CIs.
Synthesis
All study designs had a narrative synthesis. Additionally:
Randomised controlled trials and controlled trials There was only one RCT and no controlled trials.
Observational studies Observational studies had possible sources of heterogeneity carefully considered 
before any meta-analysis was attempted to avoid potentially spurious relationships being found. 
Heterogeneity was explored through assessment of the studies’ populations, methods and interventions. 
The heterogeneity of the data did not permit meta-analysis.

© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
13
Chapter 3 Results
Quantity of research available
Number and type of studies included
Electronic database searches were conducted between 8 October 2010 and 25 January 2011. The initial 
searches found 883 titles and abstracts after deduplication. When these were screened, 67 papers were 
requested for further review and two PhD theses were unobtainable. Of the 65 papers that were available, 
20 were found to meet the study inclusion criteria. Four of these were systematic reviews, one was a meta-
analysis and 15 were research papers; although a qualitative search filter was used, none of the papers 
had qualitative designs.
Further, more sensitive, qualitative searches were then conducted to see if they led to admissible studies. 
These searches yielded 2350 titles and abstracts after deduplication; when these had been screened 
14 papers were requested. The review of these papers led to the inclusion of three primary research papers 
and one more systematic review. One of these papers was a summary of a nested qualitative study from an 
included study; this had been published only as a conference poster. Contact with the author revealed that 
this study had not been published in full. No published qualitative studies were found.
In order to be certain that the search strategy was picking up all includable papers, a highly sensitive 
further scoping search of breast cancer (and breast cancer terms) and qualitative research [as a medical 
subject heading (MeSH)/EMTREE/controlled syntax term] or qualitative methods (free-text terms) and 
qualitative terms (free text) were used. This was followed by a further scoping search of the breast cancer 
terms with the qualitative cluster of terms. These searches produced an enormous number of titles and 
abstracts (n = 189,580). A sample of these was screened (n = 258) and no further includable studies 
were found.
A search for grey literature produced 13 titles after deduplication. One paper was retrieved but was 
subsequently excluded. Breast cancer charity websites were also searched; however, no includable papers 
were found.
After consultation with the information specialist (CC) it was decided to do a forwards chase of citations 
(n = 48) and a backwards chase of references (n = 50) from one of the included systematic reviews, by 
Brett et al.,82 to see if this was a more productive strategy for finding includable papers. This led to the 
retrieval of another eight papers, none of which were included. However, it was concluded that screening 
bibliographies and chasing citations of retrieved papers, together with contacting experts and authors, was 
more likely to produce includable studies than pursuing highly specific but extremely insensitive searches. 
This strategy is supported by Greenhalgh and Peacock,83 who found only 30% of includable studies 
through searches from protocol inclusion criteria. This approach produced no further includable papers.
Update searches were carried out on 26 October 2011 and 23 March 2012; no new includable studies 
were found. The search strategy is available in Appendix 2 and the updated search strategy is available 
from the authors.
In total, 24 papers were included (18 primary studies, five systematic reviews and one meta-analysis). 
The list of included papers was sent to experts in the field to confirm that there were no more relevant 
published papers; it was accepted that saturation had been obtained. A list of ongoing studies can be 
found in Appendix 4.
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No studies were found that were either about or that had subgroups of women from different ethnic, 
socioeconomic or other groups. One study was found of women who had a false-positive mammogram 
and had a family history of breast cancer (FHBC).
A flow chart of the selection process can be found in Figure 4. A list of papers excluded at the paper 
review stage with reasons for their exclusion is available in Appendix 5.
Titles yielded by database searches 6526
MEDLINE Ovid Scoping Search: 1950 to present 2357
MEDLINE In-Process-Ovid 98
EMBASE Classic EMBASE Ovid: 1947 to 2010 2672
HMIC Ovid (Health Management Information Consortium) 58
Health (Leeds University Library), King's Fund Library; 1983–2010
Source: UK Department of Health, Nuffield Institute for 2
Cochrane Central: all years 111
Cochrane CDSR: all years 7
CRD DARE: all years 17
CRD HTA: all years 8
Cochrane Methodology: all years 4
Science Citation Index Expanded: 1970 to present
Social Sciences Citation Index (SSCI): 1970 to present
Conference Proceedings Citation Index- Science (CPCI-S):
1990 to present
Conference Proceedings Citation Index- Social Science & 
Humanities (CPCI-SSH): 1990 to present
PsychINFO EBSCO: 1887–2010 152
Cinahl  EBSCO: 1981–2010 260
Sociological Abstracts CSA Illumina: 1952–2010 13
CSA Illumina: 1951–2010
British Nursing Index and Archive (BNI) 13
Social Policy and Practice (SPP) 3
Assia 78
CRD 245
Titles and abstracts screened after deduplication 4423
Excluded on title and abstract = 4328
Papers retrieved 95
Excluded on paper = 71
Population = 19
Intervention = 2
Comparator = 1
Outcomes = 13
Setting = 53
Design = 11
Length of follow-up = 2
Unobtainable = 3
Duplicate = 1
Language = 4
Papers included 24
Primary study papers = 18            (11 studies)                                            
Systematic reviews = 5                                                                   
Meta-analyses = 1
Web of Science: all years 406
International Bibliography of the Social Sciences (IBSS) 22
FIGURE 4 Flow chart of published evidence included in this systematic review.
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Quality of studies – study characteristics and risk of bias
Systematic reviews and meta-analyses
The searches identified five systematic reviews and one meta-analysis that partly or wholly addressed the 
research questions of this systematic review. It was decided to evaluate the quality of all these studies 
against PRISMA criteria which, although not designed as a quality assessment tool, can be used for the 
critical appraisal of systematic reviews and meta-analyses.79 Table 3 provides a summary of the inclusion 
criteria of these studies.
Overall, the quality of methods and reporting in these systematic reviews is not high. This is despite them 
being conducted in the post-QUORUM (quality of reporting of meta-analyses) and, in some cases, post-
PRISMA era. The exception to this is the review published by the UK HTA programme.84 The features most 
commonly missing are information about access to the study protocol, presentation or access to the full 
electronic searches and, more worryingly, consideration of the risk of bias both within and across studies. It 
seems that most authors were happy to accept the results of their included studies de facto, despite being 
largely observational with many opportunities for bias and confounding to affect the results. A summary 
of the quality of the included systematic review can be found in Table 4.
The most recent study is a meta-analysis of the detection of the psychological impact of false-positive 
screening mammograms by generic and disease-specific psychosocial measures by Salz et al.85 This is 
a secondary analysis of their previous systematic review data, published in 2007.62 The authors were 
interested in comparing the difference in sensitivity of generic and disease-specific outcome measures 
to detect the degree of well-being experienced by women who had received a false-positive screening 
mammogram. Their searches found 17 observational studies of women aged v 40 years that compared 
psychological outcomes between women who had had a false-positive mammogram with those whose 
screening results had been normal.
This meta-analysis has some weaknesses. There is no indication that any consideration of the risk of bias 
or confounding within or across studies was made, although the inclusion criteria and methods for study 
selection are clearly stated.
Additionally, Salz et al.85 do not account for the number of studies screened or provide a flow chart 
or details of the results of the individual studies they have included. In the results section, rather than 
present forest plots for each analysis, they present a table of pooled effect sizes for the different criteria of 
outcome (e.g. distress or depression). In the discussion, although they summarise their main findings, no 
comment was made on the strength of the findings or their limitations at study level.
This meta-analysis was preceded by Hafslund and Nortvedt,86 who conducted a systematic review, 
published in 2009, that looked at the impact on quality of life of mammography screening in women 
aged v 40 years, comparing those who received a false-positive result with those whose result was normal. 
Psychological measures were taken in the short to medium term. The authors found 17 observational 
studies, which were given a narrative synthesis.
Overall, this is a poor-quality systematic review. Although methods for assessing the risk of bias in 
individual studies are described, insufficient information is given about the data collection process and 
the kind of data to be collected. The results section gives an estimation of the risk of bias within studies 
but the results of individual studies are inadequately presented, with little summary data. There is no 
assessment of the risk of bias across studies. Although the review’s findings are summarised in the 
discussion, this is without relation to the strength of the evidence under review.
The systematic review by Brewer et al.62 is of reasonable quality. Brewer et al.62 were interested in the long-
term effects of false-positive screening mammograms on women’s attendance at their next routine breast 
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screening clinic. They were also interested in the impact on psychological outcomes, which they measured 
at least 1 month after the assessment. They found 23 observational studies that met their inclusion criteria.
The rationale and methods for conducting the study are well reported, with the notable exception of those 
for evaluating the risk of bias in individual studies, although methods for countering the cumulative effects 
of bias and assessing publication bias are given. Not surprisingly, the results section does not report the 
risk of bias within studies and the reporting of individual studies’ results for psychological outcomes is 
inadequate as only a vote-counting approach is taken. However, individual, summary and pooled data for 
reattendance at routine screening are presented. The discussion provides a good summary of the evidence 
and incorporates a consideration of the limitations of the review and its components, although the 
strength of the evidence is not reflected on.
In the same year (2007), Armstrong et al.87 published a systematic review with the aim of assessing the 
evidence of risks and benefits of screening mammography for women aged 40–49 years, but included a 
subgroup of women aged up to 71 years who had received false-positive results. This older population 
was compared with those with a normal screening outcome. They found 22 observational studies about 
false-positive mammograms.
Unfortunately, this is a poor-quality systematic review. The methods used are inadequately described with 
no mention of the outcomes included, methods of data synthesis or any assessment of the risk of bias 
across studies. The authors used a crude measure of study quality that is solely based on design, which 
does not consider risk of bias or confounding within studies. Furthermore, there is no indication that they 
have thought how bias might affect the validity of their results. The study results are particularly poorly 
reported; there is no account of the results of the study screening process, no results of assessment of 
risk of bias, inadequately described results of individual studies and a narrative synthesis almost devoid of 
quantified outcomes. The very brief discussion does not consider the review’s limitations at any level or 
offer an interpretation of the results with reference to other reviews.
A systematic review by Brett et al.82 was of better quality, although still lacking many of the markers 
of a good-quality systematic review. The authors aimed to assess the negative psychological impact of 
mammography screening and how long this lasted; this included the impact on women given the all-clear 
after screening as well as those with false-positive results. They found 52 observational studies that met 
their inclusion criteria.
The abstract and introduction are clear. However, the methods section is confusing to read as it contains 
paragraphs that should be in the introduction and results sections. The process of study selection is 
described, but there is no flow chart showing the progress of screening. Furthermore, the risk of bias 
affecting the results of individual studies or across studies is not considered in the methods or results 
sections. The findings of individual studies are given a comprehensive narrative summary. Recognition 
is given in the discussion to the shortcomings of some of the instruments used and that bias and 
confounding could have influenced the results. However, how this might relate to individual studies or the 
overall conclusions is not discussed.
The final systematic review that has been included is a good-quality HTA programme publication by 
Bankhead et al.84 This is a broad-ranging systematic review looking at the impact of several types of 
screening, including mammography, on health behaviours and beliefs. Bankhead et al.84 found 28 
observational studies that looked at women with false-positive mammography results.
The introduction and methods are clear and comprehensive and consideration is given to the risk of 
bias in individual studies. However, the risk of bias across studies is not mentioned. The results section, 
together with the tables in the appendices, gives a full account of the findings by outcome and study, 
although, again, the possible effects of risk of bias across studies are not reported. The discussion section 
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gives a clear and thorough summary of the findings and the limitations of the study with suggestions for 
further research.
Primary research
The searches returned 11 primary research studies (18 papers) that met the inclusion criteria (including 
being conducted in the UK). Four of the studies were prospective cohorts,59,101–106 one of these 
studies107 included a nested interview study but this was only published as a conference poster, four 
were retrospective cohorts,55,61,108,109 two had a cross-sectional design,110–113 one of these studies114 
produced national guidelines that contained research findings and one was a RCT115 of an intervention to 
improve reattendance.
Four studies looked at the psychological impact of false-positive mammograms in the normal-risk 
population.55,59,103–106 One study looked at the impact of having a false-positive screening mammogram 
among a population of women with a FHBC.101,102,107 Five studies looked at the impact on returning 
for routine mammography screening59,61,103,108,109,115 and two studies investigated the impact of written 
information on distress or reattendance.110–114
In some of the studies, groups of women were included with characteristics outside the scope of this 
systematic review; in these cases only data from the study population included in this review are extracted 
and reported.
Although worded slightly differently, the definition of woman with a false-positive mammogram is 
consistent in all of the included studies and agrees with the definition used in this systematic review (i.e. a 
woman who is recalled for assessment of any kind on the basis of a routine screening mammogram who is 
not then diagnosed with breast cancer).
This section first of all gives an overview of the relationship of the studies to each other according to 
their domain of interest (Figure 5). Some papers report outcomes in more than one domain and are 
therefore shown accordingly in Figure 5. After this, the characteristics and quality of the studies are 
discussed according to their domain. This is followed by a summary table of the characteristics of each 
paper (Table 5). Finally, a summary in Table 6 gives an overview of the quality of the observational studies. 
More detailed information about all the primary studies can be found in the data extraction forms in 
Appendix 3. A summary description of the measures used in the included primary research can be found in 
Chapter 1, Measurement of psychological consequences.
The UK research in the field of false-positive mammography screening has been dominated by the 
University of Oxford Primary Care Education Research Group (OPCERG) who first published a series of 
papers from 1997 about the information needs of women recalled for further assessment following a 
screening mammogram. This work then developed to investigate the psychological impact of false-positive 
mammograms on the general population of screened women and how this affected their reattendance 
at their next routine screening, and latterly looked at the psychological impact of receiving a false-positive 
mammogram on women who have a FHBC. Other research groups in England and Scotland have also 
studied these four aspects and in many cases preceded the Oxford research.
Psychological impact
The papers from the OPCERG study in this domain span 5 years, with measures being taken at 1 month 
(T1), 5 months (T2) and 35 months (T3) from the last screening appointment. This study is a multicentre 
prospective cohort at 13 NHSBSP clinics in England and Scotland. The papers follow the same cohort of 
women over this time but the methods used appear to vary at different time points and it is not always 
clear on what basis the women included in the study have been selected or how the main outcome 
measure, the PCQ, has been used. The study includes women with normal mammograms as the control 
group and compares them with women with false-positive outcomes according to the process used in 
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their further assessment (another mammogram, FNA or biopsy) or if they had been placed on early recall 
of 6 or 12 months following further assessment.
The first publication by OPCERG, by Ong et al.104 (n = 877), reported primarily on the adverse psychological 
consequences of being placed on early recall (6 or 12 months recall rather than 3 years) at T1. These 
effects were measured using the PCQ negative scale which has 12 items on a four-point Likert scale (scored 
0–3).67 Participants were considered to be ‘cases’ if they responded positively to at least one item.
The study by Ong et al.104 is a moderately good-quality study that used appropriate methods to address 
its aims. The authors reported almost all the key criteria specified by the STROBE statement.81 However, 
they omitted to provide demographic data for all participants, not just those on early recall, which makes 
it difficult to interpret the results. They also failed to fully discuss the limitations of their study and its 
generalisability to other situations.
Following on from the study by Ong et al.,104 Brett et al.103 (n = 284) recruited from the same pool of 
women to find out what difference, if any, a further 4 months had on how these women were feeling 
after their false-positive mammogram. This was also 1 month before those on early recall were due for 
another screening mammogram. In this prospective cohort study, the previous studies’ results (Ong et 
al.104) were used as the baseline measures for comparison with the same subgroups. This study only 
included 12 centres, as one centre did not put any women on early recall.
Although this was a fairly good-quality study,103 it did not quite meet the same standards of reporting as 
the previous one.104 Omissions include not considering potential sources of bias, giving an explanation of 
how missing data were handled and not providing demographic information.
The latest publication from OPCERG on the population at normal risk of breast cancer is by Brett and 
Austoker59 (n = 505). This study follows the same cohort of women as Brett et al.103 in 13 NHSBSP 
clinics in England and Scotland. They took measures of adverse psychological consequences with 
the PCQ at 35 months after participants’ last assessment (i.e. 1 month before their next routine 
screening mammogram was due). Brett and Austoker59 deemed that a total score # 12 (range 0–36) 
on the PCQ showed negative psychological consequences and so it is only the percentage of scores 
# 12 that are reported. It is not clear why they have chosen this total score as the cut-off point 
for showing psychological harm. The original validation paper by Cockburn et al.67 does not have 
this cut-off but indicates that the bottom quartile of scores represent no dysfunction, the second 
quartile mild psychological disturbance, the third quartile moderate disturbance and the top quartile 
marked disturbance.
Brett and Austoker59 also used an ad hoc questionnaire to measure satisfaction with the breast screening 
service and assess factors that may influence women’s level of anxiety. They also asked women about their 
intention to attend their next routine mammography screening. This last outcome was compared with 
their actual attendance.
Again, this is a generally well-described study but with similar omissions as before: no explanation of how 
missing data were dealt with or consideration of the role bias may have played in the results. However, 
they do provide some demographic information about the participants (marital status, home ownership 
and educational level).
Prior to the work by the Oxford team, Sutton et al.55 (n = 1021) conducted a retrospective cohort 
study that was primarily interested in the levels of anxiety experienced by women attending routine 
mammography screening who had normal outcomes. However, they also looked at anxiety levels in 
women who had false-positive results. Nine months after the pre-screening baseline, they asked these 
women and others with normal results to retrospectively reflect on how anxious they had felt at six stages 
of the screening process: (1) receiving the invitation; (2) waiting at the clinic for the mammogram; (3) at 
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the clinic after the mammogram; (4) waiting for the results; (5) after reading the results letter; and (6) 
now. These measures were taken on a three-point ad hoc scale, ranging from not anxious (1), a bit anxious 
(2) to very anxious (3). The retrospective results are only reported numerically at stages 3–5, therefore 
these data have been extracted. The data at other time points are reported in graphical form only and so 
could not be reliably extracted.
The baseline measures were taken using different measures (STAI76 and the GHQ72); however, the results of 
the women with false-positive mammograms are not disaggregated from the rest of the participants and 
so are not reportable.
This is a poorly designed and executed study. Initially, a cohort were recruited and followed up through 
the screening process. Additionally, another sample group was recruited which overlapped with the 
original sample group. A subset that contained participants from both groups was used for the main 
analysis (which compared women with normal mammograms with non-attenders and is therefore outside 
the scope of this review), while the whole of the first sample was used in the retrospective analysis of 
anxiety. There was no consideration of bias, confounding or the weakness of the design that relied on 
memory going back 9 months using an unvalidated measure. The results of the false-positive substudy 
are only partially numerically reported, the whole being shown in a figure that does not allow accurate 
disaggregation. Furthermore, there is no accounting of attrition or information about how missing data 
were dealt with. There is, however, acknowledgement that if they had used a disease-specific measure, 
such as the PCQ, they might have found different results.
Another similarly poor-quality study was conducted by Bull and Campbell106 in 1991 (n = 750). They 
followed a cohort of women who had attended mammography screening from their invitation to 
screening until 6 weeks after they had received the results of their follow-up assessment. The women 
were divided into four groups: (A) those invited for screening; (B) those with a normal mammogram; (C) 
those who went for further assessment with a mammogram, ultrasound or FNA; and (D) those who had 
a surgical biopsy for further assessment. The sample in groups A and B overlapped. However, no rationale 
is given for the design of the study. The outcomes measured were anxiety and depression using HADS,74 
frequency of breast self-examination and impressions of the screening programme using an open question 
in an ad hoc questionnaire.
This study had a number of reporting flaws; in particular, there was no comment on the possibility of 
bias from the design and conduct of the study, nor was there any explanation of how missing data were 
accounted for. The only description of the participants was their age and no information was given about 
attrition or reasons for this. The discussion speculates at length about possible reasons for the findings, 
but neglects to mention any limitations of the study. Bull and Campbell106 also fail to comment on the 
generalisability of their findings.
The prospective cohort study by Ellman et al.105 (n = 752) is of similarly poor quality. Ellman et al.’s105 aim 
was to compare the psychiatric morbidity experienced by women who had attended breast screening or a 
review clinic and had one of five results (group A, normal; group B, false-positive; group C, symptomatic 
with benign result; group D, symptomatic or recalled women who did have cancer; or group E, women 
with a history of breast cancer with or without symptoms). Only women in groups A and B were within 
the inclusion criteria of this systematic review and had their results reported. Morbidity was measured with 
GHQ-2872 either at the breast screening clinic (groups A and B) or the review clinic (groups C–E) before 
participants saw the clinician and was measured again 3 months later. An ad hoc questionnaire seeking 
opinions about the clinic and their experience of treatment was given to participants at follow-up.
Ellman et al.’s study105 failed to show an understanding of the limitations of their design. There was no 
consideration of potential sources of bias, no explanation of how missing data were accounted for or 
how this might affect the results. Although the tables of results were clearly presented and the results 
summarised in the discussion, there was no consideration of how generalisable they might be.
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Psychological impact with family history of breast cancer
Although the population in this section is not part of the general breast cancer screening population 
or programme, it is interesting to look at this research and compare the results with that of the general 
population. The OPCERG and others collaborated in the Psychological Impact of Mammography Screening 
(PIMMS) research programme to look at the effects of having a false-positive screening mammogram in a 
population of women with a FHBC. The three papers reported in this section are from the PIMMS group.
Tyndel et al.101 published the first paper in the series in 2007 (n = 2321). This was a prospective cohort 
study of women aged 35–49 years who had a moderate-to-high risk of breast cancer due to their family 
history and were on an annual screening programme. They were interested in comparing the psychological 
impact of having a false-positive mammogram with that of having a normal one within this group. 
Women who had previously had cancer and those with a family history of ovarian cancer were excluded. 
Disease-specific outcomes (PCQ and CWS-R68) were measured 1 month before participants’ screening 
mammogram, 1 month after the ‘all-clear’ and 6 months after assessment.
This is a reasonably good-quality observational study. It is well-designed and well-reported; almost all the 
quality indicators in the STROBE checklist are met. The only substantial omission by Tyndel et al.101 is a 
failure to report the extent of missing data and how these items were accounted for in the analysis.
The follow-on study is by Brain et al.102 (n = 1286) who conducted a multiple regression analysis of the 
participants of the Tyndel et al. study101 to find out which pre-screening variables were predictive of 
cancer-specific distress. Initially, they conducted partial correlations of pre-screening variables on a number 
of scales (CWS-R,68 brief COPE,71 perceived risk of cancer and dispositional optimism) to see how they 
correlated with cancer worry at 1 and 6 months after assessment. This was followed by a hierarchical 
multiple regression to show predictive associations between these baseline variables and cancer worry at 1 
and 6 months.
This second study from the PIMMS group was also of reasonable quality. The main criticism is the same: a 
failure to report how many data were missing and how missing data were dealt with in the analysis.
A qualitative interview study was nested within the PIMMS research. However, this was published only as 
the summary of a conference poster. The summary is reasonably detailed and, although it does not give 
the level of detail that would be expected in a qualitative research paper, it has been included because it is 
part of an included study and it gives some insight into the results found by the quantitative research. This 
interview study was conducted by Clements et al.107 on 58 women who were part of the PIMMS cohort 
study (false-positive result = 22, normal result = 36).
As this study was published only as the summary of a poster, many of the expected quality criteria are 
unreported. However, the design is suitable for the research question and the thematic method of 
analysis appropriate. There is a lack of detail about the results and their interpretation as well as a lack of 
a theoretical framework and justification for the methods used. Therefore, it is not possible to comment 
thoroughly on the robustness of this study.
Impact of false-positive mammograms on returning for routine screening
The studies in this section have been subdivided into those that report on participants’ actual returning for 
future breast screening and those that report on the intention to reattend.
Actual reattendance
Five studies measured the reattendance at routine mammography screening of women who had a false-
positive screening mammogram.
The most recent study to report the actual reattendance of women who had a false-positive screening 
mammogram was by McCann et al.61 (n = 140,387). This was a large, retrospective study that looked at 
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records going back 3.5 years from NHS screening units in East Anglia and Cancer Registry databases. As 
well as looking at reattendance, this study aimed to quantify the increased risk of interval cancer (cancer 
detected between screenings) found among women in this group and establish if there was also an 
increased risk of cancer detection at second-round screening if women had been false-positive in the first 
round. The risk of interval cancer is outside the scope of this systematic review, therefore these results are 
not reported.
This large, convincing, retrospective cohort study gives clearly presented results that are well discussed. 
However, the statistical methods used are not described and the description of demographic characteristics 
is limited to age.
Prior to this, O’Sullivan et al.108 (n = 5649) conducted a similar retrospective cohort study of women who 
had taken part in the NHS screening programme in east and central London. Their focus was only on the 
effects of having a false-positive mammogram on reattendance at the next screening round.
This data registry study clearly presents its descriptive results. However, O’Sullivan et al.108 fail to 
provide any information about the characteristics of the participants, the number of screening centres 
involved or the possible role of bias and no comment is made about the study’s generalisability to other 
screening centres.
The 2001 study by Brett and Austoker59 (n = 505) looked at actual reattendance as well as the 
psychological impact of false-positive mammograms. A summary of this paper can be found above in 
Primary research.
Previously, Meldrum et al.115 (n = 3083) conducted a RCT on reattendance that compared a standard 
invitation letter for second-round screening (3 years later) with a letter tailored to the outcome of the 
previous screening round (e.g. false-positive or normal). Additionally, a telephone interview study was 
conducted of 66 women who had tailored intervention letters to gauge their views of the letters.
This is a poor-quality RCT. It is not clear whether or not the participants were aware that they were taking 
part in a study. Very little detail is given about the intervention or the control letters, certainly not enough 
to replicate the study. Although the method of randomisation is reported, it is unclear whether or not the 
assessors were blinded to the groups. Most significantly, the analysis uses some inappropriate methods. 
In particular, an adjustment is made for multiple comparisons when only a single comparison is made. 
There is no explanation for this. This leads to an inaccurate interpretation of the results in the discussion, 
which fails to acknowledge any limitations of the study. The interview study is inadequately reported with 
no description of methods of analysis and what probably is very selective reporting of results. A CONSORT 
assessment of quality can be found in Appendix 3.
The final study in this group is by Orton et al.109 (n = 1582) using data from three GP practices. They 
looked at whether or not the acceptability of the first round of screening or having a false-positive 
mammogram could help predict attendance at second-round screening 3 years later. Unfortunately, the 
authors did not disaggregate their data to show the effect of screening satisfaction for women with false-
positive mammograms on attendance. The only usable data is a comparison of second-round attendance 
of women who had false-positive mammograms in the first screening round with those who had a 
normal result.
This retrospective cohort study reports most of the quality criteria for observational studies. The rationale 
and methods are clearly described. However, there is no description of the demographic characteristics of 
the participants, so it is not possible to judge whether or not the differences in outcomes may have been 
because of bias or confounding factors. The discussion fails to comment on the limitations of the study, 
although it does remark on the generalisability of the study.
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Intended reattendance
The most recent research looking at the intention to reattend the next screening round following a false-
positive mammogram is the 2001 study by Brett and Austoker.59 This was not the main focus of the paper: 
the data consist of women’s responses to a questionnaire about which external influences have affected 
their attitude to returning for screening in 1 months’ time. It is not possible to compare this intentional 
data with the actual reattendance. A summary of this paper can be found above in Psychological impact.
In addition to measuring adverse psychological consequences at 5 months post assessment, Brett et al.103 
(n = 284) also measured participants’ intention to attend their next breast screening appointment. For 
most of the cohort, this was 2.5 years away, but for those placed on early recall it was only 1 month away. 
A summary of this paper can be found above in Psychological impact.
Interventions to reduce the impact of being recalled for further assessment
No studies were found that directly addressed the issue of testing an intervention to relieve the negative 
psychological consequences of false-positive mammograms. However, two studies were found that looked 
at the information needs of women prior to further assessment, one from OPCERG (1994–7)110–112 and one 
from Smith et al.113 These studies do not disaggregate the data according to the outcome of the recall (i.e. 
distinguish between those who had false-positive and true-positive outcomes). This breaches the inclusion 
criteria for this systematic review. However, these studies are included because at the time of recall the 
final outcome is unknown to the women and there is no reason to suspect that, prior to the event, women 
with false-positive outcomes would have different information needs from those with other outcomes.
From 1994 to 1998 Austoker, Ong and others from OPCERG published a series of three papers about their 
research into the information needs of women who were recalled for further assessment following routine 
mammography screening, plus national guidelines on behalf of NHSBSP. This research will be presented 
first followed by a study by Smith et al.113 of recall invitation letters.
The original work that OPCERG studies came from is by Austoker and Ong112 (n = 1493). Their aim was to 
assess the need for written information among women who had been recalled for assessment following 
routine screening mammography. They did this by conducting a multicentre study of eight breast 
screening centres in the UK.
First, 484 women were invited for a questionnaire interview after recall and before assessment. Two 
weeks after assessment these and other women (total n = 1493) were given an ad hoc questionnaire to 
assess their response to being recalled and how worrying or reassuring the messages contained in recall 
literature were. Second, Austoker and Ong112 also collected samples of the literature sent to women from 
the different centres and found a wide variation in the amount of information given and the language 
used. They assessed the breadth of information given in the recall letters and leaflets and whether or not 
the women thought they had been given sufficient information on matters such as the reason for recall, 
the location of the centre, who could come with them, how long the appointment would take, what 
tests they would undergo, who they would see, when they would know the outcome and how to get 
more information. They also assessed the language used in the information literature and categorised it 
according to whether the participants found it to be particularly worrying or reassuring. Simple descriptive 
statistics are reported together with a few examples of comments made in the open questions.
This is a well-presented and clearly reported study. However, Austoker and Ong112 failed to gather 
information about the demographic profile of their participants; given that this was a large study, it would 
have been very interesting to see what light this information might have shone on the results.
Following on from this, and based on their original development of criteria for evaluating breast screening 
information material, Ong et al.111 (n = 84) evaluated the health education literature in 84 breast screening 
units in the UK. They considered both the initial screening letter given to women and the recall letter and 
leaflet sent to those with suspicious mammograms. The evaluation criteria were divided into words and 
NIHR Journals Library
RESULTS
42
phrases that were particularly worrying and those that were particularly stress relieving. The number of 
centres that mentioned items in their literature in these criteria was recorded.
As this is an evaluation of written material with simple descriptive statistics, many of the STROBE quality 
criteria do not apply. The methods and results were clearly described and comprehensively discussed. The 
main criticism is that there is a lack of discussion of the limitations of the study.
This study led into the most recent of the primary research papers, which is by Ong and Austoker110 
(n = 1493). They used an ad hoc questionnaire to elicit views of women about their experience of being 
recalled, in particular the quality of communication at the clinic (who was available to talk to at the clinic 
and related information needs). The questionnaire also had open questions that allowed a free response 
that underwent a discourse analysis.
Overall, this is a well-conducted and clearly reported survey. However, there are some omissions. The 
authors have failed to report the demographic characteristics of the participants or discussed what effect 
these may have had on the results, given no indication of how bias or confounding factors may have 
played a role in the results and have not considered other limitations of their study. Furthermore, the 
methods and results of the discourse analysis are not described, except to say that the most frequently 
occurring items or those deemed to be most important by the analysts are tabulated.
The most recent publication in this series is by Ong et al.114 and is the national guidelines for improving the 
quality of written information sent to women who are recalled for assessment. The guidelines are based 
on the findings of the previous three papers and give advice on the content and wording of assessment 
invitation letters. The research evidence that is included in the report is a conflation of the findings of 
the studies and does not contain new evidence. Therefore, these data have not been extracted as they 
are already in the primary research paper data extraction forms. The guidelines are mentioned here 
for completeness.
The final study in this section is a poorly described survey of women’s satisfaction with the Leicestershire 
Breast Screening Service in 1989–90 by Smith et al.113 (n = 103). This includes assessing the adequacy of 
information given to women recalled for further assessment. Their aim was to compare three different 
versions of a recall letter giving different amounts of information, including telephone access to a breast 
care nurse, to see which was most acceptable to recalled women.
This study is described as an audit, but it goes further than that as it includes experimental testing of the 
different forms of the recall letter. The reporting of the study is very inadequate. Not enough information 
about the methods used is provided; it is often difficult to reconcile the text with the tables and there is no 
acknowledgement of the limitations of their methods.
Results and comment
Systematic reviews and meta-analyses
The scope of the included systematic reviews was broader than that of this review; they included non-UK 
studies and outcomes measured for ! 1 month from women receiving the ‘all-clear’ after their follow-up 
assessment. Therefore their results may not reflect the medium- to long-term outcomes in the UK that are 
the subject of this review. Nevertheless, they are of interest as a comparison to this review’s findings.
All the systematic reviews and meta-analyses summary results showed a negative impact from receiving 
a false-positive mammogram on measures of well-being, depression and anxiety compared with women 
with normal screening results. The primary studies included used both disease-specific and generic 
measures, which were usually analysed together in the reviews. The exception to this was the meta-
analysis of generic psychological measures by Salz et al.85 that showed no difference in psychological 
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outcomes between women with false-positive results and those with normal ones except for anxiety, which 
was positively correlated with having a false-positive mammogram [0.03 (95% CI 0.00 to 0.07)]. The 
evidence varied concerning whether psychological distress had a short-term (! 1 month after assessment) 
or long-term impact. There was some evidence that the degree of impact varied with the severity of the 
reassessment test, with women undergoing biopsy showing greater psychological distress than those with 
a repeat mammogram.82
The results for the impact of receiving a false-positive mammogram on self-care behaviour and returning 
for the next routine screening mammogram give a more complex picture. Two reviews, Salz et al.85 and 
Armstrong et al.,87 looked at effects of having a false-positive mammogram on frequency of breast 
self-examination. In both evidence syntheses, women with false-positive mammograms reported increased 
breast self-examination, which may indicate increased anxiety about the risk of developing breast cancer. 
However, Armstrong et al.87 found there was no statistically significant difference between groups in the 
likelihood of returning for routine breast screening, although it is not clear whether the studies were 
reporting actual attendance or intention to attend. This may be important as Bankhead et al.84 found that 
women were more likely to say that they had an intention to attend their next routine mammogram than 
actually do so. Other studies showed a variation in the effect of a false-positive mammogram on returning 
for screening according to location, with European women unaffected in this domain, Canadian women 
less likely to return and women from the USA more likely to return for routine mammography.62 Table 7 
gives a summary of the results of the included systematic reviews and meta-analyses.
Primary research
As in the previous section, the results of the primary research studies have been organised according to 
their domain of interest. Figure 5 (see Primary research) shows the relationship of the included primary 
studies to the outcome categories.
With the exception of the intervention study by Meldrum et al.,115 all the included studies had 
observational designs. These designs are necessarily used when looking at the effects of a past event. 
However, results from observational studies should be interpreted with caution as bias and confounding 
may have influenced them. There may be systematic differences between the groups that do and the 
groups that do not have false-positive mammograms: those in the false-positive group will have had 
greater exposure to NHS care which could have affected their response to the questionnaires, none of the 
studies were blinded, therefore the way that measures were taken may have varied between the groups, 
and attrition bias may have skewed the results either way, as those who withdrew from the study may 
have been more or less affected by their screening outcome than those who remained in the studies.
As reported above, some of the studies included participants who are outside the inclusion criteria for 
this systematic review. Therefore, only data from the study population included in this review have been 
extracted and reported.
Psychological impact
In the first paper from OPCERG, by Ong et al.104 (n = 877), adverse psychological consequences were 
measured at T1 (1 month after the last screening appointment) using the negative PCQ subscale. The 
proportion of participants within each of the screening outcomes was recorded. The results are presented 
simply as proportions; therefore, the review authors (MB) have calculated RRs to provide greater insight 
into the relationship between false-positive and normal mammograms with adverse psychological 
consequences. Table 8 shows the outcomes at T1. These results show an increased risk of psychological 
distress at 1 month after the last screening appointment for women who had a false-positive result 
compared with women who had a normal mammogram. The risk of distress increases in line with the 
intrusiveness of the assessment process, so that women who had another mammogram had a RR of 1.71 
(95% CI 1.24 to 2.35), whereas women who had a biopsy were at the greatest risk, RR 2.96 (95% CI 2.19 
to 4.01). Those put on early recall or who had a FNA also showed increased distress, RR 2.13 (95% CI 1.58 
to 2.87) and RR 1.97 (95% CI 1.44 to 2.69), respectively.
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The next paper in this series is by Brett et al.103 (n = 284) and reports outcomes 5 months after the last 
screening appointment (T2). Although all the women included at T2 were respondents at T1, it appears 
that they are a selected subset of Ong et al.’s104 participants, who were matched with T1 respondents 
placed on 6 months early recall, using undisclosed criteria. A comparison between T1 results in Brett et 
al.103 (the selected subgroup) and T1 in Ong et al.104 indicates that the Brett et al.’s103 subset has a higher 
proportion of adverse PCQ scores than the original study found (compare Table 8 with column 2 of 
Table 9), thus leading to higher RR estimates in the study by Brett et al.103 than in that by Ong et al.104
There is another source of uncertainty about the comparability of Brett et al.’s T1 results103 with Ong et 
al.’s T1 results:104 it is unclear what the proportion of women experiencing adverse psychological events 
represents. In the earlier paper (Ong et al.104) the proportions represent those experiencing at least 
one psychological event on the PCQ and in the last paper in the series (Brett and Austoker59) it is the 
proportion of women scoring # 12 on the PCQ. However, Brett et al.103 do not disclose the method used 
for calculating the proportion. One clue is that they report that the PCQ is scored 1–4 rather than the 
conventional 0–3. If they have transposed the scores in this way, then a score # 12 would be equivalent 
TABLE 8 Adverse psychological consequences 1 month (T1) after the last screening appointment
Outcome of screening
Women reporting adverse PCs at 
T1 n/N (%) RRa (95% CI)
Normal mammogram 38/130 (29) Baseline
False-positive after
Further mammography 64/128 (50) 1.71 (1.24 to 2.35)****
FNA 61/106 (58) 1.97 (1.44 to 2.69)****
Biopsy 26/30 (87) 2.96 (2.19 to 4.01)****
ER after assessment 81/130 (62) 2.13 (1.58 to 2.87)****
****p ! 0.0001; ER, early recall at 6 or 12 months; PC, psychological consequence.
a RR calculated by authors.
Source: adapted from Ong et al.104
TABLE 9 Brett et al.:103 comparison of adverse psychological consequences 1 month (T1) and 5 months (T2) after the 
last screening appointment
Outcome of screening 
Women 
reporting 
adverse PCs at 
T1 n/N (%) RRa (95% CI)
Women 
reporting 
adverse PCs at 
T2 n/N (%) RRa (95% CI)
Normal mammogram 9/52 (17) Baseline 5/52 (10) Baseline
False-positive after
Further mammography 29/51 (57) 3.29 (1.73 to 6.23)*** 23/51 (45) 4.69 (1.93 to 11.38)***
FNA 26/41 (63) 3.66 (1.93 to 6.93)**** 18/41 (44) 4.57 (1.85 to 11.26)***
Biopsy 21/23 (91) 5.28 (2.87 to 9.68)**** 14/23 (61) 6.33 (2.59 to 15.50)****
ER after assessment 32/46 (70) 4.02 (2.15 to 7.50)**** 27/46 (59) 6.10 (2.56 to 14.54)****
*p ! 0.001; ****p ! 0.0001; ER, early recall at 6 months; PC, psychological consequence.
a RR calculated by authors.
Source: adapted from Brett et al.103
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to a score of at least 1 on the original paper (Ong et al.104) where the PCQ is scored 0–3. Assuming that 
the scores are directly comparable in this way it can be seen that, for all screening outcome categories, 
the level of psychological adverse effects has reduced over time (T1–T2) for the matched subset (see 
Table 9). This suggests that the matched subset in Brett et al.103 is not representative of the population 
in Ong et al.104 which would introduce a potential bias leading to overestimates of adverse psychological 
consequences at T1 for women having false-positive mammograms.
Furthermore, there is disagreement between tables within the paper by Brett et al.103 about the benign 
biopsy and early recall results. In their table 1, 61% of women placed on early recall and 59% of women 
who had a biopsy show adverse psychological consequences, but in their table 2 these figures are 
reversed, although we are told that the difference between the scores at T1 and T2 was lower for women 
placed on early recall than for those who had a biopsy. Therefore, it has been assumed that table 2 is 
correct. The authors were contacted about this but no reply was received.
At T2 the results show that for all groups of women the level of distress had reduced. The greatest 
decrease in distress was for those women who had a biopsy at assessment (–30%). However, the RR of 
distress compared with those with normal mammograms had increased for all false-positive subgroups. 
Those women who had a biopsy continued to be at a greater risk of distress than those with a normal 
mammogram (RR 6.33; 95% CI 2.59 to 15.50). Those women who were put on 6 months early recall were 
also at a high RR (6.10; 95% CI 2.56 to 14.54). This is probably because they were only 1 month away 
from their next screening appointment (see Table 9).
Brett et al.103 also conducted a logistic regression to find out which personal characteristics might be 
influencing the results. This showed that only having psychological consequences at 1 month (OR 5.82; 
95% CI 2.70 to 12.56) and the kind of further investigation that women had (OR 4.40; 95% CI 1.35 to 
14.35) were related to having psychological consequences at 5 months (Table 10).
In the final paper in the series, Brett and Austoker59 (n = 505) report outcomes at 35 months (T3) from the 
last screening appointment and compare them with the same participants at T1. It appears that this cohort 
has not been matched, as in the previous paper by Brett et al.,103 but is the same cohort as in the first 
paper by Ong et al.104 However, in this last paper, cases are those with a PCQ score # 12. If the assumption 
of comparability is made between methods used to calculate T1 and T3 scores, then the proportion of 
women with normal mammograms experiencing psychological adverse events is similar at T1 (26%) 
and T3 (25%), although these results are higher than at T2 (10%). For those women with false-positive 
TABLE 10 Logistic regression: variables related to psychological consequences at 5 months (T2) after the last breast 
screening appointment
Variable OR (95% CI)
Psychological consequences at 1 month 5.82 (2.70 to 12.56)***
Result group (type of investigation) 4.40 (1.35 to 14.35)**
Age of women 1.00 (0.98 to 1.03) NS
Apprehensiveness about attending 0.92 (0.80 to 1.07) NS
Greater perceived likelihood of ever getting breast cancer compared with the average 
woman
0.91 (0.35 to 2.34) NS
Likelihood of attending future breast screening 0.61 (0.03 to 11.93) NS
Need to discuss breast screening with someone 0.50 (0.24 to 1.02) NS
**p ! 0.01; ***p ! 0.001; NS, not significant.
Source: adapted from Brett et al.103
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mammograms (other screening outcomes) the proportion experiencing adverse outcomes has reduced 
over time, although for those who were assessed with FNA the proportion who were distressed at T3 
(45%) is similar that at T2 (44%) (Table 11).
An examination of the RR of experiencing psychological consequences at T3 and T1 show that this risk has 
diminished substantially for those assessed with a further mammogram, RR 1.28 (95% CI 0.82 to 2.00), 
as they were not statistically significantly more distressed than women who had a normal mammogram. 
Also, women who were placed on 6-months early recall showed a 23% reduction in their RR of distress at 
T3, RR 1.82 (95% CI 1.22 to 2.72). However, women who were assessed by FNA had the least reduction 
in RR (0.28) with a 35-month RR of 1.80 (95% CI 1.17 to 2.77). Those who had a biopsy maintained their 
status of having the highest RR of distress at T3, RR 2.07 (95% CI 1.22 to 3.52). Table 11 shows the results 
comparing T1 and T3.
The results from the OPCERG study indicate that there is an enduring relationship, lasting at least 3 years, 
between having a false-positive mammogram and exhibiting negative psychological consequences. This 
effect is shown to be in proportion to the degree of invasiveness of the assessment procedure, with 52% 
of women who were assessed by biopsy, 45% assessed by FNA, 32% assessed by further mammogram and 
46% of those placed on 6 months early recall, compared with 25% of those with a normal mammogram, 
still experiencing distress 3 years after their last screening appointment. The numbers of distressed women 
may partly be explained by the impending date for their next screening appointment, although the 
proportions are still likely to reflect their assessment procedure.
The forest plot in Figure 6 gives an overview of the RR of psychological distress from a false-
positive mammogram in relation to time and the method of assessment when compared with a 
normal mammogram.
The results from the ad hoc questionnaire, given at 35 months (T3), reported by Brett and Austoker59 shed 
some light on factors that may have influenced the level of distress experienced. Table 12 shows the items 
that were statistically significantly correlated with psychological distress at 1 month before the next routine 
screening (T3). The highest correlation with distress is with the lack of opportunity to talk to someone 
after the screening appointment (r = 0.35). The other most highly correlated factors are the waiting time 
between screening and assessment (r = 0.30), communication problems at the screening appointment 
TABLE 11 Brett and Austoker:59 comparison of adverse psychological consequences 1 month (T1) after last breast 
screening appointment and 1 month before the next screening (T3, 35 months after the first appointment)
Last breast screening 
results group (1995)
Women 
reporting 
adverse PCs at 
T1 n/N (%) RRa (95% CI)
Women 
reporting 
adverse PCs at 
T3 n/N (%) RRa (95% CI)
Normal mammogram 26/99 (26) Baseline 25/99 (25) Baseline
False-positive after
Further mammography 47/93 (51) 1.92 (1.31 to 2.83)*** 30/93 (32) 1.28 (0.82 to 2.00) NS
FNA 36/66 (55) 2.08 (1.40 to 3.09)*** 30/66 (45) 1.80 (1.17 to 2.77)***
Biopsy 15/21 (71) 2.72 (1.78 to 4.17)**** 11/21 (52) 2.07 (1.22 to 3.52)**
ER after assessment 62/100 (62) 2.36 (1.64 to 3.40)**** 46/100 (46) 1.82 (1.22 to 2.72)**
***p ! 0.001; ****p ! 0.0001; ER, early recall at 6 months; NS, not significant; PC, psychological consequence.
a RR calculated by authors.
Source: adapted from Brett and Austoker.59
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due to anxiety (r = 0.29), fear of radiation (r = 0.28), amount of written information (r = 0.28), the 
performance of health workers (r = 0.27) and the unnecessary worry caused by the last breast screen 
(r = 0.26).
Preceding the work of OPCERG, Sutton et al.55 (n = 1021) published results from their retrospective cohort 
study. These results show that, on their ad hoc questionnaire, when looking back over the previous 
9 months, women who had false-positive mammograms were more likely to report that they were more 
anxious than women with normal mammograms at three time points: at the clinic after the mammogram, 
mean difference 0.24 (95% CI 0.03 to 0.45); while waiting for the results letter, 0.25 (95% CI 0.02 to 
0.48); and after reading the results letter, 1.69 (95% CI 1.54 to 1.84). Unfortunately, Sutton et al.55 do 
not numerically report how anxious the two groups were at the time they completed the questionnaire; 
these results are only presented as a graph which it is not possible to accurately read. The findings from 
this study are questionable as, apart from other methodological considerations of bias, the experience of 
having a false-positive mammogram may have coloured the women’s view of how they felt at the time 
of screening and confounded their responses. It would seem unlikely that there should be any genuine 
difference between the two groups prior to receiving the results letter when it might be expected to find a 
difference in anxiety levels. A summary of the results from this study can be found in Table 13.
The results of Bull and Campbell’s (n = 750) cohort study106 are ambiguous. The authors’ ad hoc 
questionnaire of the frequency of breast self-examination found that 6 weeks after receiving the ‘all-clear’ 
women who had a false-positive mammogram examined their breasts more frequently than women who 
had a normal mammogram. Women who had a biopsy at assessment were more likely to self-examine 
Study ID RR (95% CI)
Further mammography
Ong et al. T1 1.71 (1.24 to 2.35)
Brett et al. T1 3.29 (1.73 to 6.23)
Brett et al. T2 4.69 (1.93 to 11.38)
Brett and Austoker T1 1.92 (1.31 to 2.83)
Brett and Austoker T3 1.28 (0.82 to 2.00)
FNA
Ong et al. T1 1.97 (1.44 to 2.69)
Brett et al. T1 3.66 (1.94 to 6.93)
Brett et al. T2 4.57 (1.85 to 11.26)
Brett and Austoker T1 2.08 (1.40 to 3.09)
Brett and Austoker T3 1.80 (1.17 to 2.77)
Biopsy
Ong et al. T1 2.96 (2.19 to 4.01)
Brett et al. T1 5.28 (2.87 to 9.68)
Brett et al. T2 6.33 (2.59 to 15.50)
Brett and Austoker T1 2.72 (1.77 to 4.17)
Brett and Austoker T3 2.07 (1.22 to 3.52)
Early recall
Ong et al. T1 2.13 (1.58 to 2.87)
Brett et al. T1 4.02 (2.15 to 7.50)
Brett et al. T2 6.10 (2.56 to 14.54)
Brett and Austoker T1 2.36 (1.64 to 3.40)
Brett and Austoker T3 1.82 (1.22 to 2.72)
10.8 2 4 8 12
FIGURE 6 Forest plot of the RRs of negative psychological consequences from having a false-positive mammogram 
compared with a normal one by type of false-positive assessment at T1 (1 month after assessment), T2 (5 months after 
assessment) and T3 (35 months after assessment), measured with the PCQ.
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TABLE 12 Correlation between psychological distress at 1 month before the next routine breast screening and 
dissatisfaction and anxiety related to past routine breast screening
Statements about last screening appointment False-positive coefficient
Opportunity to talk to somebody after the breast screening appointment 0.35***
Waiting between appointment letter and appointment(s) 0.30***
Difficulties with taking in verbal information at breast screening appointment 
because of anxiety
0.29***
Fear of radiation 0.28***
Amount of written information 0.28***
Perceived performance of health workers 0.27***
Unnecessary worry experienced as a result of the last breast screening 0.26***
The amount of time spent on verbal communication at assessment 0.24***
Verbal communication: chance to say what is on one’s mind 0.23***
Waiting for test results 0.22***
Quality of verbal communication 0.21***
Women’s understanding of test result 0.21***
Amount of information provided in advance 0.18**
Postal notification of mammographic results 0.14*
*p ! 0.05; **p ! 0.01; ***p ! 0.001; ****p ! 0.0001.
Source: adapted from Brett and Austoker.59
TABLE 13 Retrospective anxiety 9 months after receiving an invitation for breast screening
Outcome
Stage 1: 
receive 
screening 
invitation, 
mean (SD)
Stage 2: while 
waiting for the 
mammogram, 
mean (SD)
Stage 3: at the 
clinic after the 
mammogram, 
mean (SD)
Stage 4: after 
screening 
and before 
receiving the 
results, mean 
(SD)
Stage 5: 
after reading 
the results 
letter, mean 
(SD)
Stage 6: 
now, mean 
(SD) 
False-positive 
(n = 24)
Not reported Not reported 1.60 (0.68) 1.95 (0.09) 2.85 (0.37) Not 
reported
Normal 
mammogram 
(n = 671)
Not reported Not reported 1.36 (0.52) 1.70 (0.57) 1.16 (0.36) Not 
reported
Difference 
in means 
(95% CI)
– – 0.24 (0.03 to 
0.45)
0.25 (0.02 to 
0.48)
1.69 (1.54 to 
1.84)
–
Source: adapted from Sutton et al.55
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once a week or more than those who had less invasive assessments. This may indicate that the women 
with false-positive results were more anxious about having breast cancer than those with normal results, 
although there is uncertainty about the meaning of very frequent breast self-examination. These results 
can be seen in Table 14.
When the results of both false-positive groups are combined there is a clear link between frequency 
of breast self-examination and having a false-positive mammogram, with the RR increasing with the 
frequency of self-examination (Table 15).
However, Bull and Campbell’s106 results with the HADS tell a different story. They show no statistically 
significant difference in anxiety or depression between the groups at 6 weeks after assessment, with the 
majority in all groups being within the normal range on both subscales. Borderline anxiety and depression 
were higher in the false-positive group that did not have a biopsy, depression (12%) or anxiety (12%) than 
in the false-positive group that had a biopsy, depression (6%) or anxiety (8%). This may have been because 
a biopsy was seen as a more conclusive declaration of health than other methods of assessment (Table 16).
When the false-positive groups are combined, the RR of experiencing anxiety or depression is not 
statistically significantly greater in the false-positive group (Table 17).
TABLE 14 Frequency of breast self-examination by group
Frequency of breast self-
examination by group
Normal mammogram 
(N = 102), n (%)
False-positive (not 
biopsy) (N = 204), n (%)
False-positive (biopsy) 
(N = 49), n (%)
Never 22 (22) 24 (12) 7 (14)
Less than once a month 23 (23) 34 (17) 7 (14)
Once a month 47 (46) 97 (48) 18 (37)
Once a week 10 (10) 41 (20) 12 (24)
More than once a week 0 8 (4) 5 (10)
No response 0 0 0
Source: adapted from Bull and Campbell.106
TABLE 15 Relative risk of frequency of breast self-examination
Frequency of breast self-
examination
Normal mammogram 
(N = 102), n (%)
All false-positive 
(N = 253), n (%)
RRa comparing normal 
mammogram with all 
false-positive (95% CI)
Never 22 (22) 31 (12) 0.57 (0.35 to 0.93)*
Less than once a month 23 (23) 41 (16) 0.71 (0.46 to 1.13) NS
Once a month 47 (46) 115 (45) 0.99 (0.77 to 1.27) NS
Once a week 10 (10) 63 (25) 2.54 (1.36 to 4.75)**
More than once a week 0 13 (5) (0.66 to 182.48) NS
No response 0 0  
*p ! 0.05; **p ! 0.001; NS, not significant.
a RR calculated by authors.
Source: adapted from Bull and Campbell.106
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The prospective cohort study by Ellman et al.105 (n = 752) used the GHQ-28,72 another generic instrument, 
to measure psychological morbidity at the screening visit and 3 months later. They found that there were 
no statistically significant differences between women who had normal mammograms and those with 
false-positive ones. Scores # 4 on the GHQ-28 are deemed to be ‘cases’ (Table 18).
The distribution of scores on the four subscales of somatic, anxiety, social dysfunction and depression can 
be seen in Table 19. These show that the proportion of scores above ‘case’ level declined in both groups 
between baseline and follow-up, with the greatest decline in the false-positive group for the somatic and 
anxiety subscales (40% to 26% and 44% to 29%, respectively).
When the RRs are calculated for psychological morbidity these again show that there is no statistically 
significant difference between those women with and those without false-positive mammograms at 
baseline and 3 months later (Table 20).
TABLE 16 Hospital Anxiety and Depression Scale results by group
HADS subscales
Normal mammogram 
n/N (%) 
False-positive  
(not biopsy) n/N (%)
False-positive  
(biopsy) n/N (%) 
Depression
Normal (0–7) 95/104 (91) 168/202 (83) 43/49 (88) NS
Borderline (8–10) 7/104 (7) 25/202 (12) 3/49 (6) NS
Abnormal (# 10) 2/104 (2) 9/202 (5) 3/49 (6) NS
Anxiety
Normal (0–7) 91/103 (88) 174/202 (86) 42/49 (86) NS
Borderline (8–10) 10/103 (10) 24/202 (12) 4/49 (8) NS
Abnormal (# 10) 2/103 (2) 4/202 (2) 3/49 (6) NS
NS, not significant.
Source: adapted from Bull and Campbell.106
TABLE 17 Relative risk of anxiety and depression for women with false-positives measured by the HADS
HADS subscales
Normal mammogram 
n/N (%) 
False-positive  
n/N (%) RRa (95% CI)
Depression
Normal (0–7) 95/104 (91) 211/251(84) Baseline
Borderline (8–10) 7/104 (7) 28/251 (11) 1.71 (0.77 to 3.78) NS
Abnormal (# 10) 2/104 (2) 12/251 (5) 2.61 (0.60 to 11.44) NS
Anxiety
Normal (0–7) 91/103 (88) 216/251 (86) Baseline
Borderline (8–10) 10/103 (10) 28/251 (11) 1.16 (0.59 to 2.30) NS
Abnormal (# 10) 2/103 (1) 7/251 (3) 1.46 (0.31 to 6.90) NS
NS, not significant.
RR calculated by authors
Source: adapted from Bull and Campbell.106
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The forest plot in Figure 7 shows the results from Bull and Campbell106 and Ellman et al.105 Here it can be 
seen that, although none of the results show clinical levels of general anxiety and depression, there is a 
trend in that direction.
Summary: psychological impact in the general population
The OPCERG found that there was a statistically significant negative psychological impact from having a 
false-positive mammogram, whereas the main outcome measures of Bull and Campbell106 and those of 
Ellman et al.105 did not. The difference in findings between those of OPCERG and others may be explained 
in a variety of ways by differences in their design, methods and populations or they may be an artefact of 
TABLE 18 Proportion of GHQ scores (# 4) showing psychological morbidity at the screening clinic and 3 months later 
Time Normal mammogram n/N (%) False-positive n/N (%)
Screening visit 71/295 (24) 216/721 (30) NS
3 months later 56/295 (19) 137/721 (19) NS
NS. not significant.
Source: adapted from Ellman et al.105
TABLE 19 Distribution of GHQ-28 subscale scores showing percentage of cases
Symptom 
subscale
Normal mammogram False-positive 
Screening visit  
n/N (%) 
3 months later  
n/N (%)
Screening visit  
n/N (%)
3 months later  
n/N (%)
Somatic 113/295 (38) 98/287 (34) 108/271 (40) 69/266 (26)
Anxiety 104/295 (35) 75/287 (26) 119/271 (44) 77/266 (29)
Social dysfunction 104/295 (35) 86/287 (30) 89/271 (33) 77/266 (29)
Depression 42/295 (14) 29/287 (10) 38/271 (14) 27/266 (10)
Source: adapted from Ellman et al.105
TABLE 20 Relative risk of psychological morbidity GHQ-28
Time
Normal mammogram 
n/N (%)  
False-positive  
n/N (%) RRa (95% CI)
Screening visit score
Normal (0–4) 222/295 (75) 189/271 (70) Baseline
Subclinical/mild (5–9) 49/295 (17) 48/271 (18) 1.12 (0.78 to 1.60) NS
Clinical mild/moderate (10–28) 24/295 (8) 34/271 (13) 1.56 (0.96 to 2.55) NS
3 months later score
Normal (0–4) 232/287 (81) 216/266 (81) Baseline
Subclinical/mild (5–9) 31/287 (11) 23/266 (9) 0.82 (0.49 to 1.36) NS
Clinical mild/moderate (10–28) 24/287 (8) 27/266 (10) 1.19 (0.70 to 2.00) NS
NS, not significant.
a RR calculated by authors.
Source: adapted from Ellman et al.105
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bias or confounding. However, one key difference stands out: OPCERG measured outcomes with disease-
specific instruments, whereas Bull and Campbell106 and Ellman et al.105 used generic measures designed to 
detect general anxiety and depression at clinically recognisable levels.
Further possible evidence of some distress comes from the Bull and Campbell study’s106 frequency of breast 
self-examination results. In this study there is a clear relationship between the RR of increasingly frequent 
breast self-examination and having a false-positive mammogram, with those women assessing themselves 
once a week or more than this having RRs of 2.54 (95% CI 1.36 to 4.75) and 10.95 (95% CI 0.66 to 
182.48), respectively. It may be reasonable to suggest that this level of frequency of self-examination is a 
proxy for anxiety.
The disagreement about the psychological impact of false-positive screening results may be explained by 
the type of outcome measures used, whether disease-specific or generic. Brodersen et al.,116–119 from the 
University of Copenhagen, have written a number of papers on the subject of measuring psychological 
distress in women who have received false-positive mammograms. In particular, they conducted a 
literature review to find out how suitable the outcome measures used in studies of false-positive 
mammograms were for detecting psychological distress.116 The review found 23 includable studies; the 
most commonly used outcome measures were the HADS, GHQ, STAI and PCQ. By judging the instruments’ 
psychometric properties in the context of false-positive mammography, they found that HADS, GHQ and 
STAI were unsuitable for use in measuring psychological distress. This was because the content of HADS 
and the GHQ were not applicable to the screening context as they were designed to screen for general 
anxiety at clinical levels rather than the specific breast cancer anxiety that may be expected. The STAI 
had been validated using students before their exams and may not replicate the anxiety felt by women 
possibly facing cancer. None of these scales have had their content validity demonstrated in the breast 
cancer screening context and all contain items that are irrelevant to women being screened, which may 
lead to the items’ omission by respondents. Brodersen et al.116 also reported that the PCQ was the most 
suitable measure to use to test psychological morbidity resulting from breast cancer screening as it 
had been validated in this context and was specifically designed for this purpose. However, its ability to 
reliably measure the psychological consequences of mammography screening in the long term has yet to 
be determined. Table 21 shows the relationship between the types of measure used (generic or disease-
specific) and the results of studies that compared women with false-positive mammograms with those 
with normal mammograms.
Study ID RR (95% CI)
Bull and Campbell: 6 weeks after assessment
HADS depression = borderline 1.71 (0.77 to 3.78)
HADS depression = abnormal 2.61 (0.60 to 11.44)
HADS anxiety = borderline 1.16 (0.58 to 2.30)
HADS anxiety = abnormal 1.46 (0.31 to 6.90)
Ellman et al.: immediately after screening
GHQ-28 subclinical/mild 1.12 (0.78 to 1.60)
GHQ-28 moderate/severe 1.56 (0.96 to 2.55)
Ellman et al.: 3 months after screening
GHQ-28 subclinical/mild 0.82 (0.49 to 1.36)
GHQ-28 mild/moderate 1.19 (0.70 to 2.00)
10.0874 11.4
FIGURE 7 Relative risk of suffering clinical levels of general anxiety and depression following a false-positive 
mammogram compared with a normal mammogram, measured by Bull and Campbell106 (HADS) and Ellman et al.105 
(GHQ-28).
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Therefore, it may be reasonable to speculate that, for those in the general population, having a false-
positive screening mammogram can cause breast cancer-specific psychological distress that may endure for 
up to 3 years. However, it is less likely that there will be general anxiety detectable at clinically recognisable 
levels. Further research is needed in well-designed observational studies that use both disease-specific and 
generic outcomes to determine whether or not this is the case.
Psychological impact with family history of breast cancer
The PIMMS Management group’s first results are from Tyndel et al.’s101 (n = 2321) study in the FHBC 
population. When their within-study group results are considered, the women who had a normal 
mammogram showed a statistically significant decrease in their distress levels between T1 (1 month 
before screening) and T2 (1 month after screening) on both measures (CWS-R and PCQ), whereas those 
in the recall group did not. However, when the between T2-and-T3 (6 months after screening) scores are 
compared, both groups show statistically significant reductions in distress over this 5-month period on 
both measures (Table 22).
The between-group scores are harder to interpret owing to the potential for bias to be introduced by lack 
of randomisation and demographic data that indicates that there are differences between the groups. 
The false-positive group have statistically significantly greater proportions of participants with biological 
children (p = ! 0.05), a high-risk family history (p = ! 0.05) and post-mammography hospital attendance 
for symptoms (p = ! 0.05). The only statistically significant difference in the between-group scores is with 
the PCQ at T2, when those in the recall group {mean [standard deviation (SD)] 7.1 (7.44)} were more 
distressed than those in the normal result group [mean (SD) 4.08 (6.19)], this difference was no longer 
statistically significant 5 months later at T3 (see Table 22). However, these results, like those from the other 
studies, have not been adjusted for potential confounders (items on the PCQ and CWS-R). Tyndel et al.101 
present adjusted results (for the potential confounders listed above) in graphical form only (which could 
not be accurately transposed) that indicate that if these are considered then the recall group showed the 
greatest decrease in distress between T2 and T3 and the normal result group between T1 and T2 on both 
measures. The adjusted results were statistically significant; the level of significance is not reported.
Unusually, Tyndel et al.101 also took measures on the positive subscale of the PCQ to see if there were any 
benefits from having a false-positive mammogram. They found that women who were recalled scored 
statistically significantly more highly at T2 [mean (SD) 13.02 (7.6)] than those with normal mammograms 
[mean (SD) 10.81 (6.9)]. However, this effect had diminished and was not statistically significant by T3. 
Additionally, when they had received their results at T2 and T3, women were asked whether their opinion 
of the benefits of breast screening had changed since their last visit. Women who were recalled were 
statistically significantly more likely to feel positive about the benefits of screening at both time points than 
those with normal mammograms, T2 = OR 3.16 (95% CI 2.14 to 4.70) and T3 = OR 2.35 (95% CI 1.53 to 
3.61) (Table 23).
TABLE 21 Comparison of studies that used both disease-specific or generic outcomes and their results
Study Year
Disease-
specific Generic
Negative psychological 
consequences: false-
positive vs normal result
PCQ HADS GHQ-28 Found Not found
Brett and Austoker59 2001 
Brett et al.103 1998 
Ong et al.104 1997 
Bull and Campbell106 1991 
Ellman et al.105 1989    
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TABLE 22 Comparison of distress at T1 (1 month before screening), T2 (1 month after screening) and T3 (6 months 
after screening)
Questionnaire
False-
positive 
result
Within false-
positive 
result
Normal 
result 
Within 
normal 
result Between groups
Mean (SD) Paired t-test Mean (SD)
Paired 
t-test
Difference 
in means 95% CI
CWS-R
T1 (n = 111, 1171) 11.61 (2.90) – 10.99 (2.91) – 0.62 1.19 to 0.05, NS
T2 (n = 111, 1171) 11.68 (2.89) – 10.56 (2.60) – 1.12 1.63 to 0.61, NS
T3 (n = 111, 1159) 10.35 (2.65) – 10.12 (2.49) – 0.21 0.30 to 0.72, NS
Difference T1–T2 – –0.298, NS – 7.537**
Difference T2–T3 – 6.372** – 8.633**
PCQ
T1 (n = 110, 1167) 7.32 (7.66) – 5.06 (6.71) – 2.26 3.59 to 0.93, NS
T2 (n = 110, 1167) 7.1 (7.44) – 4.18 (6.19) – 2.92 4.05 to 1.69*
T3 (n = 110, 1169) 4.61 (6.42) – 3.84 (6.00) – 0.77 1.95 to 0.41, NS
Difference T1–T2 – –0.051, NS – 6.935**
Difference T2–T3 – 5.752** – 3.183**   
*p ! 0.05, **p ! 0.01; NS, not significant.
Difference in means calculated by the authors.
Source: adapted from Tyndel et al.101
TABLE 23 Positive PCQ subscale scores at T2 (1 month after screening) and T3 (6 months after screening)
Outcome False-positive 
Normal 
mammogram Mann–Whitney U-test
Positive PCQ at T2 51,561 **
Mean (SD) 13.02 (7.6) 10.81 (6.9)
Positive PCQ at T3 59,169 NS
Mean (SD) 12.65 (8.9) 11.16 (7.0)
Benefits of screening more positive at T2 OR 95% CI
No. (%) 112 (55) 1164 (27) 3.17 2.14 to 4.70***
Benefits of screening more positive at T3
No. (%) 105 (35) 1085 (19) 2.35 1.53 to 3.61***
**p ! 0.01; ***p ! 0.001; NS, not significant.
Source: adapted from Tyndel et al.101
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Overall, the levels of distress were similar in both groups although at T2, on the PCQ, the false-positive 
group showed greater distress. Additionally, 1 month after the all-clear (T2) those women with false-
positive mammograms saw statistically significantly more benefits from screening and were more positive 
about the benefits of screening at T2 and 6 months later (T3).
Brain et al.102 (n = 1286) then used the results of Tyndel et al.101 to investigate which factors, evident at 
pre-screening, predicted cancer distress at 1 month (T2) and 6 months (T3) after assessment. The results 
of hierarchical multiple regression showed that, among others, cancer worry at 1 month after screening 
was predicted by having a false-positive mammogram (p ! 0.05). This was no longer the case at 6 months 
after the all-clear. The model accounted for 61% of the variance at T2 and 57% at T3. Table 24 gives all the 
variables predictive of cancer distress in the FHBC population.
In order to gain greater understanding of their results and how women valued being in the annual FHBC 
screening programme, the PIMMS Management Group conducted an interview study of their participants 
who did (n = 22) and did not (n = 36) have a false-positive mammogram.107 As this work has been 
published only as a poster summary, it is only possible to report an overview of their findings.
The thematic analysis of the interviews by Clements et al.107 (n = 58) showed that being part of the FHBC 
screening programme helped to relieve fear of breast cancer and resulted in women feeling more in 
control of their family history. Women believed that taking part in screening would enable the earlier 
detection of cancer and that this would lead to a positive outcome. They also believed that a mammogram 
was more likely to detect early-stage cancer than actually is the case. They thought that an all-clear result 
meant that they did not have cancer. Although women who had a false-positive result were initially 
distressed, when they received the all-clear they had increased feelings of reassurance and security and a 
greater faith in the screening process than those with an initial all-clear result. They felt that being recalled 
was positive proof that screening worked.
TABLE 24 Multiple regression showing predictive associations between independent baseline variables and cancer 
worry at 1 or 6 months
T1 (1 month before screening)  
variable
T2 (1 month after screening) 
CWS-R
T3 (6 months after screening) 
CWS-R
T1 cancer worry 0.54*** 0.58***
High perceived lifetime risk of breast cancer 0.09*** 0.08**
Relative died of breast cancer in the last year – 0.05*
Belief in increased risk due to family history 0.09*** 0.08***
First attendance at the screening programme –0.07*** –0.04*
Being recalled for further tests – false-positive 0.06* –
Low emotion focused coping potential –0.06* –0.05*
Use of religion as a coping strategy 0.05** –
Dispositional optimism –0.05* 0.00, NS
Low challenge appraisal –0.04* –0.02, NS
Substance use for coping 0.04* –
*p ! 0.05; **p ! 0.01; ***p ! 0.001; NS, not significant.
Source: adapted from Brain et al.102
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Summary: psychological impact in the family history of breast cancer population
Like the women in the normal-risk population, those in the false-positive FHBC group were significantly 
more distressed at 1 month after screening than were those with normal mammograms. However, this 
similarity had disappeared 5 months later, when, although the level of distress was higher than in the 
normal mammogram group, it was no longer significantly higher in the FHBC false-positive population. 
The results from the positive PCQ may shed some light on this, as women with a false-positive result 
scored statistically significantly higher at 1 month after assessment than those with normal mammograms 
(27%) and reported that they felt more positive about the benefits of screening than at their previous visit 
(55%). It may be that the women with a FHBC were anticipating a malignant result and felt reassured by 
having further tests that they remained free of cancer, whereas those in the general population believed 
they were well and were shocked when they were recalled. A few months later the negative effects of the 
false-positive experience had diminished for both populations. However, women with a FHBC still reported 
a statistically significantly more positive attitude to screening at 6 months after their last screening 
appointment than those who had a normal result in the FHBC population, although multiple regression 
indicated that a false-positive outcome was predictive of distress 1 month after screening.
Unfortunately, there are currently (2011) no published qualitative interview studies among members 
of the normal-risk UK population who have experienced a false-positive mammogram to help us better 
understand these differences and Clements et al.’s results.107 It would seem likely that women in the 
general population approach breast screening with a different belief; they have no reason to anticipate 
breast cancer and believe themselves to be well. As Wardle and Pope120 surmise, their view of themselves 
as healthy people is challenged by being recalled and the spectre of cancer looms large. This is a very 
different scenario to those women with a family history of the disease, who may carry the belief that 
they will one day develop breast cancer.121 Therefore, rather than seeing two assessments (screening and 
follow-up tests) as giving increased reassurance of good health, women in the general population may 
view being recalled as undermining their belief in their good health. In the absence of qualitative interview 
evidence in the general population, this is, of course, speculative.
Impact of a false-positive mammogram on returning for routine screening
Actual reattendance
The results from the large data registry review of mammography screening attendance in East Anglia by 
McCann et al.61 (n = 140,387) show that women who had a false-positive mammogram were less likely 
than those with normal mammograms to reattend 3 years later for their next routine breast screen (RR 
0.97; 95% CI 0.96 to 0.98). Additionally, women who had a biopsy in order to rule out cancer were 
less likely to reattend than those who were assessed by other methods (RR 0.93; 95% CI 0.89 to 0.97) 
(Table 25).
These results do not replicate those of the earlier registry study, based in central and east London, by 
O’Sullivan et al.108 (n = 5649), which found that, although reattendance rates were lower, there was no 
statistically significant difference in reattendance levels between women with normal mammograms 
and those who had false-positive ones. These findings included those who had been put on early recall 
following further assessment (Table 26).
The difference in findings may be due to differences in study design. In McCann et al.’s study,61 
participants were invited for their second round of screening, whereas O’Sullivan et al.’s participants108 
were being invited for up to their fifth screening round. Therefore, the difference in findings may 
be partly caused by a general decrease in screening attendance over time.122 However, this does not 
explain why those who attended more screenings and therefore had an increased risk of a false-positive 
mammogram should have similar levels of reattendance to those with normal mammograms in O’Sullivan 
et al.’s study.108
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The study by Brett and Austoker,59 published in 2001 (n = 505), into the psychological consequences of 
false-positive mammograms also included data on reattendance at the next screening clinic. Their results, 
which agree with those of McCann et al.,61 showed that women who had a false-positive mammogram 
were less likely to reattend screening in 3 years’ time. It is not clear how many mammography-screening 
invitations these women had received (Table 27).
This study was preceded by the RCT by Meldrum et al.,115 in 1994 (n = 3083), which aimed to find out 
the impact of invitation letters tailored to the outcome of the previous screening round (normal or false-
positive) on reattendance. Their results show that, for the standard invitation letter, those with a normal 
mammogram were more likely to reattend (74%) 3 years later, than those with a false-positive one (70%), 
although there was no statistically significant difference in the RR of attendance between the two groups 
(Table 28).
However, those with a previous false-positive mammogram who received a tailored invitation were 
more likely to reattend (82%) than those with a previous normal mammogram (74%). There was a small 
statistically significant RR for reattendance, RR 1.10 (95% CI 1.00 to 1.21) (Table 29).
Very little information is given about the subsequent interviews. Sixty-six women were interviewed about 
the acceptability and understandability of the tailored letter. No negative comments were made about 
the letter, but only one person spontaneously mentioned that the letter was tailored to her screening 
history. Most women appeared not to have paid much attention to the content as they had previously 
TABLE 25 Relative risk of reattendance at second round mammography screening (3 years later) following 
an invitation
Study group
Reattending 
(n)
Not reattending 
(n)
Reattendance,  
% (95% CI) RRa (95% CI)
Normal mammogram 93,081 15,536 85.7 (85.5 to 85.9) Baseline
False-positive – all 3981 811 83.1 (82.0 to 84.4) 0.97 (0.96 to 
0.98)****
False-positive – no biopsy 3572 706 83.5 (82.4 to 84.6) 0.97 (0.96 to 
0.99)****
False-positive – biopsy 409 105 79.6 (76.1 to 83.1) 0.93 (0.89 to 0.97)***
***p ! 0.001; ****p ! 0.0001.
a RR calculated by the authors.
Source: adapted from McCann et al.61
TABLE 26 Relative risk of reattendance at subsequent rounds of mammography screening (3 years after a 
false-positive mammogram)
Result at initial screening
Reattending, 
n (%)
Not reattending, 
n (%)
Reattendance,  
% (95% CI) RRa (95% CI)
Normal 3841 (71) 1560 (29) 71 (69.56 to 72.44) Baseline
False-positive – all 175 (71) 73 (29) 71 (64.28 to 77.72) 0.99 (0.91 to 1.08) NS
False-positive – routine recall 119 (74) 43 (26.5) 74 (66.12 to 81.88) 1.03 (0.94 to 1.13) NS
False-positive – early recall 56 (65) 30 (35) 56 (52.51 to 77.49) 0.92 (0.78 to 1.07) NS
NS, not significant.
a RR calculated by the authors.
Source: adapted from O’Sullivan et al.108
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been through the screening process. None of the non-attenders responded that the tailored letter had 
discouraged them from being screened again.
The final study that reported actual reattendance data is by Orton et al.109 (n = 1582). Their findings 
showed that more women with previous false-positive mammograms reattended mammography screening 
(92%) than those who had a normal outcome (89%). However, the RR of reattendance was not statistically 
significant (Table 30).
Intended reattendance
The evidence about women’s intention to reattend mammography screening when they have had a false-
positive mammogram is very limited. It comes only from the final paper from the OPCERG study by Brett 
and Austoker (n = 505).59 They reported the results from a questionnaire that asked participants which 
external factors had influenced their decision to attend their next routine screening in 1 months’ time. 
These factors can be seen in Table 31, the only items that women reported as worrying influences being 
magazine or newspaper articles.
TABLE 27 Relative risk of reattendance at subsequent rounds of mammography screening (3 years after a 
false-positive mammogram)
Result at initial 
screening Reattending, n (%)
Not reattending, 
n (%)
Reattendance, % 
(95% CI) RRa (95% CI)
Normal 120 (92) 10 (08) 92 (87.15 to 96.85) Baseline
False-positive 319 (85) 56 (15) 85 (81.08 to 88.92) 0.92 (0.86 to 0.98)*
*p ! 0.05.
a RR calculated by the authors.
Source: adapted from Brett and Austoker.59
TABLE 28 Relative risk of receiving a standard invitation letter on reattendance at subsequent rounds of 
mammography screening (3 years later)
Result at initial 
screening Reattending, n (%)
Not reattending, 
n (%)
Reattendance, % 
(95% CI) RRa (95% CI)
Normal 583 (74) 208 (26) 74 (71 to 77) Baseline
False-positive 78 (70) 34 (30) 70 (61 to 78) 0.94 (0.83 to 1.08) 
NS
NS, not significant.
a RR calculated by the authors.
Source: adapted from Meldrum et al.115
TABLE 29 Relative risk of receiving a tailored invitation letter on reattendance at subsequent rounds of mammography 
screening (3 years later)
Result at initial 
screening Reattending, n (%)
Not reattending, 
n (%)
Reattendance, % 
(95% CI) RRa (95% CI)
Normal 594 (74) 206 (26) 74 (70.47 to 77.53) Baseline
False-positive 94 (82) 21 (18) 84 (74.23 to 89.77) 1.10 (1.00 to 1.21)*
*p ! 0.05.
a RR calculated by the authors.
Source: adapted from Meldrum et al.115
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The logistic regression conducted by Brett et al.103 of women with false-positive mammograms 5 months 
after assessment showed that intention to attend the next screening round was not related to experiencing 
psychological distress at that time (see Table 10).
Summary: impact of false-positive mammograms on reattendance
Figure 8 compares the RRs of the actual reattendance studies. A meta-analysis was not undertaken 
because of the lack of information about the demographic profiles of participants, making it impossible 
to assess the studies’ homogeneity, together with underlying reservations about the validity of meta-
analysis of observational data which can magnify underlying bias and confounding. Two studies showed 
a statistically significant effect on reattendance [RR 0.97 (95% CI 0.96 to 0.98)]61 and [RR 0.92 (95% CI 
0.86 to 0.98)],59 whereas two did not [RR 0.99 (95% CI 0.91 to 1.08)]108 and [RR 1.03 (95% CI 0.95 to 
1.13)].109 It could be argued that most notice should be taken of the study by McCann et al.61 on the 
basis of size (n = 140,387) and quality. However, O’Sullivan et al.108 was also a large study (n = 5549) and 
showed no such effect, although their participants differed from those in the other studies as they were 
not necessarily on their second screening round and there may be an effect of repeated screening reducing 
attendance.122 The smallest study was by Brett and Austoker (n = 505)59 who found that significantly more 
women with false-positive mammograms failed to reattend the second round of screening, whereas Orton 
et al. (n = 1582)109 found a non-statistically significant trend in the opposite direction.
There is some evidence, from the only RCT in this systematic review, that these reattendance figures can be 
improved for the false-positive group by sending women tailored invitation letters for the next screening 
round that refer back to their previous outcome. The data from Brett and Austoker59 on external influences 
on reattendance following a false-positive mammogram indicate that the media may have a greater 
TABLE 30 Relative risk of reattendance at subsequent rounds of mammography screening (3 years after a 
false-positive mammogram)
Result at initial 
screening Reattending, n (%)
Not reattending, 
n (%)
Reattendance, % 
(95% CI) RRa (95% CI)
Normal 1362 (89) 170 (11) 89 (87.43 to 90.57) Baseline
False-positive 46 (92) 4 (08) 92 (84.48 to 99.52) 1.03 (0.95 to 1.13) NS
NS, not significant.
a RR calculated by the authors.
Source: adapted from Orton et al.109
TABLE 31 External factors influencing attitudes and anxiety about attending the next routine breast screening in 
women with a previous false-positive mammogram (35 months later)
Item n/N % (95% CI) Cause worry %
Magazine or newspaper article 83/288 29 (24 to 34) 11
Television programme 72/288 25 (20 to 30) 9
GP attitude to screening 69/288 24 (19 to 29) –
Friend 60/288 21 (16 to 26) –
Poster or leaflet 50/288 17 (13 to 22) –
Family  47/288 16 (12 to 20) –
Radio programme 37/288 13 (9 to 17) –
Source: adapted from Brett and Austoker.59
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influence than GP, family or friends. The availability of a CNS at screening clinics, as well as assessment 
clinics, may help to answer questions and concerns resulting from the media.
Overall, it seems likely that the experience of having a false-positive mammogram has a detrimental effect 
on next-round screening attendance. Future studies should collect demographic information so that their 
data can be reasonably compared in meta-analysis and this hypothesis can be tested.
Interventions to reduce the impact of false-positive mammograms
As mentioned in Interventions to reduce the impact of being recalled for further assessment we found no 
studies that directly addressed this issue. However, two studies were found that looked at the information 
needs of women who are recalled after screening. The initial results from the multicentre OPCERG study by 
Austoker and Ong112 (n = 1493) found that 92% of women were distressed or very distressed when they 
received their recall letter for assessment following a screening mammogram. Although no standardised 
measures of anxiety were taken, the quotes from the answers to the open questions in Table 32 give an 
indication of the range of responses.
Further results from the questionnaire compared the responses of women who had been given particular 
items of information in recall letters or leaflets with those who had not. Austoker and Ong112 found 
that for all items women wanted more information; this was especially the case when the item was 
not mentioned in the recall literature. The item that the greatest proportion of women wanted more 
information about was the reason for their recall (item mentioned in recall literature 36%, item not 
mentioned in recall literature 46%) (Table 33).
Austoker and Ong112 then compared the level of distress at being recalled with the reported need for more 
information using an ad hoc questionnaire. They found that women who were distressed or very distressed 
at being recalled reported a greater need for more information than women who were somewhat or not 
at all distressed at the prospect of further assessment. The items with the strongest relationship between 
distress and information need were ‘wanting to have more information about why they were recalled’, RR 
1.84 (95% CI 1.58 to 2.14), and ‘more information about how to get more information’, RR 1.55 (95% CI 
1.27 to 1.89) (Table 34).
Austoker and Ong112 also examined the information in the initial invitation to screening and compared 
levels of distress, using an ad hoc questionnaire, with whether or not the initial invitation referred to the 
possibility of recall. They found that when this was not mentioned in the letter or leaflet that women 
were more likely to be distressed or very distressed if they were recalled, RR 0.76 (95% CI 0.58 to 0.99). 
They also found an additional benefit from having an information leaflet as well as a recall letter. The RR 
of finding an aspect of the information about recall reassuring increased statistically significantly when 
participants were also given an information leaflet, RR 4.04 (95% CI 3.10 to 5.26). Having an additional 
leaflet also increased women’s belief that they understood the assessment procedure, RR 1.27 (95% CI 
1.22 to 1.33).
Study ID RR (95% CI)
McCann et al. 0.97 (0.96 to 0.98)
O’Sullivan et al. 0.99 (0.91 to 1.08)
Brett and Austoker 0.92 (0.86 to 0.98)
Orton et al. 1.03 (0.95 to 1.13)
10.86 0.92 1.08 1.13
FIGURE 8 Forest plot of the likelihood of failing to reattend the next round of mammography screening following a 
false-positive mammogram compared with a normal one.
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TABLE 32 Reaction of women receiving a recall letter
Reaction
n (%) 
women Sample comments
Pleased 30 (2) Very pleased to think I was having a proper check
Neutral/not distressed 87 (6) I just felt normal
Somewhat distressed 497 (34) Concerned though not unduly
I felt rather apprehensive
Nervous, but I think it is a good thing
Unpleasantly apprehensive
Distressed 415 (28) Nervous and very apprehensive
Anxious and worried
Frightened and worried
Worried, afraid
Very distressed 439 (30) I felt the whole bottom had fallen out of my world
I felt sick then faint, then I cried then I kept thinking what I have to do if I 
have cancer
Worried to death
Panic stricken, depressed. Convinced I was going to die
Completely devastated. Reason abandoned me
All women 1468 (100)
Source: adapted from Austoker and Ong.112
TABLE 33 Comparison of the reported need for more information 
Item
Item mentioned in letter/leaflet
Item not mentioned in letter/
leaflet
Women wanting more 
information
Women wanting more 
information
% n/N % n/N
Why they were recalled 36 383/1070 46 179/388**
What tests would be done 11 65/606 35 298/847****
Who could come with them 5 44/888 35 148/419****
How to get more information 18 143/783 33 212/633****
Who they would see 13 168/1266 33 62/186****
How long the appointment would take 8 17/222 28 248/900****
How to get to the centre 8 71/854 26 75/290****
How to change the appointment 2 33/1436 –  
**p ! 0.01; ****p ! 0.0001.
Source: adapted from Austoker and Ong.112
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Austoker and Ong112 categorised words and phrases in the recall letter and information sheet, according 
to responses in the questionnaire and women’s additional comments, to produce lists of information that 
were either reassuring or worrying (Table 35).
The study that followed on from this initial research into the information needs of recalled women, by 
Ong et al.,111 used the categories developed above to evaluate the recall information letters and leaflets 
sent out by all the assessment centres in the UK. Of the total 87 centres, 84 (97%) sent their materials 
for evaluation.
The authors found that 99% of the information sent out with the initial screening invitation referred to the 
possibility of recall (Table 36).
When Ong et al. 111 compared the list of ‘worrying information’ with that contained in the recall letters and 
leaflets they found that 54% of the literature included one of these items (Table 37).
An examination of stress-relieving information found that 83% of recall literature contained at least one 
item (Table 38).
The data from the Austoker and Ong112 study was further analysed by Ong and Austoker110 (n = 1493) 
to find out women’s views of the quality of communication at the assessment clinic, how this related 
to their level of distress and what role a breast care nurse might play in mitigating this distress. Table 39 
shows that there was a strong link between whether or not participants would have liked to have talked 
with someone at the assessment centre [RR 1.42 (95% CI 1.15 to 1.74)], whether or not they thought 
they were given enough information about their physical examination [RR 1.71 (95% CI 1.02 to 2.86)] or 
X-rays [RR 2.34 (95% CI 1.47 to 3.73)] and whether they were distressed/very distressed or somewhat/not 
distressed about being recalled.
The results in Table 40 clearly show that the availability of a breast care nurse at an assessment centre 
greatly increased the probability that participants would have talked to somebody at the centre about the 
TABLE 34 Comparison of the level of distress with the need for more information
Item
Distressed/very 
distressed women
Somewhat/not 
distressed women
RR (95% CI)
Women wanting 
more information
Women wanting 
more information
% n/N % n/N
Why they were recalled 48 403/834 26 157/598 1.84 (1.58 to 2.14)****
How to get more information 29 237/811 19 116/616 1.55 (1.28 to 1.89)****
What tests would be done 27 224/828 22 130/599 1.25 (1.03 to 1.51)*
How long the appointment would take 27 173/640 20 93/466 1.35 (1.08 to1.69)**
Who they would see 18 146/826 13 80/598 1.32 (1.03 to 1.70)*
Who could come with them 13 102/762 17 94/557 0.79 (0.61 to 1.03) NS
How to get to the centre 13 83/659 13 64/497 0.98 (0.72 to 1.33) NS
How to change the appointment 2 18/824 3 15/523 0.76 (0.39 to 1.50) NS
*p ! 0.05; **p ! 0.01; ***p ! 0.0001; NS, not significant.
Source: adapted from Austoker and Ong.112
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TABLE 35 Categorisation of written information in the letters and information leaflets
Reassuring aspects of the information Worrying aspects of the information 
To receive a leaflet describing assessment as 
well as the recall letter
Receiving the recall letter on a Saturday
To be told that ‘being recalled is part of routine 
(or second stage) screening’ or that ‘the great 
majority are found to have normal breasts’
The waiting time between receiving the recall letter and the 
appointment
To be told in the recall letter that more 
information can be obtained by phoning the 
centre
The vagueness of reasons given for recall – for example, ‘for a variety of 
reasons the tests have to be repeated’
To be told that the woman could contact the 
breast care nurse at the centre
Being told ‘not to worry’ or ‘not to be alarmed’
To be told when women will receive the results Being told that the mammogram had been ‘unclear’ 
Being told that the reason for being recalled would be given to the 
women when they were seen at the centre, the implication being that 
the centres knew something (assumed to be bad news) that was being 
withheld from the women
Using the word ‘cancer’ specifically in the context of recall in the initial 
letter of invitation for mammography
Using the words ‘cancer’, ‘something wrong’, ‘treatment’ or 
‘abnormality’ in the recall letter
Recall letters stating that ‘in the majority of women the results of the 
second visit show that they do not have cancer’ rather than ‘most of 
these (recalled) women are found to have normal breasts’
Being told in the recall letter/leaflet that assessment was at a hospital 
rather than a centre/unit/clinic
Being told that women would be seen ‘by a team of specialists’
Being told that the women could contact a nurse ‘counsellor’ (rather 
than a ‘breast care nurse’, which was reassuring), or that a ‘counsellor’ 
would be available at the centre
Being given detailed descriptions in the recall leaflet about FNA
Source: adapted from Austoker and Ong.112
TABLE 36 Probability of information about the possibility of recall being mentioned in the initial screening invitation
Topic
Mentioned in any of the written information: Mentioned in 
neither leaflet 
nor letter nor 
GP letter, % 
(no.) of centres
In the letter, % 
(no.) of centres
In GP letter, % 
(no.) of centres
In the leaflet, % 
(no.) of centres
In both letter 
and leaflet, % 
(no.) of centres
Possibility of recall 46 (39/84) 5 (4/84) 99 (83/84) 45 (38/84) 1 (1/84)
Source: adapted from Ong et al.111
reason for their recall, RR 0.62 (95% CI 0.59 to 0.66). Where the opportunity to talk to someone was not 
available women were far more likely to have liked to talk to someone, RR 7.46 (95% CI 4.57 to 12.16). 
Women were also more likely to have had their assessment tests explained to them and not to need more 
information about their tests if a breast care nurse was available at the assessment centre (see Table 40).
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The final study in this section is the survey of user satisfaction with the Leicestershire breast screening 
service by Smith et al.113 (n = 103). Table 41 shows that they found that 75% of participants were upset or 
very upset when they received their recall letter.
The results of the survey about how satisfied the women were with information given in different versions 
of the recall letter about the reason for their recall and what would happen at the clinic showed that 
satisfaction varied considerably between the versions of the letter. Women were most satisfied with letter 
three that gave the most information about what would happen at the clinic and least satisfied with letter 
one that gave minimal information (Table 42).
TABLE 37 Particularly worrying information found in the recall letter or leaflet
Topics mentioned
Mentioned in any of the written information:
Mentioned in 
neither recall leaflet 
nor recall letter, % 
(no.) of centres
In recall 
letter, % (no.) 
of centres
In recall 
leaflet, % (no.) 
of centres
In both recall 
leaflet and letter, 
% (no.) of centres
One or more worrying items 43 (35/82) 18 (15/82) 7 (6/82) 46 (38/82)
Word ‘cancer’ 9 (7/82) 10 (8/82) 1 (1/82) 83 (68/82)
Words ‘treatment’, ‘something 
wrong’, ‘abnormality’, or 
‘abnormal area of the breast’
20 (16/82) 4 (3/82) 1 (1/82) 78 (64/82)
Word ‘hospital’a 10 (8/82) 1 (1/82) 0 89 (73/82)
Words ‘not to worry’b 22 (18/82) 1 (1/82) 0 77 (63/82)
Phrase ‘nurse counsellor’ 5 (4/82) 9 (7/82) 0 87 (71/82)
a ‘Hospital’ was only counted when it was mentioned other than in the context of address or directions.
b  Similar phrases counted were, ‘not to be alarmed’, ‘not to be concerned’, ‘not to feel anxious’, ‘no cause 
for concern’.
Source: adapted from Ong et al.111
TABLE 38 Particularly reassuring information in the recall letters or leaflets
Topics mentioned
Mentioned in any of the written information: Mentioned in 
neither recall 
leaflet nor recall 
letter, % (no.) of 
centres
In recall letter, % 
(no.) of centres
In recall leaflet, % 
(no.) of centres
In both recall 
leaflet and letter, 
% (no.) of centres
One or more stress-relieving 
messages
68 (56/82) 33 (27/82) 20 (16/82) 17 (14/82)
Recall is part of second 
stage/routine screening
46 (77/82) 26 (3/82) 11 (9/82) 38 (31/82)
Most recalled women are 
found to have normal 
breasts
28 (23/82) 6 (5/82) 4 (3/82) 30 (25/82)
A substantial number of 
women are recalled 
32 (26/82) 11 (9/82) 1 (1/82) 60 (49/82)
Source: adapted from Ong et al.111
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TABLE 39 Communication at the assessment centre and level of distress
Communication
Distressed/very distressed Somewhat/not distressed
RR (95% CI)% (n/N) 95% CI % (n/N) 95% CI
Women who had not had the opportunity 
to talk with a health worker at the centre 
about the reason for recall
33 
(275/835)
0.30 to 0.36 32 
(191/597)
0.28 to 0.36 1.03 (0.88 
to 1.20) NS
Women who would have liked to talk about 
the reason for recall
26 
(214/835)
0.23 to 0.29 18 
(108/597)
0.15 to 0.21 1.42 (1.15 
to 1.74)****
Women who thought they were not given 
enough information about their physical 
examination 
6 (46/757) 0.04 to 0.08 4 (20/563) 0.02 to 0.05 1.71 (1.02 
to 2.86)****
Women who thought they were not given 
enough information about their X-rays
9 (72/773) 0.07 to 0.12 4 (22/553) 0.03 to 0.06 2.34 (1.47 
to 3.73)****
****p ! 0.0001; NS, not significant.
a RR calculated by the authors.
Source: adapted from Ong and Austoker.110
TABLE 40 Communication at the assessment centre and the role of breast care nurses
Communication
Centres where women were 
not systematically provided 
with the opportunity to talk 
immediately before tests
Centres where the breast 
care nurse provided women 
with the opportunity to 
talk in private immediately 
before tests
RR (95% CI)% (n/N) 95% CI % (n/N) 95% CI
Women who had talked at the centre about the reason for recall
With ‘somebody at the 
centre’
58 (611/1055) 0.55 to 0.61 93 (374/401) 0.90 to 0.96 0.62 (0.59 to 0.66)****
With a doctor or 
radiologist
31 (323/1035) 0.28 to 0.34 7 (26/391) 0.04 to 0.10 4.69 (3.20 to 6.88)****
With a nurse 9 (97/1035) 0.08 to 0.11 60 (234/391) 0.55 to 0.65 0.16 (0.13 to 0.19)****
Women who would have 
liked to talk about reason 
for recall
30 (310/1039) 0.27 to 0.33 4 (16/400) 0.02 to 0.06 7.46 (4.57 to 12.16)****
Women who stated that the tests they had were not explained to them
Physical examination by 
a doctor
8 (82/981) 0.07 to 0.10 2 (7/381) 0.01 to 0.04 4.55 (2.12 to 9.75)****
X-rays 9 (88/996) 0.05 to 0.11 1 (5/379) 0.00 to 0.03 6.70 (2.74 to 16.36)****
Ultrasound 9 (39/413) 0.07 to 0.13 2 (5/212) 0.01 to 0.05 4.00 (1.60 to 10.01)***
Women who wanted more information about their tests
Physical examination by 
a doctor
6 (59/964) 0.05 to 0.08 2 (7/378) 0.01 to 0.04 3.31 (1.52 to 7.17)***
X-rays 7 (68/971) 0.05 to 0.09 2 (8/376) 0.01 to 0.04 3.29 (1.60 to 6.78)***
Ultrasound 10 (39/401) 0.07 to 0.13 3 (6/209) 0.01 to 0.06 3.39 (1.46 to 7.87)***
***p ! 0.001; ****p ! 0.0001.
a RR calculated by the authors.
Source: adapted from Ong and Austoker.110
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When participants were asked if they would have telephoned a breast care nurse if one was available, 98% 
said they would and 100% of the women who received letter two with the breast care nurse’s telephone 
number used this facility (Table 43).
Summary: interventions to reduce the impact of false-positive mammograms
The results from these studies evidently show that most women want clear information about the reason 
for their recall and what will happen to them at their assessment and that having this information can 
reduce stress levels; however, too much information about the process of FNA was considered stressful. 
There was a benefit from having a recall leaflet as well as a letter, as this increased the likelihood that 
women believed they understood what would happen to them. The level of stress experienced by women 
when they were recalled was increased if the possibility of recall was not mentioned in the original 
screening invitation. The value of having a breast care nurse to talk to is very apparent by increasing 
satisfaction with the process of assessment, reducing distress and satisfying the need to have someone 
at the clinic to talk to. It is also interesting to note the effect of language in the recall literature, with 
54% of the recall literature containing at least one worrying item and 83% containing at least one 
stress-relieving message.
TABLE 41 How women felt when they received their invitation letter to return for further assessment
Reaction n/%
Positive (e.g. ‘glad to be in such capable hands’) 4
Neutral (e.g. ‘I wasn’t bothered’) 10
Surprised 11
Upset (e.g. ‘anxious’, ‘worried’, ‘upset’) 44
Very upset (e.g. ‘terrified’, ‘extremely anxious’) 31
Total 100
Not all participants answered all questions.
Source: adapted from Smith et al.113
TABLE 42 Satisfaction of women with information about why they had to return to clinic and what would 
happen there
Letter version
Reasons for recall  
n (%)
Events at the clinic 
n (%)
1. Minimal information about possible tests 15(50) 17 (63)
2. Offer of telephoning a breast care nurse for more information 25 (71) 24 (74)
3. Similar to letter one but with more detail about what would 
happen at the clinic
26 (81) 27 (90)
All versions 66 (68) 68 (76)
Chi-squared 7.243 5.817
p-value 0.027 0.055
Source: adapted from Smith et al.113
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TABLE 43 Likelihood of phoning a breast care nurse
Letter version Answer n
1 – would telephone the BCN Yes 25
No 0
2 – did telephone the BCN Yes 13
No 0
3 – would telephone the BCN Yes 17
No 1
BCN, breast care nurse.
Source: adapted from Smith et al.113

© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
71
Chapter 4 Discussion
Statement of principal findings
The aim of this systematic review was to identify the psychological impact on women of false-positive 
screening mammograms and any evidence for the effectiveness of interventions designed to reduce this 
impact. We were also looking for evidence of effects in subgroups of women.
Our searches retrieved 4423 titles and abstracts after deduplication. When screening was complete, we 
found five systematic reviews,62,82,85–87 one meta-analysis and 11 primary studies that met our inclusion 
criteria. No studies were found that were either about or reported subgroups of women from different 
ethnic, socioeconomic or other groups within the general screening population. One study101,102,107 was 
found that included women who had a false-positive mammogram and a FHBC. The quality of the primary 
research was variable: we found one poor-quality RCT115 and 10 observational studies.55,59,61,101–114 The best-
quality observational research was conducted by OPCERG and PIMMS groups and the observational studies 
reporting reattendance rates. However, even here there were shortcomings in reporting key information. 
Overall, the main weaknesses in reporting were a failure to consider the possible effects of bias and 
confounding on the results and a failure to report participants’ demographic and other characteristics, 
making the interpretation of the results very difficult. These quality indicators appear to have been 
overlooked, as, in most cases, there was no consideration of the limitations of the methods or conduct of 
the study. Therefore, the results of this systematic review must be treated with caution, not just because 
they come from a limited number of observational studies, but also because many of these studies lack 
methodological robustness.
General population
The studies of the psychological impact of false-positive mammograms in the general population gave 
conflicting results. When disease-specific measures were used (PCQ), an enduring negative impact was 
found that lasted until 35 months from the last assessment. The degree of distress found was related 
to the level of invasiveness of the method of assessment used so that, at 35 months, women who had 
a biopsy were more distressed (RR 2.07; 95% CI 1.22 to 3.52) than women who had FNA (RR 1.80; 
95% CI 1.17 to 2.77) and, non-significantly, further mammography (RR 1.28; 95% CI 0.82 to 2.00). 
Additionally, women placed on early recall were also at a greater RR of distress (RR 1.82; 95% CI 1.22 
to 2.72). The greatest RR of distress was felt at 5 months after assessment and was significant for all 
assessment procedures.
Further evidence of psychological distress came from results of a comparison of the frequency of breast 
self-examination of women who had false-positive or normal mammograms. This found that significantly 
more women who were recalled examined themselves once a week or more often, which may be taken as 
a proxy for anxiety although the meaning of this behaviour is unclear.
Conversely, when generic measures of clinical levels of general anxiety and depression were used (HADS 
and GHQ-28) no significant differences were found between the two groups at 6 weeks after assessment 
and 3 months after screening.
Therefore, it may be reasonable to speculate that, for those in the general population, having a false-
positive screening mammogram can cause breast cancer-specific psychological distress that may endure 
for up to 3 years. However, it is less likely that there will be general anxiety detectable at clinically 
recognisable levels.
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Family history of breast cancer population
These results draw a slightly different picture to those in the general-risk population. Here the 
psychological distress of the false-positive group was statistically significantly greater than the normal 
group only at 1 month after screening [negative PCQ, difference in means 2.92 (95% CI 4.05 to 1.69)]. At 
the same time the false-positive group also scored significantly higher on the positive PCQ than those with 
normal mammograms (Mann–Whitney U-test  51,561; p ! 0.05). They also rated the benefits of screening 
more highly than those with normal mammograms at 1 (T2) and 6 months (T3) after screening on an ad 
hoc questionnaire [OR: T2, 3.17 (95% CI 2.14 to 4.70); T3, 2.35 (95% CI 1.53 to 3.61)]. These results may 
appear to be conflicting at first glance. However, the summary results from the unpublished interview 
study suggest that the women in the false-positive group may have been rationalising their anxiety at 
being recalled by reassuring themselves that this meant that the programme was thorough and would 
detect early cancer that could be treated.
Impact of a false-positive mammogram on returning for routine screening
The evidence for the impact of having a false-positive mammogram on returning for the next screening 
round is conflicting. It comes mainly from four retrospective observational studies55,61,108,109 that collected 
data from registries and other NHS databases. The weight of evidence, in terms of the numbers of 
participants, is that women with false-positive mammograms are less likely to return for their next round 
of screening than women with normal mammograms. The largest study61 with this finding (n = 140,387) 
had a RR of not returning of 0.97 (95% CI 0.96 to 0.98). Two studies108,109 with a combined population 
of 7231 found that there was no such association. Evidence from a poor-quality RCT115 suggests that this 
finding can be reversed if women are given screening invitation letters that are tailored to the outcome of 
their last screening (RR 1.10; 95% CI 1.00 to 1.21).
Interventions to reduce the impact of false-positive mammograms
The above evidence suggests that in the general population there is a negative psychological impact from 
having a false-positive mammogram that may endure for 3 years and may deter women from attending 
their next round of screening. Unfortunately, we were unable to find any studies that directly addressed 
these problems. Nevertheless, we identified two studies110–113 that looked at the information needs of 
women who were recalled and the importance of communication. These studies showed that women 
wanted clear information about the reason they had been recalled. However, the ability of clinicians to 
address this is limited by the need to stage the information to ensure direct and face-to-face support in 
cases where radiologists are reasonably sure that the screening mammogram indicates cancer. Women 
also indicated that they wanted clear information about what would happen at their assessment, as 
well as access to a breast care nurse or CNS to talk through their concerns. Satisfaction with the service 
increased if women were sent a recall leaflet as well as a letter as participants believed that they had better 
understanding of what would happen to them at the assessment clinic. The importance of the language 
used in the recall literature was also evident, with particular words and phrases reducing or increasing 
stress. The research by the OPCERG was used to produce national guidelines on improving the quality of 
written information sent to women who were recalled for assessment in 1998.114
These intervention studies are more than 10 years old, and it is unknown whether or not the 
recommendations in the national guidelines have been implemented. There is currently no national recall 
information leaflet similar to the NHS breast-screening leaflet.
Comparison with other systematic reviews
With the exception of the systematic review by Bankhead et al.,84 the quality of the included secondary 
research was not very high. Of particular concern was the lack of consideration of the effects of bias and 
confounding in their included observational studies.
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Our results agree with those of previous systematic reviews and meta-analyses. In particular, we agree with 
all these evidence syntheses that there can be negative psychological consequences from having a false-
positive mammogram. We also supported their finding that having a false-positive mammogram increased 
the frequency of breast self-examination, which may be a proxy for anxiety. The meta-analysis by Salz et 
al.85 that compared outcomes measured by disease-specific or generic measures of psychological distress 
agrees with our finding that the type of outcome measure used can affect whether or not an outcome 
is found to be statistically significant, although, unlike Salz et al.,85 we were unable to find evidence of 
anxiety at clinical levels. We also agree with the finding that the evidence about reattendance is conflicted. 
However, the weight of evidence suggests that women with this result are less likely to reattend.
Strengths and limitations
The strengths of this systematic review are that it was conducted by an independent research team 
using robust methods. Our searches were comprehensive and we believe that we have retrieved all 
includable studies.
The systematic review may have been influenced by publication bias. However, there were insufficient 
studies in each domain to produce a funnel plot that would give meaningful information.
The robustness of the findings of this systematic review is limited by the reliability of the included studies. 
With the exception of one weak RCT all the studies were observational and so subject to the risks of bias 
and confounding that are associated with these designs, compounded by lack of reporting key information 
such as the baseline characteristics of the groups. However, the nature of the subject under study 
necessitates observational designs; therefore, great care should be taken in matching groups and reporting 
their characteristics.

© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
75
Chapter 5 Conclusions
We conclude that the experience of having a false-positive screening mammogram, in the general risk of breast cancer population, can cause breast cancer-specific psychological distress that may 
endure for up to 3 years. However, it is less likely that there will be general anxiety detectable at clinically 
recognisable levels. The likelihood of women experiencing distress may be determined by the degree of 
invasiveness of the assessment procedure, with more invasive techniques increasing the probability of 
psychological distress.
The strongest evidence suggests that the distress caused by a false-positive mammogram may be sufficient 
to deter an additional 3% of women from attending their next breast cancer screening appointment.
It is important to provide women who are recalled with clear, carefully worded information about 
the reason for their recall and the process of the assessment (but not in such detail that they become 
distressed without the support of the screening staff being present), and to have a breast care nurse or 
CNS available to answer any concerns they may have.
There is some evidence that having a subsequent round of screening invitation letter that refers to the 
outcome of the previous screening round may encourage women with false-positive mammograms 
to reattend.
For women with a FHBC, having a false-positive mammogram, while increasing levels of distress, may 
also reassure them that they are being well looked after and that early cancer will be detected that could 
be treated.
Additionally, the evidence suggests that women with false-positive mammograms are at three times 
greater risk of interval cancer than those with normal mammograms and are more than twice as likely to 
have cancer detected at the next screening round. The reasons for this finding need further explanation.
Implications for health care
The evidence suggests that the availability of a CNS at screening clinics as well as assessment clinics 
may help to allay concerns raised by information sources other than official literature. There is also 
some evidence that including a reference to the previous recall in the next round invitation letter may 
facilitate attendance.
Research recommendations
The evidence found by this systematic review in the general population is at least 10 years old. Up-to-date 
studies are needed that reflect current screening practice.
1. A qualitative interview study of the general population of women who have had false-positive 
screening mammograms, in order to understand what this experience means to them.
2. Well-designed observational studies, in the general screening population, that use disease-specific 
and generic outcome measures in order to determine the level of severity of negative psychological 
outcomes. Including studies of women from different ethnic and socioeconomic groups.
3. The routine collection of demographic information in observational studies so that future systematic 
reviews may be able to judge whether or not the pooling of data is possible.
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4. Currently there is no standard national recall letter following a suspicious screening mammogram. 
There should be a national survey of the recall literature sent out from NHSBSP services to see if the 
national guidelines produced in 1998 are being adhered to, followed by the development of such 
a letter.
5. There is some evidence to suggest that there may be a relationship between tailored invitation letters 
for next screening round for women who have had false-positive mammograms and reattendance. A 
well-designed RCT would be able to help us understand whether or not this relationship exists and a 
nested qualitative study would give insight into the important features of such a letter.
6. Developmental and pilot work of interventions both to relieve the distress of false-positive 
mammograms and to encourage women with this outcome to reattend routine screening. 
Promising interventions should then be tested in well-designed RCTs sufficiently powered to allow for 
subgroup analysis.
A list of ongoing studies can be found in Appendix 4. We found no ongoing UK studies about 
false-positive mammograms.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
77
Acknowledgements
We would like to acknowledge Jenny Lowe and Sue Whiffin for their administrative support and especially Jaime Peters for her statistical advice.
Expert Advisory Group
We would particularly like to thank our expert advisors:
Ms Kate Blackmore Patient representative.
Dr Russell Davies Consultant radiologist, Royal Devon & Exeter NHS Foundation Trust.
Professor Jenny Hewison Professor of the Psychology of Healthcare, University of Leeds.
Ms Sue Milward Patient representative.
Professor Carl Roobottom Consultant radiologist, Plymouth Hospitals NHS Trust.
Dr Jim Steel Director of Screening, Consultant breast radiologist,  
Plymouth Hospitals NHS Trust.
Contributions of authors
Mary Bond  
(Senior Research Fellow, HTA)
Provided project management, wrote the protocol, codesigned the 
searches, led the systematic review, wrote and edited the report. This 
systematic review is part of a continuing research project and PhD 
supported by the Collaboration for Leadership in Applied Health Research 
and Care (PenCLAHRC).
Toby Pavey  
(Research Fellow, HTA)
Acted as second reviewer and commented on the draught report.
Karen Welch  
(Information Specialist)
Designed and undertook literature searches.
Chris Cooper  
(Information Specialist)
Designed and undertook literature searches and commented on the 
draught report.
Ruth Garside  
(Senior Research Fellow, HTA)
Qualitative research advisor and commented on the draught report.
Sarah Dean  
(Senior Lecturer, HSR)
Health psychology advisor and commented on the draught report.
Chris Hyde  
(Professor Public Health and 
Clinical Epidemiology)
Commented on the draught report and was overall director and guarantor 
of the report.
About the Peninsula Technology Assessment Group
The Peninsula Technology Assessment Group (PenTAG) is part of the Institute of Health Service Research 
at the Peninsula Medical School. PenTAG was established in 2000 and currently has three major work 
streams; independent Health Technology Assessments for NICE and the NIHR HTA Programme, systematic 
reviews as part of the Cochrane Collaboration Heart Group and evidence synthesis work in relation to the 
needs of PenCLAHRC, as well as for other local and national decision-makers.
NIHR Journals Library
ACKNOWLEDGEMENTS
78
The group is multidisciplinary and draws on individuals’ backgrounds in public health, health services 
research, computing and decision analysis, systematic reviewing, statistics and health economics. The 
Peninsula Medical School is a school within the Universities of Plymouth and Exeter. The Institute of Health 
Research is made up of discrete but methodologically related research groups, among which Health 
Technology Assessment is a strong and recurring theme. Recent PenTAG HTA projects include:
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, et al. The effectiveness and cost-effectiveness 
of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review 
of TA111): a systematic review and economic model. Health Technol Assess 2012;16(21).
Thompson Coon J, Hoyle M, Green C, Liu Z, Welch K, Moxham T, et al. Bevacizumab, sorafenib tosylate, 
sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health 
Technol Assess 2010;14(2).
Hoyle M, Crathorne L, Garside R, Hyde C. Ofatumumab (Arzerra®) for the treatment of chronic lymphocytic 
leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission 
from GSK. Health Technol Assess 2011;15(Suppl. 1).
Rogers G, Hoyle M, Thompson-Coon J, Pitt M, Moxham T, Liu Z, et al. Dasatinib and nilotinib for imatinib-
resistant or intolerant chronic myeloid leukaemia: a systematic review and economic evaluation. Health 
Technol Assess 2012;16(22).
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
79
References
1. Forrest P. Breast cancer screening. Report to the Health Ministers of England, Wales, Scotland and 
Northern Ireland. London: HMSO; 1986.
2. The NHS Information Centre PHIT. Breast screening results from the NHSBSP 2009–10. 2011. URL: 
www.cancerscreening.nhs.uk/breastscreen/statistics.html (cited 28 March 2011).
3. World Health Organisation (WHO) International Agency for Research on Cancer. Breast cancer 
screening. International Agency for Research on Cancer. WHO; 2002.
4. Cancer Research UK. Breast cancer-UK incidence statistics. 2010. URL: http://info.cancerresearchuk.
org (cited 4 May 2010).
5. Beral V, Banks E, Reeves G, Wallis M. Hormone replacement therapy and high incidence of breast 
cancer between mammographic screens. Lancet 1997;349:1103–4. http://dx.doi.org/10.1016/
S0140-6736(05)62328-8 
6. Quinn MJ, Cooper N, Rachet B, Mitry E, Coleman MP. Survival from cancer of the breast in 
women in England and Wales up to 2001. Br J Cancer 2008;99(Suppl. 1):S53–S55. http://dx.doi.
org/10.1038/sj.bjc.6604587
7. Parsa P, Parsa B. Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac 
J Cancer Prev 2009;10:545–50.
8. Office for National Statistics. Cancer statistics registrations: registrations of cancer diagnosed in 
2007, England. London: National Statistics; 2010.
9. ISD Scotland. ISD Cancer Information Programme. 2009. URL: www.isdscotland.org (cited 4 
November 2012).
10. Welsh Cancer Intelligence and Surveillance Unit. Cancer incidence in Wales. 2010. URL: www.wales.
nhs.uk (cited 4 November 2010).
11. Office for National Statistics. Breast Cancer: incidence rates rise, mortality rates fall. 2011. URL: 
www.statistics.gov.uk/CCI/nugget.asp?ID=575 (cited 29 March 2011).
12. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries 
with different levels of screening but similar access to treatment: trend analysis of WHO mortality 
database. BMJ 2011;343.
13. U.S. Preventative Services Task Force. Addendum and correction: screening for breast cancer: U.S. 
Preventive Services Task Force recommendation statement. Ann Intern Med 2010;152:688.
14. Bleyer A. US breast cancer mortality is consistent with European data. BMJ 2011;343.
15. de Koning H. Breast cancer mortality in neighbouring European countries with different levels 
of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 
2011;343:d4411. http://dx.doi.org/10.1136/bmj.d4411 
16. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst 
Rev 2011;1:CD001877.
17. Shapiro S, Venet W, Strax P. Selection, follow-up, and analysis in the health insurance plan study: a 
randomized trial with breast cancer screening. J Natl Cancer Inst Monogr 1985;67:65–74.
18. Strax P. Mass screening for breast cancer. Rev Fr Gynecol Obstet 1973;68:457–66.
NIHR Journals Library
REFERENCES
80
19. Fink R, Shapiro S, Roester R. Impact of efforts to increase participation in repetitive screenings for 
early breast cancer detection. Am J Public Health 1972;62:328–36. http://dx.doi.org/10.2105/
AJPH.62.3.328
20. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening 
and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988;297:943–
8. http://dx.doi.org/10.1136/bmj.297.6654.943
21. Andersson I. Radiographic screening for breast carcinoma. II. Prognostic considerations 
on the basis of a short-term follow-up. Acta Radiol Diagn 1981;22:227–33. http://dx.doi.
org/10.1111/j.1748-1716.1981.tb06887.x 
22. Andersson I. Radiographic screening for breast carcinoma. I. Program and primary findings in 
45–69 year old women. Acta Radiol Diagn 1981;22:185–94. 
23. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of 
mammography screening: updated overview of the Swedish randomised trials. Scand J Caring Sci 
2002;359:909–19.
24. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality 
from breast cancer after mass screening with mammography. Randomised trial from the Breast 
Cancer Screening Working Group of the Swedish National Board of Health & Welfare. Lancet 
1985;i:829–32.
25. Tabar L, Gad A. Screening for breast cancer: the Swedish trial. Radiology 1981;138:219–22. 
26. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county 
program of mammographic screening for breast cancer. Radio Clin North Am 1992;30:187–210.
27. Alexander F, Roberts MM, Lutz W, Hepburn W. Randomisation by cluster and the problem of social 
class bias. J Epidemiol Community Health 1989;43:29–36. http://dx.doi.org/10.1136/jech.43.1.29
28. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. The Edinburgh 
randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 
1994;70:542–8. http://dx.doi.org/10.1038/bjc.1994.342
29. Alexander FE, Anderson TJ, Brown HK, Forrest APM, Hepburn W, Kirkpatrick AE, et al. 14 years of 
follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999;353:1903–
8. http://dx.doi.org/10.1016/S0140-6736(98)07413-3
30. Baines CJ. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern 
Med 1994;120:326–34.
31. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study – 2: 13-year results of 
a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000;92:1490–9. http://dx.doi.
org/10.1093/jnci/92.18.1490
32. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study – 1: breast cancer 
mortality after 11 to 16 years of follow-up. Ann Intern Med 2002;137:E-305.
33. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study: update on breast 
cancer mortality. J Natl Cancer Inst Monogr 1997;22:37–41.
34. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Follow up after 11 years – update of mortality results 
in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997;45:263–70. http://
dx.doi.org/10.1023/A:1005872617944
35. Frisell J, Glas U, Hellstrom L, Somell A. Randomized mammographic screening for breast cancer in 
Stockholm. Design, first round results and comparisons. Breast Cancer Res Treat 1986;8:45–54. 
http://dx.doi.org/10.1007/BF01805924
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
81
36. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of 
mammography screening – preliminary report on mortality in the Stockholm trial. Breast Cancer Res 
Treat 1991;18:49–56. http://dx.doi.org/10.1007/BF01975443 
37. Frisell J, Eklund G, Hellstrom L, Glas U, Somell A. The Stockholm breast cancer screening trial 
– 5-year results and stage at discovery. Breast Cancer Res Treat 1989;13:79–87. http://dx.doi.
org/10.1007/BF01806553 
38. Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, et al. The Gothenburg Breast 
Screening Trial. Cancer 2003;97:2387–96. http://dx.doi.org/10.1002/cncr.11361 
39. Bjurstam N, Bjorneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, et al. The Gothenburg breast 
screening trial. Cancer 1997;80:2091–9. 
40. UK Trial. First results on mortality reduction in the UK Trial of Early Detection of Breast Cancer. UK 
Trial of Early Detection of Breast Cancer Group. Lancet 1988;[0140-6736 (Print)]. 
41. Moss S. A trial to study the effect on breast cancer mortality of annual mammographic screening in 
women starting at age 40. Trial Steering Group. J Med Screen 1999;6:144–8. 
42. Moss S, Waller M, Anderson TJ, Cuckle H (writing committee for the Trial Management Group). 
Randomised controlled trial of mammographic screening in women from age 40: predicted 
mortality based on surrogate outcome measures. Br J Cancer 2005;92:955–60. http://dx.doi.
org/10.1038/sj.bjc.6602395
43. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, et al. Effect of mammographic screening 
from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. 
2006;368:2053–60. 
44. Moss S, Thomas I, Evans A, Thomas B, Johns L. Randomised controlled trial of mammographic 
screening in women from age 40: results of screening in the first 10 years. Br J Cancer 
2005;92:949–54. http://dx.doi.org/10.1038/sj.bjc.6602396 
45. Kopans DB, Smith RA, Duffy SW. Mammographic Screening and Overdiagnosis. Radiology 
2011;260:616–20. http://dx.doi.org/10.1148/radiol.11110716
46. Otto SJ, Fracheboud J, Looman C, Broeders M, Boer R, Hendriks J, et al. Initiation of population-
based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a 
systematic review. Lancet 2003;361:1411–17. http://dx.doi.org/10.1016/S0140-6736(03)13132-7 
47. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, et al. Absolute numbers of lives 
saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast 
Screening Programme in England. J Med Screen 2010;17:25–30. http://dx.doi.org/10.1258/
jms.2009.009094
48. Wald NJ, Law MR, Duffy SW. Breast screening saves lives. BMJ 2009;339.
49. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and 
adjuvant therapy on mortality from breast cancer. 2005;353:1784–92. 
50. Duffy S. Re: Estimate of breast screening benefit was 6 times too large. 2009. URL: www.bmj.com/
cgi/eletters/338/jan27_2/b86 (cited 11 October 2011). 
51. Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, et al. The psychological effects of 
false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn 
1992;12:205–14. http://dx.doi.org/10.1002/pd.1970120309
52. French DP, Maissi E, Marteau TM. The psychological costs of inadequate cervical smear test results: 
three-month follow-up. Psychooncology 2006;15:498–508. http://dx.doi.org/10.1002/pon.980
NIHR Journals Library
REFERENCES
82
53. Lampic C, Thurfjell E, Bergh J, Sjoden P-O. Short- and long-term anxiety and depression in women 
recalled after breast cancer screening. Eur J Cancer 2001;37:463–9. http://dx.doi.org/10.1016/
S0959-8049(00)00426-3 
54. Scaf-Klomp W, Sanderman R, van de Wiel HB, Otter R, van den Heuvel WJ. Distressed or relieved? 
Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community 
Health 1997;51:705–10. http://dx.doi.org/10.1136/jech.51.6.705 
55. Sutton S, Saidi G, Bickler G, Hunter J. Does routine screening for breast cancer raise anxiety? Results 
from a three wave prospective study in England. J Epidemiol Community Health 1995;49:413–18. 
http://dx.doi.org/10.1136/jech.49.4.413
56. Aro AR, Pilvikki Absetz S, van Elderen TM, van der Ploeg E, van der Kamp LJT. False-positive findings 
in mammography screening induces short-term distress – breast cancer-specific concern prevails 
longer. Eur J Cancer 2000;36:1089–97. http://dx.doi.org/10.1016/S0959-8049(00)00065-4 
57. Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. Br J Cancer 
1990;62:1018–22. http://dx.doi.org/10.1038/bjc.1990.430
58. Burman ML, Taplin SH, Herta DF, Elmore JG. Effect of false-positive mammograms on interval breast 
cancer screening in a health maintenance organization. Ann Intern Med 1999;131:1–6.
59. Brett J, Austoker J. Women who are recalled for further investigation for breast screening: 
psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health 
2001;23:292–300. http://dx.doi.org/10.1093/pubmed/23.4.292
60. Lampic C, Thurfjell E, Sjoden P-O. The influence of a false-positive mammogram on a woman’s 
subsequent behaviour for detecting breast cancer. Eur J Cancer 2003;39:1730–7. http://dx.doi.
org/10.1016/S0959-8049(02)00451-3
61. McCann J, Stockton D, Godward S. Impact of false-positive mammography on subsequent 
screening attendance and risk of cancer. Breast Cancer Res 2002;4:R11. http://dx.doi.org/10.1186/
bcr455
62. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. 
Ann Intern Med 2007;146:502–10.
63. NHS Breast Screening Programme. Quality assurance guidelines for breast cancer screening 
radiology. Wilson R, Liston J, editors. 59. 2011. Sheffield: NHS Cancer Screening Programmes; 
2011.
64. NHS Breast Screening Programme. Clinical guidelines for breast cancer screening assessment. Liston 
J, Wilson R, editors. 49. 2010. Sheffield: NHS Cancer Screening Programmes; 2011.
65. NHS Cancer Screening Programme. Quality assurance guidelines for surgeons in breast cancer 
screening. Sibbering M, Watkins R, Winstanely J, Patnick J, editors. 20. 2009. Sheffield: NHS Cancer 
Screening Programme; 2011.
66. NHS Breast Screening Programme. Quality assurance guidelines for clinical nurse specialists in breast 
cancer screening. 29. 2008. Sheffield: NHS Cancer Screening Programmes; 2011. 
67. Cockburn J, De Luise T, Hurley S, Clover K. Development and validation of the PCQ: a questionnaire 
to measure the psychological consequences of screening mammography. So Sci Med 
1992;34:1129–34. http://dx.doi.org/10.1016/0277-9536(92)90286-Y 
68. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral 
implications of abnormal mammograms. Ann Intern Med 1991;114:657–61. 
69. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer 
screening. Health Psychol 1991;10:259–67. http://dx.doi.org/10.1037/0278-6133.10.4.259
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
83
70. Watson M, Lloyd S, Davidson J, Meyer L, Eeles R, Ebbs S, et al. The impact of genetic counselling 
on risk perception and mental health in women with a family history of breast cancer. Br J Cancer 
1999;79:868–74. http://dx.doi.org/10.1038/sj.bjc.6690139
71. Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J 
Behav Med 1997;4:92–100. http://dx.doi.org/10.1207/s15327558ijbm0401_6 
72. Goldberg D. The detection of psychiatric illness by questionnaire. Oxford: Oxford University Press; 
1972. 
73. Goldberg D, Williams P. A User’s guide to the General Health Questionnaire. London: NFER-Nelson; 
1988. 
74. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 
1983;67:361–70. http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x
75. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, 
self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 
1994;67:1063–78. http://dx.doi.org/10.1037/0022-3514.67.6.1063
76. Speilberger C. Manual for the State–Trait Anxiety Inventory: STAI (form Y). Palo Alto, CA: Consulting 
Psychologists Press; 1983. 
77. NHS Centre for Reviews and Dissemination. Systematic reviews: CRD’s guidance for undertaking 
reviews in health care. York: NHS Centre for Reviews and Dissemination; 2009. 
78. Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd 
edn. London: BMJ; 2001. http://dx.doi.org/10.1002/9780470693926
79. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and 
meta-analyses: the PRISMA statement. BMJ 2009;339.
80. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving 
the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191–4. http://dx.doi.
org/10.1016/S0140-6736(00)04337-3
81. Elm Ev, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the 
reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting 
observational studies. BMJ 2007;335:806–8. http://dx.doi.org/10.1136/bmj.39335.541782.AD
82. Brett J, Bankhead C, Henderson B, Watson E, Austoker J. The psychological impact of 
mammographic screening. A systematic review. Psycho Oncol 2005;14:917–38. http://dx.doi.
org/10.1002/pon.904
83. Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of 
complex evidence: audit of primary sources. BMJ 2005;33:1064–5. http://dx.doi.org/10.1136/
bmj.38636.593461.68
84. Bankhead CR, Brett J, Bukach C, Webster P, Stewart-Brown S, Munafo M, et al. The impact of 
screening on future health-promoting behaviours and health beliefs: a systematic review. Health 
Technol Assess 2003;7(42).
85. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on 
generic and specific psychosocial outcomes. Psycho Oncol 2010;19:1026–34. http://dx.doi.
org/10.1002/pon.1676
86. Hafslund B, Nortvedt MW. Mammography screening from the perspective of quality 
of life: a review of the literature. Scand J Caring Sci 2009;23:539–48. http://dx.doi.
org/10.1111/j.1471-6712.2008.00634.x 
NIHR Journals Library
REFERENCES
84
87. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Clinical guidelines. Screening 
mammography in women 40 to 49 years of age: a systematic review for the American College of 
Physicians. Ann Intern Med 2007;146:516. 
88. Meystre-Agustoni G, Paccaud F, Jeannin A, Dubois-Arber F. Anxiety in a cohort of Swiss women 
participating in a mammographic screening programme. J Med Screen 2001;8:213–19. http://
dx.doi.org/10.1136/jms.8.4.213 
89. Beck AT, Erbaugh J, Ward CH, Mock J, Mendelsohn M. An inventory for measuring depression. Arch 
Gen Psychiatry 1961;4:561–71. http://dx.doi.org/10.1001/archpsyc.1961.01710120031004
90. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults - 
evaluation of a short-form of the CES-D. Am J Prev Med 1994;10:77–84. 
91. Boer H. Psychological effects of breast cancer screening. Twente: University of Twente; 1993.
92. Goldberg DP. Manual of the General Health Questionnaire. Windsor: NFER-Nelson Publishing; 1978. 
93. Walker LG, Cordiner CM, Gilbert FJ, Needham G, Deans HE, Affleck IR, et al. How distressing is 
attendance for routine breast screening? Psycho Oncol 1994;3:299–304. http://dx.doi.org/10.1002/
pon.2960030406 
94. Derogatis L, Lipman RS, Rickels K, Uhlenhut E, Covi L. Hopkins Symptom Checklist (HSCL) – a self-
report symptom inventory. Behav Sci 1974;19:1–15. http://dx.doi.org/10.1002/bs.3830190102
95. Kellner R. Abridged manual of the illness attitude scales. Albuquerque, NM: University of New 
Mexico; 1987. 
96. Horowitz M, Wilner N, Alvarez W. Impact of event scale – measure of subjective stress. Psychosom 
Med 1979;4:209–18. 
97. Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SLT, et al. Short screening scales 
to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 
2002;32:959–76. http://dx.doi.org/10.1017/S0033291702006074
98. McNaire D, Lorr M, Droppleman LF. Manual for the profiles of moods scale. San Diego, CA: 
Educational and Industrial Testing Services; 1971. 
99. Rakowski W, Andersen M, Stoddard AM, Urban N, Rimer BK, Lane DS, et al. Confirmatory analysis 
of opinions regarding the pros and cons of mammography. Health Psychology 1997;16:433–42. 
http://dx.doi.org/10.1037/0278-6133.16.5.433
100. Derogatis L. Administration, scoring and procedures manual 1 to the (revised) version. Baltimore, 
MD: Johns Hopkins University School of Medicine; 1977. 
101. Tyndel S, Austoker J, Henderson BJ, Brain K, Bankhead C, Clements A, et al. What is the 
psychological impact of mammographic screening on younger women with a family history of 
breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. J Clin 
Oncol 2007;25:3823–30. http://dx.doi.org/10.1200/JCO.2007.11.0437
102. Brain K, Henderson BJ, Tyndel S, Bankhead C, Watson E, Clements A, et al. Predictors of breast 
cancer-related distress following mammography screening in younger women on a family history 
breast screening programme. Psychooncology 2008;17:1180–8. http://dx.doi.org/10.1002/
pon.1355
103. Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer 
adverse psychological consequences? A multi-centre follow-up study comparing different breast 
screening result groups five months after their last breast screening appointment. J Public Health 
1998;20:396–403. http://dx.doi.org/10.1093/oxfordjournals.pubmed.a024793
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
85
104. Ong G, Austoker J, Brett J. Breast screening: adverse psychological consequences one month after 
placing women on early recall because of a diagnostic uncertainty. A multicentre study. J Med 
Screen 1997;4:158–68. 
105. Ellman R, Angeli N, Christians A, Moss S, Chamberlain J, Maguire P. Psychiatric morbidity 
associated with screening for breast cancer. Br J Cancer 1989;60:781–4. http://dx.doi.org/10.1038/
bjc.1989.359
106. Bull AR, Campbell MJ. Assessment of the psychological impact of a breast screening programme. Br 
J Radiol 1991;64:510–15. http://dx.doi.org/10.1259/0007-1285-64-762-510
107. Clements A, Tyndel S, Henderson B, Brain K, Watson E, Austoker J, et al. ‘More positive about 
mammography’ – reactions of women to a false positive recall: a qualitative study of women at risk 
of familial breast cancer. Breast Cancer Res 2008;10:90. http://dx.doi.org/10.1186/bcr1974
108. O’Sullivan I, Sutton S, Dixon S, Perry N. False positive results do not have a negative effect on 
reattendance for subsequent breast screening. J Med Screen 2001;8:145–8. http://dx.doi.
org/10.1136/jms.8.3.145
109. Orton M, Fitzpatrick R, Fuller A, Mant D, Mlynek C, Thorogood M. Factors affecting women’s 
response to an invitation to attend for a second breast cancer screening examination. Br J Gen Pract 
1991;41:320–2.
110. Ong G, Austoker J. Recalling women for further investigation of breast screening: women’s 
experiences at the clinic and afterwards. J Public Health Med 1997;19:29–36. http://dx.doi.
org/10.1093/oxfordjournals.pubmed.a024582
111. Ong G, Austoker J, Brouwer A. Evaluation of the written information sent to women who are called 
back for further investigation of breast screening in the UK. Health Education Journal 1996;55:413–
29. http://dx.doi.org/10.1177/001789699605500407
112. Austoker J, Ong G. Written information needs of women who are recalled for further investigation 
of breast screening: results of a multicentre study. J Med Screen 1994;1:238–44.
113. Smith S, Botha JL, Goosey R, Daintith H. Audit of user satisfaction with the Leicestershire Breast 
Screening Service – women attending for assessment of abnormal mammograms. J Public Health 
Med 1991;13:166–71.
114. Ong G, Austoker J, Brouwer A, Programme NHSB. Guidelines on improving the quality of the 
written information sent to women who are recalled for assessment. NHSBSP Publication no. 38. 
NHSBSP; 1998.
115. Meldrum P, Turnbull D, Dobson HM, Colquhoun C, Gilmour WH, McIlwaine GM. Tailored written 
invitations for second round breast cancer screening: a randomised controlled trial. J Med Screen 
1994;1:245–8.
116. Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long-term 
consequences of false-positive screening mammography. J Med Screen 2004;11:39–44. http://
dx.doi.org/10.1258/096914104772950745
117. Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women 
having an abnormal screening mammography. Value Health 2007;10:294–304. http://dx.doi.
org/10.1111/j.1524-4733.2007.00184.x
118. Brodersen J, McKenna SP, Doward LC, Thorsen H. Measuring the psychosocial consequences of 
screening. Health Qual Life Outcomes 2007;5:3. http://dx.doi.org/10.1186/1477-7525-5-3
119. Brodersen J, Thorsen H, Anderson JS. Short-term and long-term psychosocial consequences of 
false positive screening mammography – development of two new questionnaire based on the 
psychological consequences questionnaire (the PCQ). Value Health 2004;7:786–7. http://dx.doi.
org/10.1016/S1098-3015(10)66105-0
NIHR Journals Library
REFERENCES
86
120. Wardle J, Pope R. The psychological costs of screening for cancer. J Psychosom Res 1992;36:609–
24. http://dx.doi.org/10.1016/0022-3999(92)90051-3
121. Chalmers K, Thomson K. Coming to terms with the risk of breast cancer: perceptions of women 
with primary relatives with breast cancer. 1996;6:256–82.
122. Scaf-Klomp W, van Sonderen FL, Stewart R, van Dijck JA, van den Heuvel WJ. Compliance after 17 
years of breast cancer screening. J Med Screen 1995;2:195–9.
123. Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised 
intervention studies. Health Technol Assess 2003;7(27).
124. Mays N, Pope C. Qualitative research: rigour and qualitative research. BMJ 1995;311:109–12. 
http://dx.doi.org/10.1136/bmj.311.6997.109
125. Popay J, Rogers A, Williams G. Rationale and standards for the systematic review of qualitative 
literature in health services research. Qual Health Res 1998;8:341–51. http://dx.doi.
org/10.1177/104973239800800305
126. Noblit GW, Hare RD. Meta-ethnography: synthesizing qualitative studies. Newbury Park, CA: Sage; 
1988.
127. Britten N, Campbell R, Pope C, Donovan J, Morgan M, Pill R. Using meta ethnography to synthesise 
qualitative research: a worked example. J Health Serv Res Policy 2002;7:209–15. http://dx.doi.
org/10.1258/135581902320432732
128. Garside R, Britten N, Stein K. The experience of heavy menstrual bleeding: a systematic review 
and meta-ethnography of qualitative studies. J Adv Nurs 2008;63:550–62. http://dx.doi.
org/10.1111/j.1365-2648.2008.04750.x 
129. Rodgers M, Sowden A, Pettigrew M, Arai L, Roberts H, Britten N, et al. Testing methodological 
guidance on the conduct of narrative synthesis in systematic reviews. 2009. URL: http://evi.sagepub.
com (cited 12 June 2009). 
130. Oliver S, Harden A, Rees R, Shepherd J, Brunton G, Oakley A. Young people and mental health: 
novel methods for systematic review of research on barriers and facilitators. Health Educ Res 
2008;23:770–90. http://dx.doi.org/10.1093/her/cym038 
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
87
Appendix 1 Protocol
TECHNOLOGY ASSESSMENT REPORT COMMISSIONED BY THE NETSCC HTA PROGRAMME
HTA 09/145 
Plain English Summary
In the UK women aged 50 to 70 years old are invited to come for mammography screening every 3 years. 
About 5% of these are recalled for further investigation. After follow-up it is found that about 82% 
of recalled women had nothing wrong with them (false-positives). However, the experience of being 
unnecessarily recalled can be distressing, not just in the short-term but may lead to enduring anxiety 
and affect attendance at future routine mammography screening. The purpose of this systematic review 
is to find out what the research evidence is for medium and long-term effects of having a false-positive 
mammogram on mental health and behaviour, whether some groups of women are more likely to be 
adversely affected than others and if there are ways of reducing the negative effects of being recalled 
when you are in fact well.
Decision problem
The purpose of this technology assessment is to conduct a systematic review, to identify the psychological 
and behavioural consequences following false-positive screening mammogram results that affect women 
and any evidence for the effectiveness of interventions designed to reduce these. In particular we will 
be looking at whether the psychological and behavioural consequences or the effectiveness of specific 
interventions differ in different groups of women. 
This research is necessary because of the large number of false-positive results that come from routine 
mammography screening. In the UK women aged 50-70 years, on population registers, are invited for 
mammography every 3 years through the NHS Breast Screening Programme (NHSBSP). Around two million 
women were screened by the NHSBSP in 2007/8 and of these 95,006 (5%) were recalled for further 
investigation; 16,735 cancers were detected leaving 78,271(82%) false-positive recalls.2
Quantitative observational studies looking at the psychological and behavioural consequences of false-
positive mammograms show conflicting results. Some studies indicate that, while women show increased 
distress between receiving the information about the need for a follow-up appointment and receiving the 
all-clear, in the longer term their anxieties about breast cancer and mammography are not increased.53–55 
Other studies report that there are long-term adverse psychological consequences to receiving a false-
positive mammogram.56,57,59,103 The outcomes of studies looking at whether having false-positive results 
affects future attendance at breast screening appointments is similarly conflicted.58–61
A quantitative systematic review in 2007 by Brewer and colleagues found that the impact of a false-
positive mammogram on subsequent screening attendance varied with nationality; although, the reasons 
for this were unclear. They also reported a varying impact on long-term psychological distress, anxiety and 
depression, and other behaviours such as frequency of breast self-examination.62 However, their review did 
not report the reasons for this variation in response. Furthermore, Brewer and colleague’s review found 
no statistically sound studies that investigated whether anxiety over a false-positive mammogram directly 
affects whether women return for routine screening or increase breast self-examination. There was little 
evidence about the effects on quality of life or trust of healthcare services and no evidence about whether 
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women who felt anxious after a false-positive screening result replaced routine screening attendance 
with breast self-examination.62 We also do not know what meanings women attribute to a false-positive 
mammogram or how these may determine their behaviour when invited for further routine mammogram 
screening as qualitative evidence is lacking.
Therefore, there is uncertainty about the psychological impact of false-positive mammograms on women. 
We do not know what the mediators are of negative psychological and behavioural outcomes which may 
affect attendance at future mammography screening. There is a need to answer these questions to identify 
and evaluate studies of interventions to treat the effect of false-positive results, and identify whether these 
effects differ in women from different backgrounds. The answers will have important policy implications 
for the NHS in the provision of breast cancer screening services.
The questions that this systematic review will answer are:
1. What evidence is there for medium or long-term adverse psychological consequences of false-positive 
screening mammograms?
(a) Do the types of psychological consequences differ between different groups of women?
2. Are there interventions that reduce adverse psychological consequences?
For question one the population will be women who have received a false-positive result from routine 
mammogram screening in the UK and invited for further assessment. Where studies include a comparator 
this will be women who had a routine screening mammogram but who had a normal mammogram and 
were not invited for further assessment. A range of outcomes, including qualitative, will be considered 
that report psychological and behavioural measures over the medium and long-term. Where data permit, 
subgroup analyses will be conducted of different groups of women (including socio-economic status and 
ethnic group). 
For question two the population and the outcomes will be the same as question one. The interventions 
will be those delivered to individuals to address the adverse psychological consequences of a false-positive 
mammogram result, including attendance at future routine breast screening. Where there are comparators 
this will be an absence of an individualized intervention in the same population. Where data permit, 
subgroup analyses will be conducted of different groups of women (including socio-economic status and 
ethnic group). 
It is intended that this should be a wide systematic review considering a range of study types including 
uncontrolled studies and qualitative research but excluding individual case studies. Recommendations will 
be made for future primary research.
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Methods for selection of evidence of clinical effectiveness
A systematic review will be conducted using the principles of the NHS Centre for Reviews and 
Dissemination77 including those for non-randomized and qualitative studies.123
Inclusion criteria
Question Criteria Specification Notes
1 and 2 Population Women who have received a positive result 
from routine mammogram screening in 
the UK and have been invited for further 
assessment which shows that they do not 
have breast cancer
Where data permit we will look at sub 
groups including socio-economic status, 
and ethnic group 
2 Intervention Those interventions delivered to individuals 
to address the adverse psychological and 
behavioural consequences of a false-
positive mammogram result.
These are individual interventions not group 
ones
1 Comparator Women who have received a negative 
(normal) result from routine mammogram 
screening in the UK.
2 Comparator An absence of an individual intervention in 
the same population 
1 and 2 Outcomes Psychological and behavioural outcomes 
and those from qualitative studies
Including subsequent attendance at routine 
mammography screening and quality of life
1 and 2 Setting UK Secondary care
1 and 2 Study design Systematic reviews, randomized, non-
randomized, observational and qualitative 
studies
We will not consider individual case studies
1 and 2 Length of 
follow-up
At least one month from the ‘all-clear’ Measured over the medium to long-term, 
i.e. not the immediate response to receiving 
a false-positive result
1 and 2 Language English language only Non English language papers will be 
included in the searches and screened, so 
that the number of potentially includable 
foreign language papers is known
Exclusion criteria
The following types of studies will be excluded: narrative reviews, editorials, opinion pieces, non-English 
language papers, individual case studies, and studies only reported as posters or by abstract where there is 
insufficient information to assess the quality of the study.
Search strategy
Refer to Appendix 1 for the draft search strategy for MEDLINE. 
The search strategy will comprise the following main elements:
 z Searching of electronic bibliographic databases.
 z Internet searches.
 z Scrutiny of references of included studies.
 z Contacting experts in the field.
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Databases will include:
MEDLINE, EMBASE, The Cochrane Library, PsychLIT, CINAHL EBSCO, Web of Science, Science Citation Index 
Expanded, Conference Proceedings Citation Index, Sociological Abstracts, Applied Social Sciences Index, 
Sociological Abstracts, Applied Social Sciences Index and International Bibliography of the Social Sciences.
Study selection 
Based on the above inclusion/exclusion criteria, papers will be selected for review from the titles and 
abstracts generated by the search strategy. This will be done independently by two reviewers; discrepancies 
will be resolved by discussion, with the involvement of a third reviewer if necessary. Although non-English 
language papers will not be included in the systematic review due to resource limitations, they will be 
identified and any that meet the other inclusion criteria will be recorded with their language noted as 
the reason for their exclusion. Retrieved papers will again be reviewed and selected against the inclusion 
criteria by the same independent process. 
Data extraction 
Data will be extracted from included studies by one reviewer using a standardised data extraction form 
and checked by another reviewer. Authors of studies will be contacted to provide missing information, 
as necessary.
Quality assessment
Quantitative studies will be assessed for internal and external validity according to criteria suggested by 
the updated NHS CRD Report No.4, according to study type.77,78 Qualitative studies will have their quality 
assessed using a standard assessment tool, e.g. Mays and Pope 1995124 and Popay and colleagues 1998,125 
a number of these will be piloted to assess their suitability for the task. 
Methods for analysis and synthesis of evidence of clinical 
effectiveness
Quantitative analysis and synthesis
Studies were assessed for internal and external validity according to criteria suggested by the updated 
NHS CRD Report No.4, according to study type.77,78 The quality of systematic reviews was evaluated using 
the PRISMA statement.79 Individual RCTs were appraised with the CONSORT statement80 and individual 
observational studies with STROBE guidelines.81
Qualitative analysis and synthesis
These studies will be analysed using meta-ethnography126–128 supported by Atlas.ti6 software. Here the 
included studies’ results are translated into one another, while preserving their original meaning, with an 
inductive and interpretive approach to allow comparison between them. Authors’ interpretation of the 
primary study findings become the data, which are translated across studies by the reviewers to produce a 
synthesis of meaning allowing the production of higher order concepts.
Combined synthesis of quantitative and qualitative evidence
The results of the quantitative and qualitative analyses will undergo narrative synthesis to construct an 
explanatory framework.129,130 In this method both types of data analysis undergo a further narrative 
synthesis of their combined data through a process of developing an explanatory theory, undertaking 
a preliminary synthesis, looking at the relationships between and within studies and evaluating the 
robustness of the synthesis.
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Expertise in this TAR team
People
Name Institution Expertise
Mrs Mary Bond PenTAG, University of Exeter Systematic reviewing, psychology and project 
management 
Dr Toby Pavey PenTAG, University of Exeter Systematic reviewing 
Mrs Karen Welch Karen Welch Information Consultancy Information Specialist
Mr Chris Cooper PenTAG, University of Exeter Information Specialist
Dr Ruth Garside PenTAG, University of Exeter Qualitative evidence synthesis
Prof. Chris Hyde PenTAG, University of Exeter Diagnostics and public health
In addition to the research team, we will be receiving expert clinical advice from Dr Russell Davies 
Consultant Breast Radiologist (Royal Devon and Exeter Foundation Trust), Gillian Gray (Breast Care nurse 
Royal Devon and Exeter Foundation Trust), Dr Jim Steel Consultant Breast Radiologist and Prof Carl 
Roobottom, Consultant Radiologist (both at Derriford Hospital, Plymouth), Jenny Hewison Professor of 
the Psychology of Healthcare, from the University of Leeds. We have two patient representatives, Kate 
Blackmore and Sue Milward who have both had experience of having a false-positive mammogram to 
advise us on the patient perspective.
TAR centre – PenTAG
This project is being conducted by The Peninsula Technology Assessment Group (PenTAG), which is part 
of the Institute of Health Service Research at the Peninsula Medical School, University of Exeter. PenTAG 
was established in 2000 and carries out independent Health Technology Assessments for the UK HTA 
Programme and other local and national decision-makers including NICE. The group is multi-disciplinary 
and draws on individuals’ backgrounds in public health, health services research, computing and decision 
analysis, systematic reviewing, psychology, statistics and health economics. The Institute of Health Service 
Research is made up of discrete but methodologically related research groups, among which Health 
Technology Assessment is a strong and recurring theme. 
Contributions of team members
Name Job title Contribution
Mary Bond Research Fellow in Health Technology 
Assessment
Providing project management. Writing the protocol. 
Conducting the systematic review. Writing and editing 
the report.
Toby Pavey Research Fellow in Health Technology 
Assessment
Second reviewing the titles, abstracts and papers for 
the systematic review.
Karen Welch Information Specialist Writing and running the search strategies for the 
systematic review
Chris Cooper Information Specialist Writing and running the search strategies for the 
systematic review
Ruth Garside Senior Research Fellow Overseeing qualitative evidence synthesis
Chris Hyde Professor of Public Health and Clinical 
Epidemiology
Director of the project and guarantor of the report. 
Contributing to editing the report.
NIHR Journals Library
APPENDIX 1
92
Competing interests of authors
None.
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Appendix 2 Search strategy
A ll searches combined results database summary.
Database Search date Hits
MEDLINE Ovid Scoping Search: 1950–present 8 October 2010 and 25 January 2011 2357
MEDLINE In-Process & Other Non-Indexed Citations Ovid 98
EMBASE Classic + EMBASE Ovid: 1947–2010 22 November 2010 and 25 January 2011 2672
HMIC Ovid 58
Source: U.K. Department of Health, Nuffield Institute 
for Health (Leeds University Library), King’s Fund Library; 
1983–2010
21 November 2010 and 25 January 2011 2
CCRCT: all years 22 November 2010 and 25 January 2011 111
Cochrane CDSR: all years 22 November 2010 and 25 January 2011 7
CRD DARE: all years 22 November 2010 and 25 January 2011 17
CRD HTA: all years 22 November 2010 8
Cochrane Methodology: all years 22 November 2010, 9 December 2010 and 
25 January 2011
4
Web of Science: all years 3 December 2010 and 25 January 2011 406
Science Citation Index expanded: 1970–present
SSCI: 1970–present
CPCI-S:1990–present
CPCI-SSH:1990–present
PsychINFO EBSCO: 1887–2010 6 December 2010 and 25 January 2011 152
CINAHL EBSCO: 1981–2010 6 December 2010 and 25 January 2011 260
Sociological Abstracts CSA Illumina: 1952–2010 6 December 2010 and 25 January 2011 13
IBSS CSA Illumina: 1951–2010 6 December 2010 and 25 January 2011 22
BNI 25 January 2011 13
SPP 25 January 2011 3
ASSIA 25 January 2011 78
CRD 25 January 2011 245
Total 6526
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The MEDLINE search strategy was translated and run in:
Database Search date Hits
MEDLINE Ovid Scoping Search: 1950–present 8 October 2010 559
MEDLINE In-Process & Other Non-Indexed Citations Ovid 17
EMBASE Classic + EMBASE Ovid: 1947–2010 22 November 2010 500
HMIC Ovid 2
Source: U.K. Department of Health, Nuffield Institute for Health 
(Leeds University Library), King’s Fund Library; 1983–2010
21 November 2010 2
CCRCT: all years 22 November 2010 68
Cochrane CDSR: all years 22 November 2010 7
CRD DARE: all years 22 November 2010 17
CRD HTA: all years 22 November 2010 8
Cochrane Methodology: all years 22 November 2010 and 
9 December 2010
4
Web of Science: all years 3 December 2010 129
Science Citation Index expanded: 1970–present
SSCI: 1970–present
CPCI-S:1990–present
CPCI-SSH: 1990–present
PsychINFO EBSCO: 1887–2010 6 December 2010 28
CINAHL EBSCO: 1981–2010 6 December 2010 99
Sociological Abstracts CSA Illumina: 1952–2010 6 December 2010 1
IBSS CSA Illumina: 1951–2010 6 December 2010 0
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
MEDLINE Ovid
Scoping Search 
1950–current
Searched on 8 
October 2010
1. exp mammography/ae, px
2. exp mammography/
3. FFDM.tw.
4. (mammogram* or mammograph*).tw.
5. (breast adj2 screen*).tw.
6. (breast adj2 scan*).tw.
7. “National Health Service Breast Screening Programme”.tw.
8. NHSBSP.tw.
9. UK breast screen* program*.tw.
10. NHS breast screen* program*.tw.
11. Mass Screening/
12. exp Breast Neoplasms/
13. 11 and 12
14. 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 13
15. False Positive Reactions/
16. (false* adj3 positive*).tw.
17. “false-positive”.tw.
18. “false-positives”.tw.
19. (false adj3 test*).tw.
20. (false adj3 retest*).tw.
21. (retest* adj3 negative).tw.
22. diagnostic uncertaint*.tw.
23. or/15-22
24. exp Stress, Psychological/
25. exp anxiety/
26. exp fear/
27. exp Depression/
28. exp Emotions/
29. Psychophysiologic Disorders/
30. exp Psychology/
31. exp Health Behavior/
32. exp Behavior/
33. exp attitude/
34. Motivation/
35. Decision Making/
36. exp “Quality of Life”/
37. Health Knowledge, Attitudes, Practice/ or Attitude to Health/ or Patient 
Satisfaction/ or Patient Participation/ or Consumer Participation/ or Consumer 
Satisfaction/ or Sick Role/ or “Patient Acceptance of Health Care”/
38. exp Affect/
39. exp Affective Symptoms/
40. (accept* or adhere* or affect* or anger* or anxiety or anxious or alarm* or 
attitude* or appetite or behavior* or behaviour* or belief* or believe* or 
comply or complian* or concordance or coping or concern* or confusion or 
confused or consequence* or consequential or conflict or cultural*).tw.
559
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
41. (demotivated or demotivation* or de-motivated or de-motivation* or 
disconcert* or depression or depressed or distress* or deleterious or 
disappointment or emotion* or ethnic* or ethnol* or experienc* or fear* or 
fright* or harm* or mental* or mistrust* or mood* or motivated or motivation* 
or nightmare* or perception* or perceive* or psychological or psychologically or 
psychology or psychosocial or reattend* or social*).tw.
42. “quality of life”.tw.
43. (relief or relieved or risk*).tw.
44. (sleep or stress* or terror or terrified or trust* or mistrust*).tw.
45. (worry or worried).tw.
46. (wellbeing or “well-being” or “well being”).tw.
47. or/24-46
48. exp Intervention Studies/
49. exp Questionnaires/
50. psychological tests/ or psychometrics/ or models psychological/
51. Patient Education as Topic/
52. health education/ or health promotion/ or health knowledge/
53. decision aid/ or decision support techniques/
54. Educational Technology/
55. audiovisual aids/
56. telehealth/ or telemedicine/ or telecommunication/
57. social support/ or self help groups/ or support groups/
58. exp communication/
59. persuasive communication/
60. exp counselling/
61. interviews as topic/
62. evaluation studies as topic/
63. qualitative research/ or program evaluation/ or process evaluation/
64. focus groups/
65. nursing methodology research/
66. intervention*.tw.
67. (qualitative* or findings or evaluat* or synthes?s or meta-synthesis* or meta 
synthesis* or metasynthesis or meta-ethnograph* or metaethnograph* or 
meta ethnograph* or meta-study or metastudy or meta study or systematic* 
or “technology assessment” or sampl* or study or studies or observation* or 
research or discourse* or analys?s or humanistic or biographical or biography or 
narrative*).tw.
68. (support* or literature or booklet* or leaflet* or pamphlet* or letter* or video* 
or podcast* or telephon* or transtelephon*).tw.
69. (questionnaire* or interview* or discuss* or feedback or personalised or 
personalized or assessment* or reassurance or reassur*).tw.
70. (counsel* or education* or “informed choice” or “informed choices”).tw.
71. “in person”.tw.
72. (peer* adj5 (support* or group*)).tw.
73. (“expert patients” or “expert patients”).tw.
74. (social adj network*).tw.
75. “emotional support”.tw.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Bond et al. under the terms of a commissioning contract issued by the Secretary of State for Health. 
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided 
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed 
to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, 
Southampton SO16 7NS, UK.
DOI: 10.3310/hta17130 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 13
97
Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
76. “family support”.tw.
77. focus group*.tw.
78. (“one to one” or “one on one”).tw.
79. ((patient* or consumer* or recipient* or client* or individual*) adj5 
(communicat* or counsel* or inform* or education* or choice or discuss* or 
decision* or decide* or participat* or preference* or navigat*)).tw.
80. ((patient* or consumer*or recipient* or client* or individual*) adj5 (tailor* or 
personal*)).tw.
81. ((personal or interpersonal* or individual*) adj5 (decision* or choice* or 
preference* or participat* or preference*)).tw.
82. ((tailor* or individual* or personal*) adj5 message*).tw.
83. ((allocat* or allot* or assign* or divid*) adj5 (condition* or experiment* or 
intervention* or treatment* or therap* or control* or group*)).tw.
84. or/48-83
85. 1 and 23 and 84
86. 14 and 23 and 47 and 84
87. 85 or 86
88. 1 and 23
89. 14 and 23 and 47
90. 88 or 89
91. limit 90 to (“qualitative studies (sensitivity)” or “qualitative studies (specificity)” 
or “qualitative studies (optimized)”)
92. limit 90 to systematic reviews
93. limit 90 to (case reports or clinical trial, all or clinical trial or comparative study 
or controlled clinical trial or evaluation studies or government publications or 
guideline or meta analysis or multicenter study or patient education handout 
or practice guideline or randomized controlled trial or “review” or “scientific 
integrity review” or technical report or twin study or validation studies)
94. 87 or 91 or 92 or 93
95. 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 64 or 68 or 69 or 
70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 79 or 80 or 81 or 82 or 
83
96. 48 or 49 or 61 or 62 or 63 or 65 or 66 or 67
97. 14 and 23 and 47 and 95 and 96
98. 1 and 23 and 96
99. 14 and 23 and 47 and 96
100. 94 or 97 or 98 or 99
101. 94 or 100
MEDLINE In-
Process & other 
Non-Indexed 
Citations Ovid
Adapted from MEDLINE Search 17
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
EMBASE 
Classic + EMBASE 
Ovid
1947–2010
Searched 22 
November 2010
Database: EMBASE Classic + EMBASE ! 1947 to 2010 Week 46 #
Search strategy:
1. exp MAMMOGRAPHY/ (33,626)
2. FFDM.tw. (140)
3. (mammogram* or mammograph*).tw. (24,341)
4. (breast adj2 screen*).tw. (6407)
5. (breast adj2 scan*).tw. (245)
6. (breast adj2 detect*).tw. (5038)
7. “National Health Service Breast Screening Programme”.tw. (96)
8. NHSBSP.tw. (76)
9. UK breast screen* program*.tw. (42)
10. NHS breast screen* program*.tw. (86)
11. mass screening/ (43,653)
12. exp breast cancer/ (208,636)
13. 11 and 12 (873)
14. or/1-10,13 (41,820)
15. false positive result/ (6554)
16. (false* adj3 positive*).tw. (44,807)
17. “false-positive”.tw. (36,608)
18. “false-positives”.tw. (8293)
19. “falsely-positive”.tw. (855)
20. (false adj3 test*).tw. (3821)
21. (false adj3 retest*).tw. (12)
22. (retest* adj3 negative).tw. (115)
23. diagnostic uncertaint*.tw. (743)
24. or/15-23 (48,970)
25. 14 and 24 (1368)
26. exp stress/ (158,295)
27. PSYCHOLOGICAL ASPECT/ or PSYCHOLOGICAL WELL BEING/ (413,535)
28. PSYCHOSOCIAL ADJUSTMENT TO ILLNESS SCALE/ or exp “PSYCHOLOGICAL 
AND PSYCHOSOCIAL PHENOMENA”/ (1,951,140)
29. exp ANXIETY/ or ANTICIPATORY ANXIETY/ (89,596)
30. exp FEAR/ (114,051)
31. exp DEPRESSION/ or REACTIVE DEPRESSION/ (244,313)
32. exp EMOTION/ (282,458)
33. EMOTIONAL STRESS/ (9740)
34. mental stress/ (46,546)
35. exp behavior/ (1,772,614)
36. exp ATTITUDE/ (384,744)
37. exp MOTIVATION/ (54,973)
38. PATIENT PARTICIPATION/ (12,113)
39. decision making/ (106,459)
40. exp “quality of life”/ (165,080)
41. exp patient satisfaction/ (61,974)
500
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
42. (accept* or adhere* or affect* or anger* or anxiety or anxious or alarm* 
or attitude* or appetite or behavior* or behaviour* or belief* or believe* 
or comply or complian* or concordance or cope* or coping or concern* 
or confusion or confused or consequence* or consequential or conflict or 
cultural*).tw. (3,217,709)
43. (demotivated or demotivation* or de-motivated or de-motivation* or 
disconcert* or depression or depressed or distress* or deleterious or 
disappointment or emotion* or ethnic* or ethnol* or experienc* or fear* or 
fright* or harm* or mental* or mistrust* or mood* or motivated or motivation* 
or nightmare* or perception* or perceicve* or psychological or psychologically 
or psychology or psychosocial or reattend* or social*).tw. (1,974,157)
44. “quality of life”.tw. (128,403)
45. (relief or relieved or risk*).tw. (1,252,141)
46. (sleep or stress* or terror or terrified or trust* or mistrust*).tw. (611,497)
47. (worry or worried or worries or wellbeing or “well-being” or “well being”).tw. 
(48,645)
48. or/26-47 (6,645,255)
49. 25 and 48 (635)
50. qualitative stud$.mp. (11,374)
51. nursing methodology research.mp. (11,841)
52. questionnaire/ (262,746)
53. focus group$.mp. (14,900)
54. discourse analysis.mp. (846)
55. content analysis.mp. (8358)
56. ethnographic research.mp. (570)
57. ethnological research.mp. (6)
58. ethnonursing research.mp. (27)
59. constant comparative method.mp. (597)
60. qualitative validity.mp. (83)
61. purposive sample.mp. (1167)
62. observational method$.mp. (959)
63. field stud$.mp. (10,752)
64. theoretical sampl$.mp. (293)
65. phenomenology/ (5404)
66. phenomenological research.mp. (218)
67. life experience$.mp. (2658)
68. cluster sampl$.mp. (2894)
69. ethnonursing.af. (78)
70. ethnograph$.mp. (4843)
71. phenomenol$.af. (15,839)
72. grounded theory.mp. (4137)
73. (grounded adj (theor$ or study or studies or research or analys?s)).af. (4231)
74.  (life stor$ or women$ stor$).tw. (658)
75. (emic or etic or hermeneutic$ or heuristic$ or semiotic$).af. or (data adj1 
saturat$).tw. or participant observ$.tw. (11,156)
76. (action research or cooperative inquir$ or co operative inquir$ or co-operative 
inquir$).mp. (1979)
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
77. (humanistic or existential or experiential or paradigm$).mp. (78,597)
78. (field adj (study or studies or research)).tw. (11,218)
79. human science.tw. (215)
80. biographical method.tw. (14)
81. purposive sampl$.af. (1846)
82. theoretical sampl$.af. (293)
83. ((purpos$ adj4 sampl$) or (focus adj group$)).af. (19,032)
84. (account or accounts or unstructured or “open-ended” or “open ended” or 
text$ or narrative$).mp. (395,335)
85. (life world or life-world or conversation analys?s or personal experience$ or 
theoretical saturation).mp. (22,256)
86. lived experience$.tw. (1610)
87. life experience$.tw. (2647)
88. cluster sampl$.mp. (2894)
89. questionnaire$.tw. (266,283)
90. content analysis.af. (8419)
91. thematic analysis.af. (2239)
92. constant comparative.af. (1043)
93. ((discourse$ or discuss$ or discurs$) adj3 analys?s).tw. (6735)
94. (constant adj (comparative or comparison)).af. (1486)
95. narrative analys?s.af. (358)
96. narrative synthes?s.af. (152)
97. observational study/ (16,809)
98. intervention study/ (9965)
99. intervention*.tw. (471,470)
100. evaluation/ (159,571)
101. evaluat*.tw. (2,055,889)
102. psychometry/ (31,871)
103. PSYCHOLOGICAL RATING SCALE/ or PSYCHOLOGICAL MODEL/ (27,953)
104. PATIENT EDUCATION/ or HEALTH EDUCATION/ (137,523)
105. educational technology/ or health promotion/ (55,616)
106. telecommunication/ or TELEHEALTH/ or telemedicine/ (19,465)
107. SOCIAL SUPPORT/ or SUPPORT GROUP/ (46,011)
108. self help/ (9686)
109. communication.mp. (293,687)
110. exp COUNSELLING/ (82,605)
111. qualitative research/ (11,352)
112. program evaluation.mp. or health care quality/ (143,551)
113.  (support* or literature or booklet* or leaflet* or pamphlet* or letter* or video* 
or podcast* or telephon* or transtelephon*).tw. (1,595,815)
114. (questionnaire* or interview* or discuss* or feedback or personalised or 
personalized or assessment* or reassurance or reassur*).tw. (2,123,205)
115. (counsel* or education* or “informed choice” or “informed choices”).tw. 
(378,757)
116. “in person”.tw. (3324)
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
117. (peer* adj5 (support* or group*)).tw. (5061)
118. (“expert patients” or “expert patients”).tw. (70)
119. (social adj network*).tw. (5102)
120. “emotional support”.tw. (3119)
121. “family support”.tw. (2620)
122. ((patient* or consumer* or recipient* or client* or individual*) adj5 
(communicat* or counsel* or inform* or education* or choice or discuss* or 
decision* or decide* or participat* or preference* or navigat*)).tw. (227961)
123. ((patient* or consumer*or recipient* or client* or individual*) adj5 (tailor* or 
personal*)).tw. (28,228)
124. ((tailor* or individual* or personal*) adj5 message*).tw. (629)
125. ((allocat* or allot* or assign* or divid*) adj5 (condition* or experiment* or 
intervention* or treatment* or therap* or control* or group*)).tw. (224,681)
126. or/50-125 (6,376,617)
127. 49 and 126 (426)
128. limit 49 to (clinical trial or randomized controlled trial or controlled clinical trial 
or multicenter study) (78)
129. limit 49 to (evidence based medicine or meta analysis or outcomes research or 
“systematic review”) (37)
130. limit 49 to (“qualitative studies (1 term high sensitivity)” or “qualitative studies 
(1 term high specificity)” or “qualitative studies (1 term min difference)” or 
“qualitative studies (2 or more terms high sensitivity)” or “qualitative studies 
(2 or more terms high specificity)” or “qualitative studies (2 or more terms min 
difference)”) (211)
131. 127 or 128 or 129 or 130 (498)
132. (psychological adj5 (consequence* or harm* or sequel*)).tw. (3753)
133. 25 and 132 (17)
134. 131 or 133 (500)
HMIC Ovid
(Health 
Management 
Information 
Consortium) 
Source: U.K. 
Department of 
Health, Nuffield 
Institute for Health 
(Leeds University 
Library), King’s 
Fund Library
1983–2010
Searched 21 
November 2010
Free text from MEDLINE search n = 2 added
(23 results 
downloaded 
would not 
import so 
cross-checked 
records 
manually, 
only 2 unique 
so only 
these added 
manually to 
the database)
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
CCRCT 
All Years
Searched 22 
November 2010
Save date: 22 November 2010
ID Search
#1 MeSH descriptor False Positive Reactions explode all trees
#2 false* positive*
#3 (#1 OR #2)
#4 MeSH descriptor Mammography, this term only
#5 (mammogram* or mammograph* or breast screen* or breast scan*)
#6 (National Health Service Breast Screen* Programme* or NHSBSP or FFDM)
#7 breast cancer screen* or breast cancer scan*
#8 (breast neoplasm* scan* or breast neoplasm* screen*)
#9 (#4 OR #5 OR #6 OR #7 OR #8)
#10 (#3 AND #9)
#11 (accept* or adhere* or affect* or anger* or anxiety or anxious or alarm* or 
attitude* or appetite or behavior* or behaviour* or belief* or believe* or 
comply or complian* or concordance or coping or concern* or confusion or 
confused or consequence* or consequential or conflict or cultural*)
#12 (demotivated or demotivation* or de-motivated or de-motivation* or 
disconcert* or depression or depressed or distress* or deleterious or 
disappointment or emotion* or ethnic* or ethnol* or experienc* or fear* 
or fright* or harm* or mental* or mistrust* or mood* or motivated or 
motivation* or nightmare* or perception* or perceive* or psychological or 
psychologically or psychology or psychosocial or reattend* or social*)
#13 quality of life
#14 (sleep or stress* or terror or terrified or trust* or mistrust* or worry or worries 
or worried)
#15 (wellbeing or well-being or well being)
#16 (#11 OR #12 OR #13 OR #14 OR #15)
#17 (#10 AND #16)
#18 MeSH descriptor Mammography explode all trees with qualifier: PX
#19 (#17 OR #18)
#20 psychological near false
#21 (#9 AND #20)
#22 (#19 OR #21)
68
Cochrane CDSR
All years
Searched 22 
November 2010
As above 7 selected
(out of 25 
records)
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
CRD DARE
All years
Searched 22 
November 2010
CRD HTA
All years
Searched 22 
November 2010
#1 mammogram* OR mammograph* 353 
#2 breast NEAR screen* 321 
#3 breast NEAR scan* 60 
#4 MeSH Mammography EXPLODE 1 315 
#5 NHSBSP OR FFDM 5 
#6 #1 or #2 or #3 or #4 or #5 583 
#7 MeSH False Positive Reactions EXPLODE 1 119 
#8 MeSH False Positive Reactions EXPLODE 1 119 
#9 false* NEAR positive* 736 
#10 “false-positive” 556 
#11 “false-positives” 220 
#12 false NEAR test* 398 
#13 false NEAR retest* 2 
#14 retest* NEAR negative 5 
#15 negative NEAR retest* 5 
#16 diagnos* NEAR uncertaint* 181 
#17 #7 or #9 or #10 or #11 or #12 or #13 or #14 or #16 995 
#18 #6 and #17 87 
#19 ( accept* OR adhere* OR affect* OR anger* OR anxiety OR anxious OR alarm* 
OR attitude* OR appetite OR behavior* OR behaviour* OR belief* OR believe* 
OR comply OR complian* OR concordance OR coping OR concern* OR 
confusion OR confused OR consequence* OR consequential OR conflict OR 
cultural* ) 14608 
#20 ( demotivated OR demotivation* OR de-motivated OR de-motivation* OR 
disconcert* OR depression OR depressed OR distress* OR deleterious OR 
disappointment OR emotion* OR ethnic* OR ethnol* OR experienc* OR fear* 
OR fright* OR harm* OR mental* OR mistrust* OR mood* OR motivated OR 
motivation* OR nightmare* OR perception* OR perceive* OR psychological 
OR psychologically OR psychology OR psychosocial OR reattend* OR social* ) 
12173 
#21 “quality of life” 5283 
#22 ( sleep OR stress* OR terror OR terrified OR trust* OR mistrust* ) 2165 
#23 ( worry OR worried ) 50 
#24 ( wellbeing OR “well-being” OR “well being” ) 568 
#25 MeSH Mammography EXPLODE 1 315 
#26 #19 or #20 or #21 or #22 or #23 or #24 22424 
#27 #18 and #26 63 
#28 MeSH Mammography QUALIFIERS PX EXPLODE 1 4 
#29 #27 or #28 66
17 DARE; 8 
HTA
Cochrane 
Methodology 
All years searched 
22 November 
2010 and 9 
December 2010
4 references manually added to Reference Manager 4
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
Web of Science
Searched 3 
December 2010
Cross searched: 
databases
Timespan = all 
available years 
SCI-Expanded: 
1970–present
SSCI:1970–present
CPCI-S: 1990–
present
CPCI-SSH: 1990–
present
#1 25,094 TS=(mammogram* or mammograph*)
#2 84 TS=(NHSBP or “National Health Service Breast Screening Programme”) 
#3 243 TS=(UK breast screen* program*) 
#4 115 TS=(NHS breast screen* program*) 
#5 34,318 TS=(false* positive*) 
#6 12,091 TS=(diagnos* uncertain*)
#7 60 TS=(false SAME retest*) 
#8 267 TS=(retest* SAME negative) 
#9 25,226 (#1 or #2 or #3 or #4) 
#10 46,453 (#5 or #6 or #7 or #8) 
#11 1,344 #9 and #10 
#12 #100,000 TS=(“quality of life”)
#13 #100,000 TS=(stress* or anxiety or anxious or worry or worried or fright*) 
#14 #100,000 Ts=(psychol*) 
#15 48,994 TS=(psychosocial*) 
#16 #100,000 TS=(depress* or emotion* or fear* or behavior* or behaviour* or 
confused or confusion) 
#17 #100,000 (#12 or #13 or #14 or #15 or #16) 
#18 144 (#11 and #17) 
#19 #100,000 TS=(qualitative*) 
#20 #100,000 TS=(evaluat* or analys* or analyt* or ehnograph* or ethnonurs* or 
validity) 
#21 #100,000 TS=(intervention*) 
#22 #100,000 TS=(cluster* or sampl*) 
#23 #100,000 TS=(interview*) 
#24 #100,000 TS=(trial* or study or studies) 
#25 47,396 TS=(phenomolog* or story or stories) 
#26 60,726 TS=(life experience*) 
#27 42,972 TS=(focus group*) 
#28 17,445 TS=(narrative) 
#29 #100,000 TS=(support* or literature or booklet* or leaflet* or pamphlet* or 
letter* or video* or podcast* or telephon* or transtelephon*)
#30 56,051 TS=(communicat* or counsel*) 
#31 #100,000 TS=(discuss* or feedback or personalised or personalized or 
assessment* or reassurance or reassur*) 
#32 #100,000 Ts=(personal or interpersonall) 
#33 #100,000 TS=(session* or group* or scheme*) 
#34 27,100 TS=(patient education) 
#35 #100,000 (#19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 
or #28 or #29 or #30 or #31 or #32 or #33 or #34) 
#36 123 #18 and #35 - note all 123 results downloaded
#37 21 #18 not #36 - note additional 6 selected from here.
n = 129
(123 from 
line 36 + 
extra 6 
chosen out of 
line 37)
PsychINFO EBSCO
1887–2010
Searched 6 
December 2010
S1 DE “Mammography” (703)
S2 TX (mammogram* or mammograph*) (1268)
S3 TX . “National Health Service Breast Screening Programme” (4)
S4 TX NHSBSP (2)
S5 UK breast screen* program* (8)
S6 NHS breast screen* program* (7)
S7 S1 or S2 or S3 or S4 or S5 or S6 (1274)
S8 TX false* positive* (2109)
S9 S7 and S8 (28)
28
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
CINAHL EBSCO
1981–2010
Searched 6 
December 2010
S1 (MH “Mammography/PF”) (146)
S2 (MH “Mammography”) (4578)
S3 TX (mammogram* or mammograph*) (5651)
S4 TX “National Health Service Breast Screening Programme (18)
S5 TX NHSBSP (16)
S6 TX UK breast screen* program* (21)
S7 TX NHS breast screen* program* (43)
S8 S2 or S3 or S4 or S5 or S6 or S7 (5683)
S9 (MH “False Positive Results”) (2001)
S10 TX false* positive* or TX “false-positive” (3302)
S11 S9 or S10 (3302)
S12 S8 and S11 (210)
S13 S1 and S11 (20)
S14 (MH “Stress+”) (31,953)
S15 (MH “Psychological Well-Being”) OR (MH “Adaptation, Psychological”) 
(14,735)
S16 (MH “Anxiety”) OR (MH “Anticipatory Anxiety”) (10,394)
S17 (MH “Psychology+”) (6182)
S18 (MH “Behavior+”) (325,908)
S19 (MH “Help Seeking Behavior”) (1831)
S20 (MH “Quality of Life+”) (32,163)
S21 (MH “Depression+”) (31,871)
S22 (MH “Emotions+”) (35,643)
S23 TX (affect* or anger* or anxiety or anxious or alarm* or attitude* or appetite 
or behavior* or behaviour* or comply or complian* or coping or concern* or 
confusion or confused) (382,003)
S24 TX (demotivated or demotivation* or de-motivated or de-motivation* 
or disconcert* or depression or depressed or distress* or deleterious or 
disappointment or emotion* or fear* or fright* or harm* or mental* 
or mistrust* or mood* or motivated or motivation* or nightmare* or 
psychological or psychologically or psychology or psychosocial) (402,584)
S25 TX (sleep or stress* or terror or terrified or trust* or mistrust or wellbeing or 
“well being” or “well-being” or worry or worried or worries) (133,261)
S26 S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 
or S25 (766,002)
S27 S12 and S26 (87)
S28 S13 or S27 (87)
S29 (MH “Rescreening”) (52)
S30 S2 and S29 (5)
S31 S28 or S30 (92)
S32 (MH “Qualitative Studies”) (33,774)
S33 (MH “Clinical Nursing Research”) (2266)
S34 (MH “Questionnaires+”) (124,819)
S35 (MH “Attitude+”) (152,372)
S36 (MH “Focus Groups”) (14,223)
S37 (MH “Discourse Analysis”) (1391)
99
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Databases, host, 
date searched, 
years
Search strategy, keywords added to Reference Manager (Thomson 
ResearchSoft, San Francisco, CA, USA)
Number of 
results
S38 (MH “Content Analysis”) (12,487)
S39 (MH “Ethnographic Research”) (3238)
S40 (MH “Ethnonursing Research”) (127)
S41 (MH “Constant Comparative Method”) (3941)
S42 (MH “Qualitative Validity”) (345)
S43 (MH “Purposive Sample”) (11,853)
S44 (MH “Observational Methods+”) (10,984)
S45 (MH “Field Studies”) (1256)
S46 (MH “Theoretical Sample”) (921)
S47 (MH “Phenomenology”) OR (MH “Phenomenological Research”) (7951)
S48 (MH “Life Experiences+”) (10,200)
S49 (MH “Cluster Sample+”) (1565)
S50 S32 or S33 or S34 or S35 or S36 or S37 or S38 or S39 or S40 or S41 or S42 
or S43 or S44 or S45 or S46 or S47 or S48 or S49 (284,910)
S51 S12 and S50 (27)
S52 S13 and S50 (10)
S53 S31 or S51 or S52 (94)
S54 TX intervention* (123,688)
S55 TX program* N5 psycholog* (952)
S56 S54 or S55 (124,358)
S57 S12 and S56 (25)
S58 S13 and S54 (2)
S59 S53 or S57 or S58 (99)
Sociological 
Abstracts
Host: CSA Illumina
1952–2010
Searched 6 
December 2010
(mammograph* or mammogram*) and (false* or retest or “re-test”) 9 results 1 
downloaded
1
IBSS 
Host: CSA Illumina
1951–2010
Searched 6 
December 2010
(mammograph* or mammogram* or (breast scceen*)) and ((false* positive*) or 
“false-positive”) ) results
Mammography as a descriptor only 3 results.
1. Testing a model of mammography intention
Baumann, Linda J.; Brown, R.L.; Fontana, Susan A.; Cameron, Linda
Journal of applied social psychology, vol. 23 no. 21, pp. 1733-1756, Nov 1993
View Record | Cited by 4 | Database: 
IBSS: International Bibliography of the Social Sciences 
Descriptors:
Model testing | Habits | Social influence | Cancer | Health promotion | Women’s 
health | More...
2. Determinants of mammography intentions among prior screenees and 
nonscreenees
Jepson, Christopher; Rimer, Barbara K.
Journal of applied social psychology, vol. 23 no. 1, pp. 40-51, Jan 1993
View Record | Cited by 3 | Database: 
IBSS: International Bibliography of the Social Sciences 
Descriptors:
Health care | Patients | Prevention | Women | Mammography
3. Cancer-related channel selection: a focus on women who have had a 
mammography
Johnson, J. David; Meischke, Hendrika
Journal of applied social psychology, vol. 22 no. 24, pp. 1879-1893, Dec 1992
Mammograph* or mammogram* 66 journal results. Nothing relating to false 
positive results.
(mammograph* or mammogram*) and (retest or “re-test” or false test*) 0 results
0
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Checked Reference Manager database for these items after PsychLIT search: all added in 
manually to Reference Manager 9 December 2010.
A model of the influence of false-positive mammography screening results on subsequent screening.
Health Psychol Rev 2010;4:112–27.
Authors: DeFranka JT, Brewera N. 
Affiliation:  a Department of Health Behavior and Health Education, UNC Gillings School of Global Public 
Health, Chapel Hill, NC, USA.
How possible benefits and harms related to screening for breast cancer are presented to women on 
web sites.
Barcelona, Spain: XI Cochrane Colloquium: Evidence, Health Care and Culture; 2003. p. 17.
Authors: Jorgensen K, Gotzsche P.
Cochrane Methodology Register (CMR) keywords CMR: Review methodology – applicability and 
recommendations – individual risk; CMR: other methodology – Internet; CMRA3.
ID CMR-5160.
The Cochrane Methodology Register 2010 Issue 4.
Copyright© 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
False-negative results in screening programmes: systematic review of impact and implications.
Health Technol Assess 2000;4(5).
Authors: Petticrew MP, Sowden AJ, Lister Sharp D, Wright K. 
CMR keywords CMR: Evaluation methdology - diagnostic test accuracy - general;CMRA4 
ID CMR-3593.
Are benefits and harms in mammography screening given equal attention in scientific articles? A 
cross-sectional study.
BMC Medicine  2007;5:12.
Authors: Jorgensen KJ, Klahn A, Gotzsche PC.
CMR keywords CMR: Other methodology – adverse effects; CMR: Evaluation methodology – bias in trials – 
outcome reporting bias; CMR: Evaluation methodology – bias in trials – general; CMRA3.
Correspondence address: The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, Copenhagen, 
Denmark. kj@cochrane.dk. 
ID CMR-10812.
The Cochrane Methodology Register 2010 Issue 4.
Copyright© 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Other search strategies undertaken are available from the authors.
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Appendix 4 Ongoing studies
O ngoing trials search: the psychological consequences of false-positive mammograms.
Sources searched for ongoing trials: UKCRN, ControlledTrials.com, ClinicalTrials.gov, WHO ICTRP, www.nhs.
uk/Conditions/Clinical-trials/Pages/clinical-trial.aspx, DUETs.
Searches found one UK ongoing study, which is probably outside this scope:
http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=8080
Predicting Risk Of Cancer At Screening (PROCAS).
Breast cancer risk assessment and validation in the National Breast Screening Programme.
Topic.
Cancer (co-adopted by Congenital Disorders).
Portfolio eligibility.
Funded by UK Cancer Research Campaign (CRC), CRC partner. 
Current status: open. 
Closure date: 1 June 2012. 
Not many details – probably not relevant.
Four other non-UK studies were found, which may be of general interest:
http://clinicaltrials.gov/show/NCT00742755
No specific mention of false-positive.
Increasing Adherence to Follow-up of Breast Abnormalities in Low-Income Korean American Women.
This study has been completed.
Study type: interventional.
Study design: allocation, randomised.
End point classification: safety/efficacy study.
Intervention model: parallel assignment.
Masking: single blind (subject).
Primary purpose: screening.
Enrolment: 160.
Study start date: September 2003. 
Study completion date: September 2009.
The purpose of this study is to design an intervention to assist Korean American women who have been 
identified with a potential breast abnormality through the Breast Cancer Early Detection Program and 
who have missed their first follow-up appointment (at risk women). Intervention activities will include 
reminder telephone calls or home visits by a trained peer navigator to explain the importance of follow-up 
procedures, emotional support, help with transportation to follow-up appointments, translations, 
organising care for children or grandchildren during medical appointments, and other assistance to 
overcome barriers to follow-up identified during the initial phase of the study. The investigators will collect 
extensive process measures including number and type of intervention activities requested and delivered 
in order to estimate the feasibility for institutionalising intervention activities. The investigators will 
conduct chart reviews and a follow-up survey to evaluate the effectiveness of the intervention in increasing 
adherence to follow-up procedures.
Included as it said ‘Potential breast abnormality’ – so could result in a false-positive on re-examination.
http://clinicaltrials.gov/ct2/show/NCT00247442
Australian Screening Mammography Decision Aid Trial (ASMDAT).
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Not specifically false-positive but interventions might be of interest.
http://clinicaltrials.gov/ct2/show/NCT01267110 – USA study.
Not false-positive – included only for educational to ethnic intervention information.
Engaging Diverse Underserved Communities to Bridge the Mammography Divide.
Estimated enrolment: 242.
Study start date: September 2010.
Estimated study completion date: June 2015.
http://clinicaltrials.gov/show/NCT01261520
Not false-positive – routine mammography – video intervention.
Chinese Women and Mammography Screening.
Enrolment: 671.
Study start date: July 2005.
Primary completion date: August 2009 (final data collection date for primary outcome measure).
Publications:
Wang JH, Mandelblatt JS, Liang W, Yi B, Ma IJ, Schwartz MD. Knowledge, cultural, and attitudinal barriers 
to mammography screening among nonadherent immigrant Chinese women: ever versus never screened 
status. Cancer 2009;115:4828–38.
Sources searched for ongoing trials 26 March 2012: UKCRN, ControlledTrials.com, clinicaltrials.gov, 
WHO ICTRP.
www.controlled-trials.com/ISRCTN89206644
A clinical trial to investigate the effect of psychological support for women called back for assessment 
following breast cancer screening: the TLC study is a randomised controlled trial to investigate the effect 
of psychological support for women called back for assessment following breast cancer screening: the TLC 
study. Latest information loaded on 21 February 2012.
Primary sponsor: Breast Test Wales (UK).
Date of first enrolment: 1 July 2007.
Target sample size: 300.
Recruitment status: completed/not recruiting.
URL: http://isrctn.org/ISRCTN89206644.
Inclusion criteria: (1) females, aged 50–64; (2) those attending a Breast Test Wales Centre for a recall 
visit following initial breast screening; (3) participant should be willing to give verbal and written consent 
for the study; and (4) participant should be willing to complete a questionnaire prior to assessment at 
baseline, within 1 month, 6 months and 12 months post assessment.
Exclusion criteria: (1) those who are recalled for technical reasons (technical recall); (2) women who 
have had a previous recall within the last 3 years; (3) women who have any hearing, visual or learning 
impairment which would not allow them to complete the questionnaires or listen to the support package; 
(4) women who themselves have identified breast problems (clinical override); and (5) women who cannot 
answer questionnaires in English or Welsh.
Outcomes:
Primary: score on the negative subscale of the PCQ. All primary and secondary outcomes will be assessed 
at baseline, 6 weeks, 6 months and 1 year.
Secondary: (1) SF-36 Health Survey; (2) HADS; (3) Euroquol EQ-5D; and (4) Short Explanatory Model 
Interview for patient experiences. All primary and secondary outcomes will be assessed at baseline, 
6 weeks, 6 months and 1 year.
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Intervention: some women invited for breast screening are then asked to attend for further tests. 
This study looks at a relaxation and self-help package known as ‘Travel Lightly Companion’ (TLC) to 
see if it reduces any distress linked to recall. The TLC pack consists of guided self-help presented as 
a CD of relaxation music with relaxation exercises including breathing and guided imagery exercises. 
Women agreeing to take part will get either the TLC package or care as usual. Participants fill out some 
questionnaires at the start, 6 weeks, 6 months and 1 year later.
Conference searches:
7th European Breast Cancer Conference (EBCC-7).
Barcelona, Spain, 24–27 March 2010 – nothing relevant.
First British Breast Cancer Research Conference.
East Midlands Conference Centre, Nottingham, UK.
15–17 September 2010 (planned to be held biennially).
www.bbcrc.org.uk/bbx/contact.asp
No abstracts online only programme.
15th Annual Mammography Update for Physicists (2011).
www.mtmi.net/seminars/mam_phys_update.php
American Society of Clinical Oncology (ASCO) Breast Cancer Symposium 2010 – nothing relevant.
11th St. Gallen International Breast Cancer Conference – nothing relevant.
Society of Radiographers.
 www.sor.org/
Radiological Society of North America (RSNA) 2010 – nothing relevant for conference. 
www.rsna.org/media/pressreleases/pr_target.cfm?ID=475
www.rsna.org/Publications/rsnanews/oct05/digitalmammography.cfm
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Appendix 5 Papers excluded at full review
Citation Reason excluded
1. Absetz P, Aro AR, Sutton SR. Experience with breast cancer, pre-screening 
perceived susceptibility and the psychological impact of screening. Psychooncology 
2003;12:305–18.
Setting only
2. Andersen SB, Vejborg I, von Euler-Chelpin M. Participation behaviour following a 
false positive test in the Copenhagen mammography screening programme. Acta 
Oncol 2008;47:550–5.
Setting only
3. Andrykowski MA, Carpenter JS, Studts JL, Cordova MJ, Cunningham LLC, Beacham 
A, et al. Psychological impact of benign breast biopsy: a longitudinal, comparative 
study. Health Psychol 2002;21:485–94.
Setting only
4. Aro AR, Pilvikki Absetz S, van Elderen TM, van der Ploeg E, van der Kamp LJ. False-
positive findings in mammography screening induces short-term distress – breast 
cancer-specific concern prevails longer. Eur J Cancer 2000;36:1089–97.
Setting only
5. Austoker J. Screening and self examination for breast cancer. BMJ 1994;309:168–
74.
Design
6. Baines CJ, To T, Wall C. Women’s attitudes to screening after participation in the 
National Breast Screening Study. A questionnaire survey. Cancer 1990;65:1663–9.
Setting only
7. Barton MB, Moore S, Morley DS, Allen JD, Kleinman KP, Emmons KE, et al. 
Decreasing anxiety after false-positive mammograms: a controlled trial. J Gen Intern 
Med 2002;17:141.
Setting only
8. Barton MB, Morley DS, Moore S, Allen JD, Kleinman KP, Emmons KM, et al. 
Decreasing women’s anxieties after abnormal mammograms: a controlled trial. J 
Natl Cancer Inst 2004;96:529–38.
Setting only
9. Barton MB, Moore S, Polk S, Shtatland E, Elmore JG, Fletcher SW. Increased 
patient concern after false-positive mammograms – clinician documentation and 
subsequent ambulatory visits. J Gen Intern Med 2001;16:150–6.
Setting only
10. Baskinsmith J, Miaskowski C, Dibble SL, Weekes D, Nielsen BB. Perceptions of the 
mammography experience. Cancer Nurs 1995;18:47–52.
Setting, population
11. Bishop C, Fisher EB, Heckman BD, Merbaum M, Monsees B, Ristvedt S. Coping 
and anxiety in women recalled for additional diagnostic procedures following an 
abnormal screening mammogram. Health Psychol 2004;23:42–8.
Duplicate 
12. Boekema AG, Dornseiffen G, Mulder HJ, de Vos RA, Kluft-de Haas BA. Initial results 
with breast screening in the Enschede area. II. Efficiency. Ned Tijdschr Geneeskd 
1992;136:1761–4.
Language, population, 
setting
13. Brewer NT, Salz T, Lillie SE. Research digest: false-positive mammogram results may 
affect feelings, actions. Patient Care 2007;41:2.
Design
14. Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and 
long-term consequences of false-positive screening mammography. J Med Screen 
2004;11:39–44.
Design
15. Brown ML, Chiu Y, Currence B, Moore A, Earp J, Pisano ED. A telephone survey to 
determine the psychosocial effects of a false positive mammogram leading to a 
breast biopsy vs short-term follow-up mammography. Radiology 2002;225:369.
Setting, design
16. Burman ML, Taplin SH, Herta DF, Elmore JG. Effect of false-positive mammograms on 
interval breast cancer screening in a health maintenance organization. Ann Int Med 
1999;131:1–6.
Setting only
17. Byram SJ. Breast cancer and mammogram screening: mental models and 
quantitative assessments of beliefs. ProQuest Information & Learning; 1999.
Unobtainable thesis
18. Calnan MW, Moss S, Chamberlain J. Explaining attendance at a breast screening 
clinic. Patient Educ Couns 1985;7:87–96.
Population, length of 
follow up
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19. del Carmen C, Rodriguez A, Cruzado JA, Gonzalez A, Gonzalez MJ, Roa A. Anxiety, 
depression and quality of life in the course of mammography screening among 
women of the Madrid Region. Psicooncologia 2008;5:129–46.
Language, population, 
setting
20. Chiarelli AM, Moravan V, Halapy E, Majpruz V, Mai V, Tatla RK. False-positive 
result and reattendance in the Ontario Breast Screening Program. J Med Screen 
2003;10:129–33.
Setting only
21. Champion V. Development of a benefits and barriers scale for mammography 
utilization. Cancer Nurs 1995;18:53–9.
Population, outcomes, 
setting
22. Champion V, Huster G. Effect of interventions on stage of mammography adoption. 
J Behav Med 1995;18:169–87.
Intervention, 
population, outcomes, 
setting
23. Clutton S, Pakenham KI, Buckley B. Predictors of emotional well-being following a 
‘false-positive’ breast cancer screening result. Psychol Health 1999;14:263–75.
Setting only
24. Cockburn J, Staples M, Hurley SF, De Luise T. Psychological consequences of 
screening mammography. J Med Screen 1994;1:7–12.
Setting only
25. Currence BV, Pisano ED, Earp JA, Moore A, Chiu YF, Brown ME, et al. Does biopsy, 
aspiration or six-month follow-up of a false-positive mammogram reduce future 
screening or have large psychosocial effects? Acad Radiol 2003;10:1257.
Setting only
26. DeFrank JT, Brewer N. A model of the influence of false-positive mammography 
screening results on subsequent screening. Health Psychol Rev 2010;4:112–17.
Outcomes, setting, 
design
27. Ekeberg O, Skjauff H, Karesen R. Screening for breast cancer is associated with a low 
degree of psychological distress. Breast 2001;10:20–4.
Setting only
28. Eardley A, Elkind A. Breast screening among women aged 65 and over – what do 
they think of it? J Public Health Med 1991;13:172–7.
Population
29. Edwards Adrian GK, Evans R, Dundon J, Haigh S, Hood K, Elwyn Glyn J. Personalised 
risk communication for informed decision making about taking screening tests. In 
Cochrane Database of Systematic Reviews. Issue 4. Chichester: John Wiley & Sons, 
Ltd; 2006.
Intervention, 
population, 
comparator, outcomes
30. Elkind A, Eardley A. Consumer satisfaction with breast screening – a pilot study. J 
Public Health Med 1990;12:15–18.
Population
31. Fallowfield LJ, Rodway A, Baum M. What are the psychological factors influencing 
attendance, nonattendance and re-attendance at a breast screening center. J R Soc 
Med 1990;83:547–51.
Population
32. Ganott MA, Sumkin JH, King JL, Klym AH, Catullo VJ, Cohen CS, et al. Screening 
mammography: do women prefer a higher recall rate given the possibility of earlier 
detection of cancer? Radiology 2006;238:793–800.
Population, outcomes
33. Gibson CJ, Weiss J, Goodrich M, Onega T. False-positive mammography and 
depressed mood in a screening population: findings from the New Hampshire 
Mammography Network. J Pub Health 2009;31:554–60.
Setting only
34. Gilbert FJ, Cordiner CM, Affleck IR, Hood DB, Mathieson D, Walker LG. Breast 
screening: the psychological sequelae of false-positive recall in women with and 
without a family history of breast cancer. Eur J Cancer 1998;34:2010–14.
Population
35. Godby CJ, Peticolas A, Carter JM, Ghebrehewet S, Woloshin S, Schwartz L, et al. 
Women’s attitudes to false positive mammography results. 2000;321:1409–11.
Design
36. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. The 
Cochrane Collaboration. 2006;4.
Unobtainable
37. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane 
Database of Systematic Reviews 2009;4: 
Outcomes
38. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane 
Database of Systematic Reviews 2011;1. 
Outcomes
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39. Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. 
Br J Cancer 1990;62:1018–22.
Setting only
40. Gram IT, Slenker SE. Cancer anxiety and attitudes toward mammography among 
screening attenders, nonattenders, and women never invited. Am J Public Health 
1992;82:249–51.
Setting, length of 
follow-up
41. Haas J, Kaplan C, McMillan A, Esserman LJ. Does timely assessment affect the 
anxiety associated with an abnormal mammogram result? J Womens Health Gend 
Based Med 2001;10:599–605.
Population, outcomes, 
setting
42. Heckman BD, Fisher EB, Monsees B, Merbaum M, Ristvedt S, Bishop C. Coping 
and anxiety in women recalled for additional diagnostic procedures following an 
abnormal screening mammogram. Health Psychol 2004;23:42–8.
Setting only
43. Heckman BD. Psychosocial factors that promote adjustment among women 
recalled for a diagnostic assessment following a screening mammogram. ProQuest 
Information & Learning; 2001.
Unobtainable thesis
44. Hislop TG, Harris SR, Jackson J, Thorne SE, Rousseau EJ, Coldman AJ, et al. 
Satisfaction and anxiety for women during investigation of an abnormal screening 
mammogram. Breast Cancer Res Treat 2002;76:245–54.
Outcomes, population, 
setting
45. Hoekstra SA, Gentry D. Benefits of same day mammogram results. Am J Clin Oncol 
2009;32:552–3.
Setting, design, 
outcomes, population
46. Hofvind S, Thoresen S, Tretli S. The cumulative risk of a false-positive recall in the 
Norwegian Breast Cancer Screening Program. Cancer 2004;101:1501–7.
Setting only
47. Jatoi I, Zhu K, Shah M, Lawrence W. Psychological distress in U.S. women who have 
experienced false-positive mammograms. Breast Cancer Res Treat 2006;100:191–
200.
Setting only
48. Kahn BE, Luce MF. Repeated-adherence protection model: ‘I’m OK, and it’s a hassle’. 
J Public Policy Mark 2006;25:79–89.
Setting design
49. Lampic C, Thurfjell E, Bergh J, Sjoden PO. Short- and long-term anxiety and 
depression in women recalled after breast cancer screening. Eur J Cancer 
2001;37:463–9.
Setting only
50. Lampic C, Thurfjell E, Sjoden PO. The influence of a false-positive mammogram 
on a woman’s subsequent behaviour for detecting breast cancer. Eur J Cancer 
2003;39:1730–7.
Setting only
51. Lerman C, Ross E, Boyce A, Gorchov PM, McLaughlin R, Rimer B, et al. The impact of 
mailing psychoeducational materials to women with abnormal mammograms. Am J 
Public Health 1992;82:729–30.
Setting only
52. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological 
and behavioral implications of abnormal mammograms. Ann Intern Med 
1991;114:657–61.
Setting only
53. Lidbrink E, Levi L, Pettersson I, Rosendahl I, Rutqvist LE, Delatorre B, et al. Single-view 
screening mammography – psychological, endocrine and immunological effects of 
recalling for a complete 3-view examination. Eur J Cancer 1995;31A:932–3.
Setting only
54. Lipkus IM, Halabi S, Strigo TS, Rimer BK. The impact of abnormal mammograms on 
psychosocial outcomes and subsequent screening. Psychooncology 2000;9:402–10.
Setting only
55. Lowe JB, Balanda KP, Del Mar C, Hawes E. Psychologic distress in women with 
abnormal findings in mass mammography screening. Cancer 1999;85:1114–18.
Population, setting
56. Medical Advisory Secretariat. Screening mammography for women aged 40 to 
49 years at average risk for breast cancer: an evidence-based analysis. 2007. URL: 
www.health.gov.on.ca/english/providers/program/mas/mas_mn.html
Outcomes, setting, 
population
57. Miller EG, Luce MF, Kahn BE, Conant EF. Understanding emotional reactions for 
negative services: the impact of efficacy beliefs and stage in process. J Serv Res 
2009;12:87–99.
Population, setting
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58. Olsson P, Armelius K, Nordahl G, Lenner P, Westman G.Women with false positive 
screening mammograms: how do they cope?. J Med Screen 1999;6:89–93.
Setting only
59. Padgett DK, Yedidia MJ, Kerner J, Mandelblatt J. The emotional consequences of 
false positive mammography: African-American women’s reactions in their own 
words. Women Health 2001;33:1–14.
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60. Pinckney RG, Geller BM, Burman M, Littenberg B. Effect of false-positive 
mammograms on return for subsequent screening mammography. Am J Med 
2003;114:120–5.
Setting only
61. Pisano ED, Earp JA, Gallant TL. Screening mammography behavior after a false 
positive mammogram. Cancer Detect Prev 1998;22:161–7.
Setting only
62. Pisano ED, Earp J, Schell M, Vokaty K, Denham A. Screening behavior of women 
after a false-positive mammogram. Radiology 1998;208:245–9.
Setting only
63. Rimer BK, Keintz MK, Kessler HB, Engstrom PF, Rosan JR. Why women resist 
screening mammography – patient related barriers. Radiology 1989;172:243–6.
Population, setting
64. Scaf-Klomp W, Sanderman R, Van De Wiel HBM, Otter R, Van Den Heuvel WJA. 
Distressed or relieved? Psychological effects of participation in the population 
screening for breast cancer milder than expected. Ned Tijdschr Geneeskd 
1999;143:459–64.
Language, setting
65. Scaf-Klomp W, Sanderman R, van de Wiel HB, Otter R, van den Heuvel WJ. 
Distressed or relieved? Psychological side effects of breast cancer screening in The 
Netherlands. J Epidemiol Community 1997;51:705–10.
Setting only
66. Stewart KA, Neumann PJ, Fletcher SW, Barton MB. The effect of immediate reading 
of screening mammograms on medical care utilization and costs after false-positive 
mammograms. Health Serv Res 2007;42:1464–82.
Setting only
67. Stewart KA, Neumann PN, Fletcher SW, Barton MB. Impact on utilization and cost of 
an intervention to decrease anxiety after false-positive mammograms. J Gen Intern 
Med 2005;20:212.
Outcomes, setting, 
design
68. Tobias IS, Baum M. False positive findings of mammography will have psychological 
consequences. BMJ 1996;312:1227.
Outcomes, setting, 
design
69. van Wijngaarden DA. Distressed or relieved? Psychological sequelae of breast cancer 
screening in Netherlands. Ned Tijdschr Geneeskd 1999;143:873–4.
Language, setting
70. Wardle J, Pope R. The psychological costs of screening for cancer. J Psychosom Res 
1992;36:609–24.
Design
71. Zapka JG, Puleo E, Taplin SH, Goins KV, Ulcickas Yood M, et al. Processes of 
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